[{"entities":{"mentions":[{"start":3,"end":14,"username":"luca__pani","id":"2176193576"}],"urls":[{"start":111,"end":133,"url":"http://t.co/VzqeNBgsDW","expanded_url":"http://bit.ly/1x418U2","display_url":"bit.ly/1x418U2"}],"annotations":{},"hashtags":{}},"conversation_id":"529688265776193538","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @luca__pani: Work continues at the Strategic Presidency Meeting of the Committee on Herbal Products (HMPC): http://t.co/VzqeNBgsDW","id":"529688265776193538","possibly_sensitive":false,"created_at":"2014-11-04T17:34:58.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"WHO_Europe_VPI","id":"561122363"},{"start":125,"end":136,"username":"PATHtweets","id":"44763075"}],"urls":{},"annotations":[{"start":105,"end":113,"probability":0.3956,"type":"Place","normalized_text":"RotaFlash"}],"hashtags":[{"start":48,"end":58,"tag":"rotavirus"},{"start":59,"end":67,"tag":"vaccine"}]},"conversation_id":"529687806483128320","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO_Europe_VPI: News on acceleration of new #rotavirus #vaccine devt &amp; latest global introduction in RotaFlash alert @PATHtweets http:/…","id":"529687806483128320","possibly_sensitive":false,"created_at":"2014-11-04T17:33:08.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"529676818329374720"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":{},"annotations":[{"start":74,"end":79,"probability":0.9943,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":44,"end":51,"tag":"vector"}]},"conversation_id":"529687453297569792","source":"TweetDeck","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_EU: Epidemiology of emerging &amp; #vector-borne diseases: Trends in Europe. 1st chapter of 2014 Annual Epi report released: http://t.…","id":"529687453297569792","possibly_sensitive":false,"created_at":"2014-11-04T17:31:44.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"529676679963496448"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"WHO_Europe_VPI","id":"561122363"}],"urls":[{"start":115,"end":137,"url":"http://t.co/pw0P1uCVMa","expanded_url":"http://bit.ly/10iaRt1","display_url":"bit.ly/10iaRt1"}],"annotations":{},"hashtags":[{"start":20,"end":27,"tag":"Norway"},{"start":54,"end":64,"tag":"rotavirus"},{"start":65,"end":73,"tag":"vaccine"}]},"conversation_id":"529687419655061505","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO_Europe_VPI: #Norway 70th country to introduce #rotavirus #vaccine to protect children from severe diarrhea http://t.co/pw0P1uCVMa h…","id":"529687419655061505","possibly_sensitive":false,"created_at":"2014-11-04T17:31:36.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"529675751390724097"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"},{"start":31,"end":46,"username":"NatRevDrugDisc","id":"36066745"}],"urls":[{"start":85,"end":107,"url":"http://t.co/94D8OBmO2Y","expanded_url":"http://bit.ly/1Aby4xF","display_url":"bit.ly/1Aby4xF"}],"annotations":{},"hashtags":{}},"conversation_id":"529671364622688257","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IMI_JU: Special edition of @NatRevDrugDisc focuses on drug development consortia http://t.co/94D8OBmO2Y - Interesting stuff!","id":"529671364622688257","possibly_sensitive":false,"created_at":"2014-11-04T16:27:48.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"529670209259708416"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"urls":[{"start":115,"end":137,"url":"http://t.co/hMgGEUU8wW","expanded_url":"http://bit.ly/1qny0Bs","display_url":"bit.ly/1qny0Bs"}],"annotations":{},"hashtags":[{"start":93,"end":105,"tag":"domperidone"}]},"conversation_id":"529668347550765056","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"RT @ansm: The French medicines agency has published a summary of the October CMDh: after the #domperidone referral http://t.co/hMgGEUU8wW","id":"529668347550765056","possibly_sensitive":false,"created_at":"2014-11-04T16:15:49.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":81,"end":103,"url":"http://t.co/MFgheyUyFV","expanded_url":"http://bit.ly/1E1yGmb","display_url":"bit.ly/1E1yGmb"}],"annotations":{},"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":43,"end":54,"tag":"veterinary"}]},"conversation_id":"529658196089389056","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the #agenda of this week's #veterinary committee (CVMP) meeting: http://t.co/MFgheyUyFV","id":"529658196089389056","possibly_sensitive":false,"created_at":"2014-11-04T15:35:29.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"annotations":{},"hashtags":[{"start":25,"end":36,"tag":"journalist"},{"start":80,"end":90,"tag":"medicines"},{"start":91,"end":104,"tag":"publichealth"},{"start":109,"end":115,"tag":"media"}]},"conversation_id":"529654024010993664","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @edqm_news: Are you a #journalist? You have 2 weeks left to register for the #medicines #publichealth and #media workshop! http://t.co/U…","id":"529654024010993664","possibly_sensitive":false,"created_at":"2014-11-04T15:18:54.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"529648024902193152"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":75,"end":97,"url":"http://t.co/PGBaTXu4Ha","expanded_url":"http://bit.ly/1twggHo","display_url":"bit.ly/1twggHo"}],"annotations":{},"hashtags":{}},"conversation_id":"529639433180815360","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @LV_MPA: Patient leaflet on generic substitution now in eight languages http://t.co/PGBaTXu4Ha","id":"529639433180815360","possibly_sensitive":false,"created_at":"2014-11-04T14:20:55.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"urls":[{"start":66,"end":88,"url":"http://t.co/qMqzjq5qRm","expanded_url":"http://1.usa.gov/1ofOy2w","display_url":"1.usa.gov/1ofOy2w"}],"annotations":{},"hashtags":[{"start":21,"end":25,"tag":"FDA"}]},"conversation_id":"529638592889765888","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDAanimalhealth: #FDA Ensures Your Food from Animals are Safe http://t.co/qMqzjq5qRm","id":"529638592889765888","possibly_sensitive":false,"created_at":"2014-11-04T14:17:35.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"529635505894621184"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":82,"end":104,"url":"http://t.co/WmMKpzE1tJ","expanded_url":"http://bit.ly/1ztOi3R","display_url":"bit.ly/1ztOi3R"}],"annotations":{},"hashtags":{}},"conversation_id":"529623768269090816","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @AEMPSGOB: Triptych: The judicious use of anthelmintics in veterinary medicine http://t.co/WmMKpzE1tJ","id":"529623768269090816","possibly_sensitive":false,"created_at":"2014-11-04T13:18:40.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":105,"end":127,"url":"http://t.co/KG3On2gVL3","expanded_url":"http://bit.ly/18SjN71","display_url":"bit.ly/18SjN71"}],"annotations":{},"hashtags":[{"start":63,"end":81,"tag":"pharmacovigilance"},{"start":128,"end":140,"tag":"procurement"}]},"conversation_id":"529616441797279745","source":"Bitly","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've launched a tender for literature monitoring services for #pharmacovigilance. Apply by 12 December: http://t.co/KG3On2gVL3 #procurement","id":"529616441797279745","possibly_sensitive":false,"created_at":"2014-11-04T12:49:34.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":85,"end":107,"url":"http://t.co/RmuZOgJCm8","expanded_url":"http://bit.ly/1x0Qk7t","display_url":"bit.ly/1x0Qk7t"}],"annotations":{},"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":27,"end":45,"tag":"pharmacovigilance"}]},"conversation_id":"529604076099883008","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"The #agenda of this week's #pharmacovigilance committee (PRAC) meeting is available: http://t.co/RmuZOgJCm8","id":"529604076099883008","possibly_sensitive":false,"created_at":"2014-11-04T12:00:25.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":90,"end":112,"url":"http://t.co/iCxp3tc2td","expanded_url":"http://bit.ly/10oUXgE","display_url":"bit.ly/10oUXgE"},{"start":113,"end":135,"url":"http://t.co/VgX8F890CP","expanded_url":"http://bit.ly/1phEmrd","display_url":"bit.ly/1phEmrd"}],"annotations":{},"hashtags":{}},"conversation_id":"529603491770404864","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @URPLWMiPB: The Polish medicines agency has prepared forms to report an adverse event: http://t.co/iCxp3tc2td http://t.co/VgX8F890CP","id":"529603491770404864","possibly_sensitive":false,"created_at":"2014-11-04T11:58:06.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"}],"urls":{},"annotations":{},"hashtags":[{"start":24,"end":36,"tag":"antibiotics"},{"start":118,"end":123,"tag":"EAAD"}]},"conversation_id":"529594992332140544","source":"TweetDeck","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EAAD_EU: Never save #antibiotics for later use, take leftover antibiotics or share leftover antibiotics w/ others #EAAD","id":"529594992332140544","possibly_sensitive":false,"created_at":"2014-11-04T11:24:20.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"529559944195244033"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":107,"end":129,"url":"http://t.co/fp9Bih7XIu","expanded_url":"http://bit.ly/1ztDumt","display_url":"bit.ly/1ztDumt"}],"annotations":{},"hashtags":{}},"conversation_id":"529594917551869952","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"RT @GCessak: Information on the review of data on medicines containing polymyxin carried out by the EMA... http://t.co/fp9Bih7XIu","id":"529594917551869952","possibly_sensitive":false,"created_at":"2014-11-04T11:24:02.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"annotations":{},"hashtags":[{"start":15,"end":24,"tag":"european"},{"start":25,"end":39,"tag":"pharmacopoeia"},{"start":114,"end":120,"tag":"PhEur"}]},"conversation_id":"529594363668873216","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @edqm_news: #european #pharmacopoeia texts to be revised or elaborated: read the updated work programme of the #PhEur Commission: http:/…","id":"529594363668873216","possibly_sensitive":false,"created_at":"2014-11-04T11:21:50.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"529554364386791424"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":14,"username":"luca__pani","id":"2176193576"}],"urls":[{"start":118,"end":140,"url":"http://t.co/OjE4hVPbXu","expanded_url":"http://bit.ly/1ztD1kh","display_url":"bit.ly/1ztD1kh"}],"annotations":{},"hashtags":{}},"conversation_id":"529593500497883136","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"RT @luca__pani: Strategic Meeting on Herbal Medicinal Products: not to spread the incorrect idea that natural = safe! http://t.co/OjE4hVPbXu","id":"529593500497883136","possibly_sensitive":false,"created_at":"2014-11-04T11:18:24.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":99,"end":114,"username":"FilippaLentzos","id":"1294931262"}],"urls":{},"annotations":[{"start":117,"end":126,"probability":0.895,"type":"Person","normalized_text":"Simon Wain"},{"start":128,"end":133,"probability":0.5738,"type":"Person","normalized_text":"Hobson"}],"hashtags":[{"start":32,"end":37,"tag":"DURC"}]},"conversation_id":"529588258570002432","source":"TweetDeck","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_EU: Join 1st debate on #DURC \"Why engineer microbes to be more dangerous to humankind” w/ @FilippaLentzos &amp; Simon Wain-Hobson use …","id":"529588258570002432","possibly_sensitive":false,"created_at":"2014-11-04T10:57:34.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"529551637422309376"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":9,"username":"Fiddaman","id":"43524728"},{"start":10,"end":19,"username":"SanofiFR","id":"771517543"},{"start":20,"end":29,"username":"SanofiUS","id":"183033795"},{"start":30,"end":37,"username":"sanofi","id":"35846368"}],"urls":[{"start":114,"end":136,"url":"http://t.co/yvHeumjixX","expanded_url":"http://bit.ly/1phx7iX","display_url":"bit.ly/1phx7iX"}],"annotations":{},"hashtags":{}},"conversation_id":"529288896019185664","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"@Fiddaman @SanofiFR @SanofiUS @sanofi The issue was referred to us in October 2013 after publication of new data: http://t.co/yvHeumjixX","id":"529565849829801984","possibly_sensitive":false,"created_at":"2014-11-04T09:28:32.000Z","author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"529345886942674945"}],"in_reply_to_user_id":"43524728","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":{},"annotations":{},"hashtags":[{"start":44,"end":50,"tag":"Ebola"},{"start":78,"end":87,"tag":"vaccines"},{"start":94,"end":106,"tag":"diagnostics"}]},"conversation_id":"529320414171123712","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IMI_JU: IMI is preparing a programme on #Ebola - 1st Call topics to cover #vaccines &amp; #diagnostics. Read the Call summary: http://t.co/…","id":"529320414171123712","possibly_sensitive":false,"created_at":"2014-11-03T17:13:15.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"529319829350932480"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":93,"end":115,"url":"http://t.co/RmuZOgJCm8","expanded_url":"http://bit.ly/1x0Qk7t","display_url":"bit.ly/1x0Qk7t"}],"annotations":{},"hashtags":[{"start":25,"end":32,"tag":"agenda"},{"start":48,"end":66,"tag":"pharmacovigilance"}]},"conversation_id":"529316980474793984","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've just published the #agenda of this week's #pharmacovigilance committee (PRAC) meeting: http://t.co/RmuZOgJCm8","id":"529316980474793984","possibly_sensitive":false,"created_at":"2014-11-03T16:59:37.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"},{"start":42,"end":49,"username":"US_FDA","id":"208120290"}],"urls":[{"start":93,"end":115,"url":"http://t.co/Zx6CLTrScm","expanded_url":"http://www.medpagetoday.com/Psychiatry/Addictions/48358","display_url":"medpagetoday.com/Psychiatry/Add…"}],"annotations":{},"hashtags":{}},"conversation_id":"529314815811260416","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @DrugInfoAssn: No Clear Consensus from @US_FDA Meeting to Discuss Abuse-Deterrent Opioids http://t.co/Zx6CLTrScm","id":"529314815811260416","possibly_sensitive":false,"created_at":"2014-11-03T16:51:00.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"529302608335630337"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"},{"start":68,"end":84,"username":"FDAanimalhealth","id":"109290405"}],"urls":[{"start":115,"end":137,"url":"http://t.co/lE2DQLxwvt","expanded_url":"http://go.usa.gov/7pAV","display_url":"go.usa.gov/7pAV"}],"annotations":[{"start":12,"end":14,"probability":0.5759,"type":"Organization","normalized_text":"FDA"}],"hashtags":{}},"conversation_id":"529314092503531520","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @US_FDA: FDA Ensures Your Foods From Animals Are Safe, Thanks to @FDAanimalhealth Division of Residue Chemistry http://t.co/lE2DQLxwvt","id":"529314092503531520","possibly_sensitive":false,"created_at":"2014-11-03T16:48:08.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"529292593373646848"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"annotations":[{"start":123,"end":128,"probability":0.9684,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":34,"end":39,"tag":"EDQM"},{"start":69,"end":82,"tag":"publichealth"},{"start":101,"end":111,"tag":"Medicines"}]},"conversation_id":"529314026367778818","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @edqm_news: Still time to join #EDQM and FAHMP to discuss current #publichealth challenges, QC of #Medicines and API in Europe http://t.…","id":"529314026367778818","possibly_sensitive":false,"created_at":"2014-11-03T16:47:52.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"529292369037119488"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":9,"username":"Fiddaman","id":"43524728"},{"start":10,"end":19,"username":"SanofiFR","id":"771517543"},{"start":20,"end":29,"username":"SanofiUS","id":"183033795"},{"start":30,"end":37,"username":"sanofi","id":"35846368"}],"urls":[{"start":98,"end":120,"url":"http://t.co/aMvhc8nEvL","expanded_url":"http://bit.ly/1qmihSY","display_url":"bit.ly/1qmihSY"}],"annotations":{},"hashtags":{}},"conversation_id":"529288896019185664","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"@Fiddaman @SanofiFR @SanofiUS @sanofi See the latest information on our review of valproate here: http://t.co/aMvhc8nEvL","id":"529312451998023681","possibly_sensitive":false,"created_at":"2014-11-03T16:41:37.000Z","author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"529288896019185664"}],"in_reply_to_user_id":"43524728","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"urls":[{"start":34,"end":56,"url":"http://t.co/PZcr90g0JB","expanded_url":"http://www.efsa.europa.eu/en/efsajournal/pub/3877.htm","display_url":"efsa.europa.eu/en/efsajournal…"}],"annotations":{},"hashtags":[{"start":17,"end":22,"tag":"PEDV"},{"start":27,"end":33,"tag":"PDCoV"}]},"conversation_id":"529286430213046272","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"und","text":"RT @EFSAJournal: #PEDV and #PDCoV http://t.co/PZcr90g0JB","id":"529286430213046272","possibly_sensitive":false,"created_at":"2014-11-03T14:58:13.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"529286140441137154"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":84,"end":106,"url":"http://t.co/ahjigUIJov","expanded_url":"http://bit.ly/1q3O5Mk","display_url":"bit.ly/1q3O5Mk"}],"annotations":{},"hashtags":{}},"conversation_id":"529284248021499904","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Registration is open to attend the annual review of the year at EMA on 20 November: http://t.co/ahjigUIJov","id":"529284248021499904","possibly_sensitive":false,"created_at":"2014-11-03T14:49:33.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":97,"end":119,"url":"http://t.co/JzgUCwFcIN","expanded_url":"http://bit.ly/1xFCSpu","display_url":"bit.ly/1xFCSpu"}],"annotations":{},"hashtags":[{"start":4,"end":12,"tag":"minutes"}]},"conversation_id":"529284004558950400","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The #minutes of the September meeting of our committee for human medicines (CHMP) are available: http://t.co/JzgUCwFcIN","id":"529284004558950400","possibly_sensitive":false,"created_at":"2014-11-03T14:48:34.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"urls":[{"start":82,"end":104,"url":"http://t.co/GwelFElVau","expanded_url":"http://ht.ly/DJeVO","display_url":"ht.ly/DJeVO"},{"start":118,"end":140,"url":"http://t.co/UZuGfmUEbc","expanded_url":"http://ht.ly/DJeVP","display_url":"ht.ly/DJeVP"}],"annotations":[{"start":14,"end":16,"probability":0.8276,"type":"Organization","normalized_text":"FDA"}],"hashtags":{}},"conversation_id":"529282277084508161","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDA_MCMi: FDA's Risk Communication Advisory Committee meets Nov. 3-4. Agenda: http://t.co/GwelFElVau View online: http://t.co/UZuGfmUEbc","id":"529282277084508161","possibly_sensitive":false,"created_at":"2014-11-03T14:41:43.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"529273099548913665"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"EUnetHTA","id":"56493220"},{"start":114,"end":122,"username":"YouTube","id":"10228272"}],"urls":[{"start":87,"end":109,"url":"http://t.co/UcP8RvPwY0","expanded_url":"http://youtu.be/CAZx4e0lODM?a","display_url":"youtu.be/CAZx4e0lODM?a"}],"annotations":{},"hashtags":{}},"conversation_id":"529266299218956288","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EUnetHTA: \"Information Management Infrastructure and Services (EUnetHTA JA2WP6)\" : http://t.co/UcP8RvPwY0 via @YouTube","id":"529266299218956288","possibly_sensitive":false,"created_at":"2014-11-03T13:38:13.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"529265948125970432"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"EUnetHTA","id":"56493220"}],"urls":[{"start":70,"end":92,"url":"http://t.co/IPdtEdMJcF","expanded_url":"http://www.eunethta.eu/outputs/hta-20-europe-teaming-value-conference-presentations","display_url":"eunethta.eu/outputs/hta-20…"}],"annotations":[{"start":41,"end":46,"probability":0.5546,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":95,"end":107,"tag":"HTA2014Rome"}]},"conversation_id":"529265687790125056","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EUnetHTA: Presentations from HTA 2.0 Europe conference available: http://t.co/IPdtEdMJcF - #HTA2014Rome","id":"529265687790125056","possibly_sensitive":false,"created_at":"2014-11-03T13:35:47.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"529265590880722945"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"MHRApress","id":"330990243"}],"urls":[{"start":62,"end":84,"url":"http://t.co/wZeGT9DfEi","expanded_url":"http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON471139","display_url":"mhra.gov.uk/NewsCentre/Pre…"}],"annotations":[{"start":29,"end":44,"probability":0.6802,"type":"Person","normalized_text":"Sir Mike Rawlins"}],"hashtags":{}},"conversation_id":"529261555868004354","source":"TweetDeck","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @MHRApress: MHRA appoints Sir Mike Rawlins as new chairman http://t.co/wZeGT9DfEi","id":"529261555868004354","possibly_sensitive":false,"created_at":"2014-11-03T13:19:22.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"529261102090452993"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":69,"end":91,"url":"http://t.co/KdQl9jmaSn","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/10/news_detail_002204.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"annotations":{},"hashtags":{}},"conversation_id":"529239588402106368","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @GCessak: Revised framework for development of influenza vaccines http://t.co/KdQl9jmaSn","id":"529239588402106368","possibly_sensitive":false,"created_at":"2014-11-03T11:52:05.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"529235587593949184"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"urls":[{"start":105,"end":127,"url":"http://t.co/tg1noVC2cY","expanded_url":"http://ow.ly/DIy9S","display_url":"ow.ly/DIy9S"}],"annotations":[{"start":17,"end":19,"probability":0.4251,"type":"Organization","normalized_text":"EGA"}],"hashtags":{}},"conversation_id":"529213910998867969","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @egagenerics: EGA and EBG welcome a new milestone in the EU biosimilar medicines regulatory framework http://t.co/tg1noVC2cY #EGAbiosimi…","id":"529213910998867969","possibly_sensitive":false,"created_at":"2014-11-03T10:10:03.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"529213742761140224"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"}],"urls":{},"annotations":{},"hashtags":[{"start":13,"end":25,"tag":"Antibiotics"},{"start":126,"end":131,"tag":"EAAD"}]},"conversation_id":"529209078581850112","source":"TweetDeck","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EAAD_EU: #Antibiotics can only be prescribed by a doctor who has examined you. Never try to buy them without prescription #EAAD","id":"529209078581850112","possibly_sensitive":false,"created_at":"2014-11-03T09:50:51.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"529190657781665792"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":73,"end":95,"url":"http://t.co/yKVx9VvGlF","expanded_url":"http://bit.ly/1rmWXQU","display_url":"bit.ly/1rmWXQU"}],"annotations":{},"hashtags":[{"start":96,"end":108,"tag":"recruitment"}]},"conversation_id":"527875289775636480","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"One week left to apply to our vacancy for a Continuous Improvement Lead: http://t.co/yKVx9VvGlF #recruitment","id":"527875289775636480","possibly_sensitive":false,"created_at":"2014-10-30T17:30:51.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":90,"end":112,"url":"http://t.co/OxWQM0P37Q","expanded_url":"http://bit.ly/1xF2tio","display_url":"bit.ly/1xF2tio"}],"annotations":{},"hashtags":[{"start":4,"end":22,"tag":"pharmacovigilance"}]},"conversation_id":"527875236608622596","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Our #pharmacovigilance committee (PRAC) is meeting next week. Highlights out next Friday: http://t.co/OxWQM0P37Q","id":"527875236608622596","possibly_sensitive":false,"created_at":"2014-10-30T17:30:38.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":97,"end":119,"url":"http://t.co/NXtujHa2N8","expanded_url":"http://bit.ly/1wIDYlY","display_url":"bit.ly/1wIDYlY"}],"annotations":{},"hashtags":[{"start":18,"end":29,"tag":"veterinary"}]},"conversation_id":"527875183349366784","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Our committee for #veterinary medicines (CVMP) is meeting next week. Highlights out next Friday: http://t.co/NXtujHa2N8","id":"527875183349366784","possibly_sensitive":false,"created_at":"2014-10-30T17:30:25.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":96,"end":118,"url":"http://t.co/3sITZLwLuK","expanded_url":"http://bit.ly/13j7aW4","display_url":"bit.ly/13j7aW4"}],"annotations":{},"hashtags":[{"start":74,"end":84,"tag":"influenza"},{"start":85,"end":94,"tag":"vaccines"},{"start":119,"end":132,"tag":"consultation"}]},"conversation_id":"527875047130955776","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've issued a further module of our revised framework for development of #influenza #vaccines: http://t.co/3sITZLwLuK #consultation","id":"527875047130955776","possibly_sensitive":false,"created_at":"2014-10-30T17:29:53.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":95,"end":117,"url":"http://t.co/JzgUCwFcIN","expanded_url":"http://bit.ly/1xFCSpu","display_url":"bit.ly/1xFCSpu"}],"annotations":{},"hashtags":[{"start":20,"end":28,"tag":"minutes"}]},"conversation_id":"527874825562648576","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the #minutes of our committee for human medicines (CHMP) meeting in September: http://t.co/JzgUCwFcIN","id":"527874825562648576","possibly_sensitive":false,"created_at":"2014-10-30T17:29:00.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":104,"end":116,"username":"GRiPNetwork","id":"2166362149"}],"urls":[{"start":118,"end":140,"url":"http://t.co/3u2LquX1Rt","expanded_url":"http://bit.ly/104ihjP","display_url":"bit.ly/104ihjP"}],"annotations":{},"hashtags":{}},"conversation_id":"527869109518995456","source":"Bitly","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"EMA is involved in a new MSc programme in paediatric medicines development and evaluation, developed by @GRiPnetwork: http://t.co/3u2LquX1Rt","id":"527869109518995456","possibly_sensitive":false,"created_at":"2014-10-30T17:06:17.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"EUnetHTA","id":"56493220"}],"urls":{},"annotations":[{"start":111,"end":116,"probability":0.5943,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":118,"end":130,"tag":"HTA2014Rome"}]},"conversation_id":"527857335751159808","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EUnetHTA: EUnetHTA Recommendations on implementation of sustainable European network for HTA live! HTA 2.0 Europe #HTA2014Rome http://t…","id":"527857335751159808","possibly_sensitive":false,"created_at":"2014-10-30T16:19:30.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"527825113329438720"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EUTenders","id":"294046348"},{"start":93,"end":102,"username":"EU_Markt","id":"2815632681"}],"urls":[{"start":103,"end":125,"url":"http://t.co/jpu9Y7AEIl","expanded_url":"http://owl.li/ARsMU","display_url":"owl.li/ARsMU"}],"annotations":{},"hashtags":{}},"conversation_id":"527857175872700416","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EUTenders: Find out the new rules on public contracts and concessions in this leaflet by @EU_Markt http://t.co/jpu9Y7AEIl #PublicProcur…","id":"527857175872700416","possibly_sensitive":false,"created_at":"2014-10-30T16:18:52.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"527833007814877184"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":[{"start":106,"end":128,"url":"http://t.co/nZ3bNWWdhb","expanded_url":"http://bit.ly/1FYTdLR","display_url":"bit.ly/1FYTdLR"}],"annotations":{},"hashtags":{}},"conversation_id":"527857125138378752","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_ECHA: Check out the updated Community Rolling Action Plan for substance evaluation on our website. http://t.co/nZ3bNWWdhb","id":"527857125138378752","possibly_sensitive":false,"created_at":"2014-10-30T16:18:40.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"527835854312841216"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"my_ueg","id":"487344065"}],"urls":[{"start":116,"end":138,"url":"http://t.co/yxX8ngMBZi","expanded_url":"http://ueg.sagepub.com/content/2/1_suppl.toc","display_url":"ueg.sagepub.com/content/2/1_su…"}],"annotations":{},"hashtags":[{"start":23,"end":31,"tag":"UEGWeek"},{"start":74,"end":84,"tag":"Abstracts"}]},"conversation_id":"527857094494793728","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @my_ueg: Access all #UEGWeek abstracts including late breakers and Top #Abstracts in PubMed indexed UEG Journal: http://t.co/yxX8ngMBZi","id":"527857094494793728","possibly_sensitive":false,"created_at":"2014-10-30T16:18:33.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"527837396269023232"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"PrimaryCare4um","id":"164835748"},{"start":100,"end":106,"username":"irdes","id":"84332464"}],"urls":{},"annotations":{},"hashtags":[{"start":20,"end":25,"tag":"EFPC"},{"start":57,"end":69,"tag":"PrimaryCare"},{"start":92,"end":99,"tag":"France"}]},"conversation_id":"527856924088631296","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @PrimaryCare4um: #EFPC Newsflash 20 Multiprofessional #PrimaryCare &amp; remuneration in #France @irdes, behavior change &amp; health outcomes h…","id":"527856924088631296","possibly_sensitive":false,"created_at":"2014-10-30T16:17:52.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"527842309467955200"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"urls":{},"annotations":[{"start":51,"end":53,"probability":0.3427,"type":"Person","normalized_text":"TED"}],"hashtags":[{"start":110,"end":122,"tag":"raredisease"}]},"conversation_id":"527856877783498752","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @eurordis: What do we do with big data? Watch a TED talk on why we need to deepen critical thinking skills #raredisease  http://t.co/yRH…","id":"527856877783498752","possibly_sensitive":false,"created_at":"2014-10-30T16:17:41.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"527843692389085185"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"}],"urls":{},"annotations":{},"hashtags":[{"start":77,"end":88,"tag":"antibiotic"}]},"conversation_id":"527856824373248000","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EAAD_EU: Read stories of people whose lives were changed dramatically by #antibiotic-resistant bugs. Share your story: http://t.co/ddTo…","id":"527856824373248000","possibly_sensitive":false,"created_at":"2014-10-30T16:17:28.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"527845153118359553"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"urls":[{"start":118,"end":140,"url":"http://t.co/MGxuiyFSsw","expanded_url":"http://go.usa.gov/7Cwx","display_url":"go.usa.gov/7Cwx"}],"annotations":[{"start":34,"end":37,"probability":0.5718,"type":"Organization","normalized_text":"NCTR"},{"start":40,"end":42,"probability":0.9125,"type":"Organization","normalized_text":"FDA"}],"hashtags":{}},"conversation_id":"527856701660475393","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @US_FDA: Read the latest about NCTR, FDA’s internationally acclaimed research center, in their latest Newsletter … http://t.co/MGxuiyFSsw","id":"527856701660475393","possibly_sensitive":false,"created_at":"2014-10-30T16:16:59.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"527848896580812800"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"urls":{},"annotations":{},"hashtags":[{"start":14,"end":24,"tag":"Influenza"}]},"conversation_id":"527856661768466433","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_Flu: #Influenza vaccines are updated annually; taking the shot each year offers the best continued protection http://t.co/nPdrzQ7H…","id":"527856661768466433","possibly_sensitive":false,"created_at":"2014-10-30T16:16:49.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"527849577874202626"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":71,"end":93,"url":"http://t.co/ahjigUIJov","expanded_url":"http://bit.ly/1q3O5Mk","display_url":"bit.ly/1q3O5Mk"}],"annotations":{},"hashtags":{}},"conversation_id":"527856075962609664","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Register to attend our annual review of the year event on 20 November: http://t.co/ahjigUIJov","id":"527856075962609664","possibly_sensitive":false,"created_at":"2014-10-30T16:14:30.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":81,"end":103,"url":"http://t.co/8j3kJC8JD4","expanded_url":"http://bit.ly/1tmgGA7","display_url":"bit.ly/1tmgGA7"}],"annotations":{},"hashtags":[{"start":20,"end":28,"tag":"minutes"}]},"conversation_id":"527855590912299008","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the #minutes of our committee for orphan medicines in September: http://t.co/8j3kJC8JD4","id":"527855590912299008","possibly_sensitive":false,"created_at":"2014-10-30T16:12:34.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":98,"end":120,"url":"http://t.co/3sITZLwLuK","expanded_url":"http://bit.ly/13j7aW4","display_url":"bit.ly/13j7aW4"}],"annotations":{},"hashtags":[{"start":76,"end":86,"tag":"influenza"},{"start":87,"end":96,"tag":"vaccines"},{"start":121,"end":134,"tag":"consultation"}]},"conversation_id":"527777973995601920","source":"Bitly","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've released the final module of our revised framework for development of #influenza #vaccines: http://t.co/3sITZLwLuK #consultation","id":"527777973995601920","possibly_sensitive":false,"created_at":"2014-10-30T11:04:09.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":92,"end":114,"url":"http://t.co/NXtujHa2N8","expanded_url":"http://bit.ly/1wIDYlY","display_url":"bit.ly/1wIDYlY"}],"annotations":{},"hashtags":[{"start":18,"end":29,"tag":"veterinary"}]},"conversation_id":"527772228193353728","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Our committee for #veterinary medicines (CVMP) meets next week. Highlights out next Friday: http://t.co/NXtujHa2N8","id":"527772228193353728","possibly_sensitive":false,"created_at":"2014-10-30T10:41:19.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":85,"end":107,"url":"http://t.co/OxWQM0P37Q","expanded_url":"http://bit.ly/1xF2tio","display_url":"bit.ly/1xF2tio"}],"annotations":{},"hashtags":[{"start":4,"end":22,"tag":"pharmacovigilance"}]},"conversation_id":"527771934042644481","source":"Bitly","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Our #pharmacovigilance committee (PRAC) meets next week. Highlights out next Friday: http://t.co/OxWQM0P37Q","id":"527771934042644481","possibly_sensitive":false,"created_at":"2014-10-30T10:40:09.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":73,"end":95,"url":"http://t.co/yKVx9VvGlF","expanded_url":"http://bit.ly/1rmWXQU","display_url":"bit.ly/1rmWXQU"}],"annotations":{},"hashtags":[{"start":96,"end":108,"tag":"recruitment"}]},"conversation_id":"527771613358751745","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"One more week to apply to our vacancy for a Continuous Improvement Lead: http://t.co/yKVx9VvGlF #recruitment","id":"527771613358751745","possibly_sensitive":false,"created_at":"2014-10-30T10:38:52.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":107,"end":129,"url":"http://t.co/cGSaRGTOCx","expanded_url":"http://bit.ly/1zJAfZ4","display_url":"bit.ly/1zJAfZ4"}],"annotations":{},"hashtags":{}},"conversation_id":"527769503326019584","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We are closed tomorrow. An emergency hotline is available for potentially serious problems with medicines: http://t.co/cGSaRGTOCx","id":"527769503326019584","possibly_sensitive":false,"created_at":"2014-10-30T10:30:29.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":93,"end":115,"url":"http://t.co/NDHyNkuZ5L","expanded_url":"http://bit.ly/1yHUqT1","display_url":"bit.ly/1yHUqT1"}],"annotations":{},"hashtags":[{"start":23,"end":33,"tag":"guideline"},{"start":70,"end":81,"tag":"biosimilar"}]},"conversation_id":"527769233577771008","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":1,"like_count":2,"quote_count":0},"lang":"en","text":"We've issued a revised #guideline to facilitate global development of #biosimilar medicines: http://t.co/NDHyNkuZ5L","id":"527769233577771008","possibly_sensitive":false,"created_at":"2014-10-30T10:29:25.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":81,"end":103,"url":"http://t.co/PDVu7J2SIg","expanded_url":"http://bit.ly/1rzTryy","display_url":"bit.ly/1rzTryy"}],"annotations":{},"hashtags":[{"start":65,"end":71,"tag":"Ebola"}]},"conversation_id":"527769109153726464","source":"TweetDeck","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"We've given rapid scientific advice on a development plan for an #Ebola vaccine: http://t.co/PDVu7J2SIg","id":"527769109153726464","possibly_sensitive":false,"created_at":"2014-10-30T10:28:55.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"annotations":{},"hashtags":[{"start":19,"end":24,"tag":"EDQM"}]},"conversation_id":"527498215810428928","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @edqm_news: The #EDQM is still looking for a Scientific Programme Officer in the framework of a Secondment. See all positions: http://t.…","id":"527498215810428928","possibly_sensitive":false,"created_at":"2014-10-29T16:32:29.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"527497779435032576"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"urls":[{"start":67,"end":89,"url":"http://t.co/8DGSnXE758","expanded_url":"http://ow.ly/Dwg55","display_url":"ow.ly/Dwg55"}],"annotations":{},"hashtags":[{"start":53,"end":66,"tag":"breastcancer"}]},"conversation_id":"527488605217128448","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @myESMO: Hormone therapy adherence in early-stage #breastcancer http://t.co/8DGSnXE758","id":"527488605217128448","possibly_sensitive":false,"created_at":"2014-10-29T15:54:18.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"527487332447166464"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":116,"end":138,"url":"http://t.co/EeWfyMms98","expanded_url":"http://goo.gl/QbTlLA","display_url":"goo.gl/QbTlLA"}],"annotations":[{"start":49,"end":57,"probability":0.3403,"type":"Organization","normalized_text":"Phase III"}],"hashtags":[{"start":112,"end":115,"tag":"TB"}]},"conversation_id":"527488525269479424","source":"TweetDeck","public_metrics":{"retweet_count":49,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: WHO strongly recommends acceleration of Phase III trials to inform future policy on delamanid drug for #TB http://t.co/EeWfyMms98","id":"527488525269479424","possibly_sensitive":false,"created_at":"2014-10-29T15:53:59.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"527486344994357251"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":79,"end":101,"url":"http://t.co/N9aWGiENay","expanded_url":"http://goo.gl/zvTjlR","display_url":"goo.gl/zvTjlR"}],"annotations":[{"start":62,"end":77,"probability":0.6149,"type":"Person","normalized_text":"Dr Bruce Aylward"}],"hashtags":[{"start":33,"end":39,"tag":"Ebola"}]},"conversation_id":"527488466939293696","source":"TweetDeck","public_metrics":{"retweet_count":53,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: Audio file from today's #Ebola press conference with Dr Bruce Aylward http://t.co/N9aWGiENay","id":"527488466939293696","possibly_sensitive":false,"created_at":"2014-10-29T15:53:45.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"527485457635217408"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":98,"end":120,"url":"http://t.co/EeWfyMms98","expanded_url":"http://goo.gl/QbTlLA","display_url":"goo.gl/QbTlLA"}],"annotations":{},"hashtags":[{"start":24,"end":27,"tag":"TB"}]},"conversation_id":"527488421401751552","source":"TweetDeck","public_metrics":{"retweet_count":41,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: Info about new #TB drug delamanid is limited. WHO is therefore issuing interim guidance: http://t.co/EeWfyMms98","id":"527488421401751552","possibly_sensitive":false,"created_at":"2014-10-29T15:53:34.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"527485267536384003"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":102,"end":124,"url":"http://t.co/EeWfyMms98","expanded_url":"http://goo.gl/QbTlLA","display_url":"goo.gl/QbTlLA"}],"annotations":{},"hashtags":[{"start":15,"end":18,"tag":"TB"}]},"conversation_id":"527488396193959936","source":"TweetDeck","public_metrics":{"retweet_count":171,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: A new #TB drug, delamanid, is now available and approved for treatment of adults with MDR-TB http://t.co/EeWfyMms98","id":"527488396193959936","possibly_sensitive":false,"created_at":"2014-10-29T15:53:28.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"527484279870083072"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":112,"end":134,"url":"http://t.co/cGSaRGTOCx","expanded_url":"http://bit.ly/1zJAfZ4","display_url":"bit.ly/1zJAfZ4"}],"annotations":{},"hashtags":{}},"conversation_id":"527478307189981185","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Our offices are closed on Friday. We have an emergency hotline for potentially serious problems with medicines: http://t.co/cGSaRGTOCx","id":"527478307189981185","possibly_sensitive":false,"created_at":"2014-10-29T15:13:23.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"urls":[{"start":85,"end":107,"url":"http://t.co/6qyuiOTkyt","expanded_url":"http://ow.ly/Dt08Z","display_url":"ow.ly/Dt08Z"}],"annotations":{},"hashtags":[{"start":108,"end":120,"tag":"RareDisease"}]},"conversation_id":"527477496099651584","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"ro","text":"RT @eurordis: New video series for primary doctors on Lymphangioleiomyomatosis (LAM) http://t.co/6qyuiOTkyt\n#RareDisease","id":"527477496099651584","possibly_sensitive":false,"created_at":"2014-10-29T15:10:09.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"527476290207887361"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":96,"end":118,"url":"http://t.co/NDHyNkuZ5L","expanded_url":"http://bit.ly/1yHUqT1","display_url":"bit.ly/1yHUqT1"}],"annotations":{},"hashtags":[{"start":26,"end":36,"tag":"guideline"},{"start":73,"end":84,"tag":"biosimilar"}]},"conversation_id":"527469338203541505","source":"Bitly","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've published a revised #guideline to facilitate global development of #biosimilar medicines: http://t.co/NDHyNkuZ5L","id":"527469338203541505","possibly_sensitive":false,"created_at":"2014-10-29T14:37:44.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":91,"end":113,"url":"http://t.co/PDVu7J2SIg","expanded_url":"http://bit.ly/1rzTryy","display_url":"bit.ly/1rzTryy"}],"annotations":{},"hashtags":[{"start":75,"end":81,"tag":"Ebola"}]},"conversation_id":"527462354146295808","source":"Bitly","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"We've given our first rapid scientific advice on a development plan for an #Ebola vaccine: http://t.co/PDVu7J2SIg","id":"527462354146295808","possibly_sensitive":false,"created_at":"2014-10-29T14:09:59.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"urls":[{"start":115,"end":137,"url":"http://t.co/0Kncs63QlE","expanded_url":"http://ow.ly/Dsu87","display_url":"ow.ly/Dsu87"}],"annotations":{},"hashtags":[{"start":81,"end":93,"tag":"raredisease"}]},"conversation_id":"527458304172515328","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @eurordis: Applications open for ExPRESS 2015, the EURORDIS Summer School for #raredisease patient empowerment! http://t.co/0Kncs63QlE","id":"527458304172515328","possibly_sensitive":false,"created_at":"2014-10-29T13:53:54.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"527457442104610816"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":{},"annotations":{},"hashtags":[{"start":21,"end":39,"tag":"ResearchHeadlines"},{"start":85,"end":93,"tag":"Cancers"}]},"conversation_id":"527454457072984064","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @innovationunion: #ResearchHeadlines - New tests aim to detect breast and ovarian #Cancers earlier: The EU-funded project EPIFEMCARE… ht…","id":"527454457072984064","possibly_sensitive":false,"created_at":"2014-10-29T13:38:36.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"527451667654922240"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"urls":[{"start":114,"end":136,"url":"http://t.co/uIQW5yBOmt","expanded_url":"http://go.usa.gov/7qQh","display_url":"go.usa.gov/7qQh"}],"annotations":[{"start":35,"end":54,"probability":0.3045,"type":"Organization","normalized_text":"Commissioner Hamburg"},{"start":59,"end":61,"probability":0.8228,"type":"Organization","normalized_text":"FDA"}],"hashtags":[{"start":14,"end":23,"tag":"FDAVoice"},{"start":107,"end":113,"tag":"Ebola"}]},"conversation_id":"527448296714141696","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDA_MCMi: #FDAVoice: Hear from Commissioner Hamburg on FDA as part of a coordinated global response on #Ebola http://t.co/uIQW5yBOmt","id":"527448296714141696","possibly_sensitive":false,"created_at":"2014-10-29T13:14:08.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"527442140205690880"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"},{"start":37,"end":51,"username":"NICESciAdvice","id":"2834291205"}],"urls":{},"annotations":{},"hashtags":{}},"conversation_id":"527430409660162048","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @NICEcomms: Follow our colleagues @NICESciAdvice who provide fee-for-service advice to pharmaceutical companies and device manufacturers","id":"527430409660162048","possibly_sensitive":false,"created_at":"2014-10-29T12:03:03.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"527428397094678528"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":17,"username":"FDADeviceInfo","id":"140427956"}],"urls":[{"start":74,"end":96,"url":"http://t.co/4eHux5e2kG","expanded_url":"http://1.usa.gov/1thoF1i","display_url":"1.usa.gov/1thoF1i"}],"annotations":[{"start":19,"end":21,"probability":0.8511,"type":"Organization","normalized_text":"FDA"}],"hashtags":[{"start":67,"end":73,"tag":"Ebola"},{"start":97,"end":101,"tag":"fda"},{"start":102,"end":116,"tag":"medicaldevice"}]},"conversation_id":"527416407391469569","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDADeviceInfo: FDA as part of a coordinated global response on #Ebola http://t.co/4eHux5e2kG #fda #medicaldevice","id":"527416407391469569","possibly_sensitive":false,"created_at":"2014-10-29T11:07:25.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"527415102031794177"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":98,"end":120,"url":"http://t.co/CRrucwr4jE","expanded_url":"http://bit.ly/1te9zK4","display_url":"bit.ly/1te9zK4"}],"annotations":{},"hashtags":[{"start":13,"end":21,"tag":"Accofil"},{"start":23,"end":34,"tag":"filgrastim"},{"start":56,"end":68,"tag":"neutropenia"}]},"conversation_id":"527400823664676864","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The EPAR for #Accofil (#filgrastim), a medicine used in #neutropenia is available on our website: http://t.co/CRrucwr4jE","id":"527400823664676864","possibly_sensitive":false,"created_at":"2014-10-29T10:05:29.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":93,"end":115,"url":"http://t.co/ZlrazWFfts","expanded_url":"http://bit.ly/1wDl7Xw","display_url":"bit.ly/1wDl7Xw"}],"annotations":{},"hashtags":[{"start":117,"end":129,"tag":"recruitment"}]},"conversation_id":"527397007259074561","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We're looking to recruit a Scientific Officer to contribute to our Scientific Advice Office: http://t.co/ZlrazWFfts  #recruitment","id":"527397007259074561","possibly_sensitive":false,"created_at":"2014-10-29T09:50:19.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":104,"end":126,"url":"http://t.co/kxY5FGrwok","expanded_url":"http://bit.ly/1wyeGGe","display_url":"bit.ly/1wyeGGe"}],"annotations":{},"hashtags":[{"start":127,"end":139,"tag":"recruitment"}]},"conversation_id":"527396398426501120","source":"Twitter Web Client","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"We're looking to recruit a Health Communication Expert for our Stakeholders and Communication Division: http://t.co/kxY5FGrwok #recruitment","id":"527396398426501120","possibly_sensitive":false,"created_at":"2014-10-29T09:47:54.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":93,"end":115,"url":"http://t.co/nENzIqBHcA","expanded_url":"http://bit.ly/1FSmo39","display_url":"bit.ly/1FSmo39"}],"annotations":{},"hashtags":[{"start":117,"end":129,"tag":"recruitment"}]},"conversation_id":"527394794063273984","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We're looking to recruit an Information Security and Identity and Access Management Officer: http://t.co/nENzIqBHcA  #recruitment","id":"527394794063273984","possibly_sensitive":false,"created_at":"2014-10-29T09:41:32.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":61,"end":83,"url":"http://t.co/hzhc1r31KA","expanded_url":"http://bit.ly/1DpscgD","display_url":"bit.ly/1DpscgD"}],"annotations":{},"hashtags":[{"start":85,"end":97,"tag":"recruitment"}]},"conversation_id":"527393442637557760","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We're looking to recruit an Information and Content Manager: http://t.co/hzhc1r31KA  #recruitment","id":"527393442637557760","possibly_sensitive":false,"created_at":"2014-10-29T09:36:09.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":105,"end":127,"url":"http://t.co/gSXzxFf552","expanded_url":"http://bit.ly/ZVRNkn","display_url":"bit.ly/ZVRNkn"}],"annotations":{},"hashtags":[{"start":128,"end":140,"tag":"recruitment"}]},"conversation_id":"527392930848604161","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"We're looking for Scientific Officers to work in our Procedure Management and Business Support Division: http://t.co/gSXzxFf552 #recruitment","id":"527392930848604161","possibly_sensitive":false,"created_at":"2014-10-29T09:34:07.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"urls":[{"start":94,"end":116,"url":"http://t.co/LKzsnJfh0M","expanded_url":"http://ow.ly/DcYZL","display_url":"ow.ly/DcYZL"}],"annotations":[{"start":82,"end":92,"probability":0.4183,"type":"Place","normalized_text":"Rome, Italy"}],"hashtags":[{"start":55,"end":67,"tag":"RareDisease"}]},"conversation_id":"527392194190376961","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @eurordis: E-Rare Symposium (Research Programmes on #RareDisease): 30 October, Rome, Italy http://t.co/LKzsnJfh0M","id":"527392194190376961","possibly_sensitive":false,"created_at":"2014-10-29T09:31:12.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"527380646336163840"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":118,"end":140,"url":"http://t.co/TCgSLZeWO3","expanded_url":"http://bit.ly/101iG6i","display_url":"bit.ly/101iG6i"}],"annotations":{},"hashtags":{}},"conversation_id":"527391115683848192","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Aifa_ufficiale: EU presidency: the Italian medicines agency hosts the CHMP, CAT and COMP Joint Presidency Meeting\nhttp://t.co/TCgSLZeWO3","id":"527391115683848192","possibly_sensitive":false,"created_at":"2014-10-29T09:26:55.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/U4BLpLJH4F","expanded_url":"http://bit.ly/1wanHXb","display_url":"bit.ly/1wanHXb"}],"annotations":{},"hashtags":[{"start":93,"end":104,"tag":"veterinary"},{"start":105,"end":114,"tag":"medicine"}]},"conversation_id":"527168223545131008","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Comment on guidance on the assessment of persistent, bioaccumulative and toxic substances in #veterinary #medicine: http://t.co/U4BLpLJH4F","id":"527168223545131008","possibly_sensitive":false,"created_at":"2014-10-28T18:41:13.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":99,"end":121,"url":"http://t.co/CRrucwr4jE","expanded_url":"http://bit.ly/1te9zK4","display_url":"bit.ly/1te9zK4"}],"annotations":{},"hashtags":[{"start":42,"end":50,"tag":"Accofil"},{"start":52,"end":63,"tag":"filgrastim"},{"start":85,"end":97,"tag":"neutropenia"}]},"conversation_id":"527167904782225409","source":"Bitly","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the assessment report for #Accofil (#filgrastim), a medicine used in #neutropenia: http://t.co/CRrucwr4jE","id":"527167904782225409","possibly_sensitive":false,"created_at":"2014-10-28T18:39:57.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"FDAWomen","id":"65416742"}],"urls":[{"start":82,"end":104,"url":"http://t.co/9vH4qGu3Xy","expanded_url":"http://ow.ly/DtpHr","display_url":"ow.ly/DtpHr"},{"start":105,"end":127,"url":"http://t.co/l32PbeSiYB","expanded_url":"http://ow.ly/i/7nuw8","display_url":"ow.ly/i/7nuw8"}],"annotations":{},"hashtags":{}},"conversation_id":"527139643595448320","source":"TweetDeck","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDAWomen: Mixing medications and dietary supplements can endanger your health http://t.co/9vH4qGu3Xy http://t.co/l32PbeSiYB","id":"527139643595448320","possibly_sensitive":false,"created_at":"2014-10-28T16:47:39.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"527137709174042624"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"annotations":{},"hashtags":[{"start":33,"end":39,"tag":"PhEur"},{"start":81,"end":91,"tag":"bacterial"},{"start":92,"end":103,"tag":"endotoxins"}]},"conversation_id":"527077954799800321","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @edqm_news: In June 2014, the #PhEur Commission recommended two approaches to #bacterial #endotoxins. Read the new policy: http://t.co/8…","id":"527077954799800321","possibly_sensitive":false,"created_at":"2014-10-28T12:42:31.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"527037700168495104"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":14,"username":"IAPOtweets","id":"14682411"}],"urls":[{"start":78,"end":100,"url":"http://t.co/JxOjxsHvun","expanded_url":"http://iapo.org.uk/membership","display_url":"iapo.org.uk/membership"}],"annotations":{},"hashtags":{}},"conversation_id":"527077638352154625","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IAPOtweets: Interested in becoming an IAPO member? Want to find out more? http://t.co/JxOjxsHvun","id":"527077638352154625","possibly_sensitive":false,"created_at":"2014-10-28T12:41:16.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"527068587434213376"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":102,"end":124,"url":"http://t.co/ZlrazWFfts","expanded_url":"http://bit.ly/1wDl7Xw","display_url":"bit.ly/1wDl7Xw"}],"annotations":{},"hashtags":[{"start":125,"end":137,"tag":"recruitment"}]},"conversation_id":"527076811776466944","source":"Bitly","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We're recruiting a Scientific Officer to contribute to the operation of our Scientific Advice Office: http://t.co/ZlrazWFfts #recruitment","id":"527076811776466944","possibly_sensitive":false,"created_at":"2014-10-28T12:37:59.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":103,"end":125,"url":"http://t.co/kxY5FGrwok","expanded_url":"http://bit.ly/1wyeGGe","display_url":"bit.ly/1wyeGGe"}],"annotations":{},"hashtags":[{"start":126,"end":138,"tag":"recruitment"}]},"conversation_id":"527076343071404034","source":"Bitly","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We're recruiting a Health-communication expert to work in our Stakeholders and Communication Division: http://t.co/kxY5FGrwok #recruitment","id":"527076343071404034","possibly_sensitive":false,"created_at":"2014-10-28T12:36:07.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":85,"end":107,"url":"http://t.co/nENzIqBHcA","expanded_url":"http://bit.ly/1FSmo39","display_url":"bit.ly/1FSmo39"}],"annotations":{},"hashtags":[{"start":108,"end":120,"tag":"recruitment"}]},"conversation_id":"527075811254599680","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We're recruiting an Information Security and Identity and Access Management Officer: http://t.co/nENzIqBHcA #recruitment","id":"527075811254599680","possibly_sensitive":false,"created_at":"2014-10-28T12:34:00.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":53,"end":75,"url":"http://t.co/hzhc1r31KA","expanded_url":"http://bit.ly/1DpscgD","display_url":"bit.ly/1DpscgD"}],"annotations":{},"hashtags":[{"start":76,"end":88,"tag":"recruitment"}]},"conversation_id":"527074122309042176","source":"Bitly","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We're recruiting an Information and Content Manager: http://t.co/hzhc1r31KA #recruitment","id":"527074122309042176","possibly_sensitive":false,"created_at":"2014-10-28T12:27:17.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":104,"end":126,"url":"http://t.co/gSXzxFf552","expanded_url":"http://bit.ly/ZVRNkn","display_url":"bit.ly/ZVRNkn"}],"annotations":{},"hashtags":[{"start":127,"end":139,"tag":"recruitment"}]},"conversation_id":"527065641900326912","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We're recruiting Scientific Officers to work in our Procedure Management and Business Support Division: http://t.co/gSXzxFf552 #recruitment","id":"527065641900326912","possibly_sensitive":false,"created_at":"2014-10-28T11:53:36.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":118,"end":140,"url":"http://t.co/U4BLpLJH4F","expanded_url":"http://bit.ly/1wanHXb","display_url":"bit.ly/1wanHXb"}],"annotations":{},"hashtags":[{"start":95,"end":106,"tag":"veterinary"},{"start":107,"end":116,"tag":"medicine"}]},"conversation_id":"527064952532901888","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Comment on draft guidance on assessment of persistent, bioaccumulative and toxic substances in #veterinary #medicine: http://t.co/U4BLpLJH4F","id":"527064952532901888","possibly_sensitive":false,"created_at":"2014-10-28T11:50:51.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"urls":[{"start":93,"end":115,"url":"http://t.co/ffxcQRlwr9","expanded_url":"http://ow.ly/DpwH8","display_url":"ow.ly/DpwH8"}],"annotations":[{"start":12,"end":14,"probability":0.4342,"type":"Organization","normalized_text":"EMA"}],"hashtags":[{"start":73,"end":92,"tag":"gynaecologiccancer"}]},"conversation_id":"526782978161410048","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @myESMO: EMA recommends granting marketing authorisation for olaparib #gynaecologiccancer http://t.co/ffxcQRlwr9","id":"526782978161410048","possibly_sensitive":false,"created_at":"2014-10-27T17:10:23.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"526782458696855552"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"annotations":{},"hashtags":[{"start":19,"end":24,"tag":"EDQM"}]},"conversation_id":"526779339426525184","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @edqm_news: The #EDQM Standard Terms database has undergone major revision for greater flexibility. Read about the launch: http://t.co/X…","id":"526779339426525184","possibly_sensitive":false,"created_at":"2014-10-27T16:55:56.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"526778610733318144"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"urls":[{"start":85,"end":107,"url":"http://t.co/LbHKMMBY5z","expanded_url":"http://go.usa.gov/GHBz","display_url":"go.usa.gov/GHBz"}],"annotations":{},"hashtags":{}},"conversation_id":"526766144389390337","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDA_Drug_Info: Learn about challenges in neonatal research and drug development: http://t.co/LbHKMMBY5z","id":"526766144389390337","possibly_sensitive":false,"created_at":"2014-10-27T16:03:30.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"526764866464649217"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"Martinharvey100","id":"113148426"},{"start":21,"end":30,"username":"EMA_News","id":"116716199"}],"urls":{},"annotations":{},"hashtags":[{"start":45,"end":51,"tag":"Ebola"}]},"conversation_id":"526752006263033858","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Martinharvey100: @EMA_News publishes new #Ebola microsite on its actions since the outbreak, including R&amp;D support for new treatments  …","id":"526752006263033858","possibly_sensitive":false,"created_at":"2014-10-27T15:07:19.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"526750580136763392"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":19,"end":28,"username":"EMA_News","id":"116716199"}],"urls":{},"annotations":{},"hashtags":{}},"conversation_id":"526745855890833408","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EAHPtweet: The @EMA_News has reviewed safety&amp;effectiveness of products containing antibiotics colistin or colistimethate sodium http://…","id":"526745855890833408","possibly_sensitive":false,"created_at":"2014-10-27T14:42:53.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"526745250371358720"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"urls":{},"annotations":[{"start":15,"end":16,"probability":0.5192,"type":"Organization","normalized_text":"EU"}],"hashtags":{}},"conversation_id":"526743402264936448","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EAHPtweet: EU to boost Ebola research with €24.4 million funding for 5 projects including large scale clinical trial of vaccine http://…","id":"526743402264936448","possibly_sensitive":false,"created_at":"2014-10-27T14:33:08.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"526743262950727680"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":29,"end":38,"username":"EMA_News","id":"116716199"}],"urls":{},"annotations":{},"hashtags":{}},"conversation_id":"526741745233850368","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EAHPtweet: Last week the @EMA_News CHMP recommended 6 new medicines for approval including 2 for orphan conditions http://t.co/pGgIFN4L…","id":"526741745233850368","possibly_sensitive":false,"created_at":"2014-10-27T14:26:33.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"526741652895854592"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"urls":[{"start":101,"end":123,"url":"http://t.co/bC4iDIgy9v","expanded_url":"http://echo4.bluehornet.com/hostedemail/email.htm?CID=28259787330&ch=B519CE01120E3291691BEF45053446FE&h=e17ba255205a0f3318ff5ecbdee68cb1&ei=TDTbmrm0N","display_url":"echo4.bluehornet.com/hostedemail/em…"}],"annotations":{},"hashtags":{}},"conversation_id":"526741526324715520","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @DrugInfoAssn: Last Chance: How is the New Draft OASIS eTMF Standards Applied in Clinical Trials? http://t.co/bC4iDIgy9v","id":"526741526324715520","possibly_sensitive":false,"created_at":"2014-10-27T14:25:40.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"526740485730488321"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"annotations":{},"hashtags":[{"start":15,"end":31,"tag":"50thanniversary"},{"start":64,"end":69,"tag":"EDQM"}]},"conversation_id":"526741384003596288","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @edqm_news: #50thanniversary conference recommendations help #EDQM better understand issues and determine direction to take http://t.co/…","id":"526741384003596288","possibly_sensitive":false,"created_at":"2014-10-27T14:25:07.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"526740442982133760"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"},{"start":22,"end":26,"username":"WHO","id":"14499829"}],"urls":[{"start":93,"end":115,"url":"http://t.co/iFjMC1G6af","expanded_url":"http://apne.ws/1tZ3F2Z","display_url":"apne.ws/1tZ3F2Z"}],"annotations":{},"hashtags":[{"start":53,"end":59,"tag":"Ebola"},{"start":60,"end":69,"tag":"Vaccines"}]},"conversation_id":"526736014958923776","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @DrugInfoAssn: The @WHO Could Deploy Experimental #Ebola #Vaccines To “Millions” In 2015. http://t.co/iFjMC1G6af","id":"526736014958923776","possibly_sensitive":false,"created_at":"2014-10-27T14:03:46.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"526735435889139712"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"},{"start":101,"end":117,"username":"ECspokesScience","id":"613378164"}],"urls":[{"start":78,"end":100,"url":"http://t.co/xHPjfVF5Y9","expanded_url":"http://europa.eu/!Mt46gR","display_url":"europa.eu/!Mt46gR"}],"annotations":{},"hashtags":[{"start":19,"end":22,"tag":"EU"},{"start":118,"end":124,"tag":"H2020"}]},"conversation_id":"526735819558903808","source":"TweetDeck","public_metrics":{"retweet_count":22,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Commission: #EU breast cancer research targets personalised treatment: http://t.co/xHPjfVF5Y9 @ECSpokesScience #H2020","id":"526735819558903808","possibly_sensitive":false,"created_at":"2014-10-27T14:03:00.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"526733405229428736"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":98,"end":120,"url":"http://t.co/mb0NLHmaEc","expanded_url":"http://bit.ly/1ytRCss","display_url":"bit.ly/1ytRCss"}],"annotations":{},"hashtags":[{"start":65,"end":75,"tag":"medicines"}]},"conversation_id":"526717463086792704","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The highlights of last week's meeting of our committee for human #medicines (CHMP) are available: http://t.co/mb0NLHmaEc","id":"526717463086792704","possibly_sensitive":false,"created_at":"2014-10-27T12:50:03.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":86,"end":108,"url":"http://t.co/mOCFFGlaCc","expanded_url":"http://bit.ly/1DHTHnE","display_url":"bit.ly/1DHTHnE"}],"annotations":{},"hashtags":[{"start":42,"end":51,"tag":"Lynparza"},{"start":53,"end":62,"tag":"olaparib"},{"start":68,"end":76,"tag":"ovarian"},{"start":77,"end":84,"tag":"cancer"}]},"conversation_id":"526717209167806465","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":2,"quote_count":0},"lang":"en","text":"Last week we recommended authorisation of #Lynparza (#olaparib) for #ovarian #cancer: http://t.co/mOCFFGlaCc","id":"526717209167806465","possibly_sensitive":false,"created_at":"2014-10-27T12:49:03.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":117,"end":139,"url":"http://t.co/OskK1djUpB","expanded_url":"http://bit.ly/1vYCN1P","display_url":"bit.ly/1vYCN1P"}],"annotations":{},"hashtags":[{"start":42,"end":51,"tag":"Scenesse"},{"start":53,"end":67,"tag":"afamelanotide"}]},"conversation_id":"526717026031923200","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Last week we recommended authorisation of #Scenesse (#afamelanotide) for rare disease erythropoietic protoporphyria: http://t.co/OskK1djUpB","id":"526717026031923200","possibly_sensitive":false,"created_at":"2014-10-27T12:48:19.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":118,"end":140,"url":"http://t.co/XY5SCCz47s","expanded_url":"http://bit.ly/12q2BsA","display_url":"bit.ly/12q2BsA"}],"annotations":{},"hashtags":[{"start":33,"end":43,"tag":"polymyxin"},{"start":50,"end":60,"tag":"medicines"}]},"conversation_id":"526716736733970433","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've issued recommendations for #polymyxin-based #medicines in serious infections resistant to standard antibiotics: http://t.co/XY5SCCz47s","id":"526716736733970433","possibly_sensitive":false,"created_at":"2014-10-27T12:47:10.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/cMj9KmfpU5","expanded_url":"http://bit.ly/1rsOCHk","display_url":"bit.ly/1rsOCHk"}],"annotations":{},"hashtags":[{"start":93,"end":101,"tag":"Iclusig"},{"start":103,"end":113,"tag":"ponatinib"}]},"conversation_id":"526716148633841664","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":1,"quote_count":0},"lang":"en","text":"Last week we recommended further measures to minimise the risk of blood-vessel blockage with #Iclusig (#ponatinib): http://t.co/cMj9KmfpU5","id":"526716148633841664","possibly_sensitive":false,"created_at":"2014-10-27T12:44:50.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":67,"end":89,"url":"http://t.co/oWgGmQ8tjr","expanded_url":"http://bit.ly/1uQh0ox","display_url":"bit.ly/1uQh0ox"}],"annotations":{},"hashtags":{}},"conversation_id":"526715999169826816","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We're changing our scientific advice procedures as of 17 November: http://t.co/oWgGmQ8tjr","id":"526715999169826816","possibly_sensitive":false,"created_at":"2014-10-27T12:44:14.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":91,"end":113,"url":"http://t.co/O6BrVNbfPT","expanded_url":"http://bit.ly/ZQ7s4R","display_url":"bit.ly/ZQ7s4R"}],"annotations":{},"hashtags":{}},"conversation_id":"526715767212232705","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Companies: please try to submit quality type-I variations for 2014 by the end of November: http://t.co/O6BrVNbfPT","id":"526715767212232705","possibly_sensitive":false,"created_at":"2014-10-27T12:43:19.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":107,"end":129,"url":"http://t.co/EbY7jFCO9V","expanded_url":"http://bit.ly/10rEb1k","display_url":"bit.ly/10rEb1k"}],"annotations":{},"hashtags":[{"start":27,"end":36,"tag":"referral"},{"start":56,"end":68,"tag":"eSubmission"}]},"conversation_id":"526715510189486081","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Companies: please send all #referral procedures via our #eSubmission Gateway / Web Client from 1 November: http://t.co/EbY7jFCO9V","id":"526715510189486081","possibly_sensitive":false,"created_at":"2014-10-27T12:42:18.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":8,"username":"Eu2P","id":"420241833"},{"start":64,"end":73,"username":"EMA_News","id":"116716199"}],"urls":[{"start":75,"end":97,"url":"http://t.co/c7mjJz4bcy","expanded_url":"http://youtu.be/PFgXKjChUgQ","display_url":"youtu.be/PFgXKjChUgQ"}],"annotations":{},"hashtags":[{"start":32,"end":36,"tag":"ADR"},{"start":98,"end":113,"tag":"EudraVigilance"}]},"conversation_id":"526712136584921088","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Eu2P: \"Increasing access to #ADR reports on the Web\" by the @EMA_News  http://t.co/c7mjJz4bcy #EudraVigilance","id":"526712136584921088","possibly_sensitive":false,"created_at":"2014-10-27T12:28:53.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"526685715997143040"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":22,"end":28,"username":"EFPIA","id":"52084584"},{"start":35,"end":46,"username":"HCWHeurope","id":"282063958"}],"urls":[{"start":96,"end":118,"url":"http://t.co/4shw5EpW9C","expanded_url":"http://bit.ly/1wB4TA3","display_url":"bit.ly/1wB4TA3"}],"annotations":{},"hashtags":[{"start":119,"end":129,"tag":"PieDebate"}]},"conversation_id":"526711989373247488","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: PR ALERT - @EFPIA &amp; @HCWHeurope joint Press Release on pharma in the environment http://t.co/4shw5EpW9C #PieDebate","id":"526711989373247488","possibly_sensitive":false,"created_at":"2014-10-27T12:28:18.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"526682202504200192"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"urls":[{"start":59,"end":81,"url":"http://t.co/niyRs32dZy","expanded_url":"http://bit.ly/ZTat4h","display_url":"bit.ly/ZTat4h"}],"annotations":{},"hashtags":{}},"conversation_id":"526711652637765632","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @INFARMED_IP: Polymyxins - conclusion of safety review \nhttp://t.co/niyRs32dZy","id":"526711652637765632","possibly_sensitive":false,"created_at":"2014-10-27T12:26:58.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"urls":[{"start":44,"end":66,"url":"http://t.co/vj0pu1CR3W","expanded_url":"http://bit.ly/ZTaoh3","display_url":"bit.ly/ZTaoh3"}],"annotations":{},"hashtags":{}},"conversation_id":"526711300970545152","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"fr","text":"RT @INFARMED_IP: Iclusig - Recommendations \nhttp://t.co/vj0pu1CR3W","id":"526711300970545152","possibly_sensitive":false,"created_at":"2014-10-27T12:25:34.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":{},"annotations":{},"hashtags":[{"start":21,"end":39,"tag":"ResearchHeadlines"},{"start":74,"end":81,"tag":"Cancer"}]},"conversation_id":"526709886877728768","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @innovationunion: #ResearchHeadlines - New horizons in treating breast #Cancer: Today, in most developed countries, a woman’s chance… ht…","id":"526709886877728768","possibly_sensitive":false,"created_at":"2014-10-27T12:19:57.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"526656697641598976"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":[{"start":88,"end":110,"url":"http://t.co/3q3rBlsqYn","expanded_url":"http://echa.europa.eu/websurvey-2014","display_url":"echa.europa.eu/websurvey-2014"},{"start":111,"end":133,"url":"http://t.co/JV31bvq3TJ","expanded_url":"https://twitter.com/EU_ECHA/status/526656172741255170/photo/1","display_url":"pic.twitter.com/JV31bvq3TJ"}],"annotations":{},"hashtags":{}},"conversation_id":"526709614931628033","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_ECHA: Still time until 4 November to share your views with us about our website. http://t.co/3q3rBlsqYn http://t.co/JV31bvq3TJ","id":"526709614931628033","possibly_sensitive":false,"created_at":"2014-10-27T12:18:52.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"526656172741255170"}],"attachments":{"media_keys":["3_526656171071897600"]}},{"entities":{"mentions":{},"urls":[{"start":111,"end":133,"url":"http://t.co/TH8TzuQg8q","expanded_url":"http://bit.ly/1tzbzQb","display_url":"bit.ly/1tzbzQb"}],"annotations":{},"hashtags":[{"start":134,"end":139,"tag":"ATMP"}]},"conversation_id":"525684977347084289","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"One week left to comment on a draft reflection paper on classification of advanced-therapy medicinal products: http://t.co/TH8TzuQg8q #ATMP","id":"525684977347084289","possibly_sensitive":false,"created_at":"2014-10-24T16:27:20.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":106,"end":128,"url":"http://t.co/nuRMD5Yn4t","expanded_url":"http://bit.ly/1x0AfNJ","display_url":"bit.ly/1x0AfNJ"}],"annotations":{},"hashtags":[{"start":47,"end":63,"tag":"aminoglycosides"}]},"conversation_id":"525684945982062592","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"One week to comment on concept paper on use of #aminoglycosides in animals and development of resistance: http://t.co/nuRMD5Yn4t","id":"525684945982062592","possibly_sensitive":false,"created_at":"2014-10-24T16:27:12.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":118,"end":140,"url":"http://t.co/nTCexuC4Qz","expanded_url":"http://bit.ly/1jXr3sN","display_url":"bit.ly/1jXr3sN"}],"annotations":{},"hashtags":[{"start":55,"end":62,"tag":"herbal"},{"start":82,"end":92,"tag":"Juniperus"}]},"conversation_id":"525684918454870016","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"One week to answer call for scientific data for use in #herbal assessment work on #Juniperus communis L., summitates: http://t.co/nTCexuC4Qz","id":"525684918454870016","possibly_sensitive":false,"created_at":"2014-10-24T16:27:05.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":109,"end":131,"url":"http://t.co/uEx71U8H8k","expanded_url":"http://bit.ly/UvlSnX","display_url":"bit.ly/UvlSnX"}],"annotations":{},"hashtags":[{"start":55,"end":62,"tag":"herbal"},{"start":82,"end":91,"tag":"Gentiana"}]},"conversation_id":"525684892177543168","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"One week to answer call for scientific data for use in #herbal assessment work on #Gentiana lutea L., radix: http://t.co/uEx71U8H8k","id":"525684892177543168","possibly_sensitive":false,"created_at":"2014-10-24T16:26:59.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":117,"end":139,"url":"http://t.co/rrSKgeollE","expanded_url":"http://bit.ly/1z7YP2f","display_url":"bit.ly/1z7YP2f"}],"annotations":{},"hashtags":[{"start":55,"end":62,"tag":"herbal"},{"start":82,"end":93,"tag":"Centaurium"}]},"conversation_id":"525684862423154688","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"One week to answer call for scientific data for use in #herbal assessment work on #Centaurium erythraea Rafn, herba: http://t.co/rrSKgeollE","id":"525684862423154688","possibly_sensitive":false,"created_at":"2014-10-24T16:26:52.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":110,"end":132,"url":"http://t.co/HEtAoVcS7M","expanded_url":"http://bit.ly/1rd7FHe","display_url":"bit.ly/1rd7FHe"}],"annotations":{},"hashtags":[{"start":55,"end":62,"tag":"herbal"},{"start":82,"end":90,"tag":"Curcuma"}]},"conversation_id":"525684833000095744","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"One week to answer call for scientific data for use in #herbal assessment work on #Curcuma longa L., rhizoma: http://t.co/HEtAoVcS7M","id":"525684833000095744","possibly_sensitive":false,"created_at":"2014-10-24T16:26:45.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":112,"end":134,"url":"http://t.co/F3yd5yOllS","expanded_url":"http://bit.ly/1Absgle","display_url":"bit.ly/1Absgle"}],"annotations":{},"hashtags":[{"start":55,"end":62,"tag":"herbal"},{"start":82,"end":92,"tag":"Equisetum"}]},"conversation_id":"525684800192270336","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week to answer call for scientific data for use in #herbal assessment work on #Equisetum arvense L., herba: http://t.co/F3yd5yOllS","id":"525684800192270336","possibly_sensitive":false,"created_at":"2014-10-24T16:26:37.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":115,"end":137,"url":"http://t.co/nigo8HLsDP","expanded_url":"http://bit.ly/1x6QhFI","display_url":"bit.ly/1x6QhFI"}],"annotations":{},"hashtags":[{"start":55,"end":62,"tag":"herbal"},{"start":82,"end":92,"tag":"Artemisia"}]},"conversation_id":"525684765207564289","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week to answer call for scientific data for use in #herbal assessment work on #Artemisia absinthium L., herba: http://t.co/nigo8HLsDP","id":"525684765207564289","possibly_sensitive":false,"created_at":"2014-10-24T16:26:29.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":88,"end":110,"url":"http://t.co/CUbnW3zrIz","expanded_url":"http://bit.ly/UvpQNk","display_url":"bit.ly/UvpQNk"}],"annotations":{},"hashtags":[{"start":29,"end":36,"tag":"herbal"},{"start":50,"end":61,"tag":"Matricaria"}]},"conversation_id":"525684738980605952","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week to comment on draft #herbal monograph on #Matricaria recutita L., aetheroleum: http://t.co/CUbnW3zrIz","id":"525684738980605952","possibly_sensitive":false,"created_at":"2014-10-24T16:26:23.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":82,"end":104,"url":"http://t.co/DimgP5Wflm","expanded_url":"http://bit.ly/1kdZXy6","display_url":"bit.ly/1kdZXy6"}],"annotations":{},"hashtags":[{"start":29,"end":36,"tag":"herbal"},{"start":50,"end":61,"tag":"Matricaria"}]},"conversation_id":"525684707724644352","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week to comment on draft #herbal monograph on #Matricaria recutita L., flos:  http://t.co/DimgP5Wflm","id":"525684707724644352","possibly_sensitive":false,"created_at":"2014-10-24T16:26:15.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":112,"end":134,"url":"http://t.co/WtlVKSHAsF","expanded_url":"http://bit.ly/WPwMXL","display_url":"bit.ly/WPwMXL"}],"annotations":{},"hashtags":[{"start":50,"end":61,"tag":"cocrystals"}]},"conversation_id":"525684678158999552","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week to comment on reflection paper on use of #cocrystals and other solid-state forms of active substances: http://t.co/WtlVKSHAsF","id":"525684678158999552","possibly_sensitive":false,"created_at":"2014-10-24T16:26:08.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":90,"end":112,"url":"http://t.co/0K6ujODxaL","expanded_url":"http://bit.ly/1wgxQ4e","display_url":"bit.ly/1wgxQ4e"}],"annotations":{},"hashtags":[{"start":29,"end":36,"tag":"herbal"},{"start":50,"end":63,"tag":"Eschscholzia"}]},"conversation_id":"525684650589827073","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week to comment on draft #herbal monograph on #Eschscholzia californica Cham., herba: http://t.co/0K6ujODxaL","id":"525684650589827073","possibly_sensitive":false,"created_at":"2014-10-24T16:26:02.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":112,"end":134,"url":"http://t.co/06YJd2wH7a","expanded_url":"http://bit.ly/1AD26It","display_url":"bit.ly/1AD26It"}],"annotations":{},"hashtags":[{"start":29,"end":39,"tag":"guideline"},{"start":87,"end":94,"tag":"sodium"},{"start":105,"end":109,"tag":"18F"}]},"conversation_id":"525684624308310016","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"One week to comment on draft #guideline on core summary of product characteristics for #sodium fluoride (#18F): http://t.co/06YJd2wH7a","id":"525684624308310016","possibly_sensitive":false,"created_at":"2014-10-24T16:25:55.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":91,"end":113,"url":"http://t.co/THCyEobhVP","expanded_url":"http://bit.ly/1u2XwyG","display_url":"bit.ly/1u2XwyG"}],"annotations":{},"hashtags":[{"start":49,"end":60,"tag":"Picrorhiza"},{"start":114,"end":121,"tag":"herbal"}]},"conversation_id":"525684596781096960","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week to comment on draft public statement on #Picrorhiza kurroa Royle ex Benth, radix: http://t.co/THCyEobhVP #herbal","id":"525684596781096960","possibly_sensitive":false,"created_at":"2014-10-24T16:25:49.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":122,"end":144,"url":"http://t.co/qyYQI1PhXm","expanded_url":"http://bit.ly/1nRf8gh","display_url":"bit.ly/1nRf8gh"}],"annotations":{},"hashtags":[{"start":58,"end":65,"tag":"gluten"},{"start":96,"end":106,"tag":"guideline"}]},"conversation_id":"525684556394151936","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week to comment on Q&amp;A on wheat starch containing #gluten in the context of revision of #guideline on excipients: http://t.co/qyYQI1PhXm","id":"525684556394151936","possibly_sensitive":false,"created_at":"2014-10-24T16:25:39.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":110,"end":132,"url":"http://t.co/bFHbqHYYUY","expanded_url":"http://bit.ly/UQeunm","display_url":"bit.ly/UQeunm"}],"annotations":{},"hashtags":[{"start":40,"end":50,"tag":"guideline"},{"start":93,"end":108,"tag":"immunoglobulin"}]},"conversation_id":"525684528569151488","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week to comment on concept paper on #guideline on clinical investigation of human normal #immunoglobulin: http://t.co/bFHbqHYYUY","id":"525684528569151488","possibly_sensitive":false,"created_at":"2014-10-24T16:25:33.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":87,"end":109,"url":"http://t.co/6NBT0afyDm","expanded_url":"http://bit.ly/11B4qT7","display_url":"bit.ly/11B4qT7"}],"annotations":{},"hashtags":[{"start":34,"end":41,"tag":"herbal"},{"start":55,"end":65,"tag":"Hieracium"}]},"conversation_id":"525684481156739072","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One more week to comment on draft #herbal monograph on #Hieracium pilosella L., herba: http://t.co/6NBT0afyDm","id":"525684481156739072","possibly_sensitive":false,"created_at":"2014-10-24T16:25:21.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":114,"end":136,"url":"http://t.co/3rWsxM7P2L","expanded_url":"http://bit.ly/1mRpcY6","display_url":"bit.ly/1mRpcY6"}],"annotations":{},"hashtags":[{"start":29,"end":39,"tag":"guideline"},{"start":49,"end":56,"tag":"plasma"},{"start":81,"end":93,"tag":"coagulation"}]},"conversation_id":"525684418388975616","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"One week to comment on draft #guideline on human #plasma-derived and recombinant #coagulation factor-IX products: http://t.co/3rWsxM7P2L","id":"525684418388975616","possibly_sensitive":false,"created_at":"2014-10-24T16:25:06.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":108,"end":130,"url":"http://t.co/y0QF3ba7TS","expanded_url":"http://bit.ly/1sYX7A6","display_url":"bit.ly/1sYX7A6"}],"annotations":{},"hashtags":{}},"conversation_id":"525684375342841856","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"One week left to comment on draft functional specifications for the clinical trials EU portal and database: http://t.co/y0QF3ba7TS","id":"525684375342841856","possibly_sensitive":false,"created_at":"2014-10-24T16:24:56.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":74,"end":96,"url":"http://t.co/yKVx9VvGlF","expanded_url":"http://bit.ly/1rmWXQU","display_url":"bit.ly/1rmWXQU"}],"annotations":{},"hashtags":[{"start":97,"end":109,"tag":"recruitment"}]},"conversation_id":"525684270086778880","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two more weeks to apply to our vacancy for a Continuous Improvement Lead: http://t.co/yKVx9VvGlF #recruitment","id":"525684270086778880","possibly_sensitive":false,"created_at":"2014-10-24T16:24:31.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":99,"end":121,"url":"http://t.co/EbY7jFCO9V","expanded_url":"http://bit.ly/10rEb1k","display_url":"bit.ly/10rEb1k"}],"annotations":{},"hashtags":[{"start":48,"end":60,"tag":"eSubmission"}]},"conversation_id":"525684165371781120","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"All referral procedures need to be sent via our #eSubmission Gateway / Web Client from 1 November: http://t.co/EbY7jFCO9V","id":"525684165371781120","possibly_sensitive":false,"created_at":"2014-10-24T16:24:06.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":93,"end":115,"url":"http://t.co/O6BrVNbfPT","expanded_url":"http://bit.ly/ZQ7s4R","display_url":"bit.ly/ZQ7s4R"}],"annotations":{},"hashtags":{}},"conversation_id":"525683956214407168","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We're encouraging companies to submit quality type I variations for 2014 by end of November: http://t.co/O6BrVNbfPT","id":"525683956214407168","possibly_sensitive":false,"created_at":"2014-10-24T16:23:16.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":68,"end":90,"url":"http://t.co/oWgGmQ8tjr","expanded_url":"http://bit.ly/1uQh0ox","display_url":"bit.ly/1uQh0ox"}],"annotations":{},"hashtags":{}},"conversation_id":"525683801671094272","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Changes to our scientific advice procedures apply from 17 November: http://t.co/oWgGmQ8tjr","id":"525683801671094272","possibly_sensitive":false,"created_at":"2014-10-24T16:22:39.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":109,"end":131,"url":"http://t.co/cMj9KmfpU5","expanded_url":"http://bit.ly/1rsOCHk","display_url":"bit.ly/1rsOCHk"}],"annotations":{},"hashtags":[{"start":86,"end":94,"tag":"Iclusig"},{"start":96,"end":106,"tag":"ponatinib"}]},"conversation_id":"525642585822740481","source":"Bitly","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've recommended further measures to minimise the risk of blood vessel blockage with #Iclusig (#ponatinib): http://t.co/cMj9KmfpU5","id":"525642585822740481","possibly_sensitive":false,"created_at":"2014-10-24T13:38:53.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":57,"end":79,"url":"http://t.co/XY5SCCz47s","expanded_url":"http://bit.ly/12q2BsA","display_url":"bit.ly/12q2BsA"}],"annotations":{},"hashtags":[{"start":28,"end":38,"tag":"polymyxin"},{"start":45,"end":55,"tag":"medicines"}]},"conversation_id":"525642350421626880","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've completed a review of #polymyxin-based #medicines: http://t.co/XY5SCCz47s","id":"525642350421626880","possibly_sensitive":false,"created_at":"2014-10-24T13:37:56.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":99,"end":121,"url":"http://t.co/OskK1djUpB","expanded_url":"http://bit.ly/1vYCN1P","display_url":"bit.ly/1vYCN1P"}],"annotations":{},"hashtags":[{"start":18,"end":27,"tag":"Scenesse"},{"start":29,"end":43,"tag":"afamelanotide"},{"start":66,"end":81,"tag":"erythropoietic"},{"start":82,"end":97,"tag":"protoporphyria"}]},"conversation_id":"525642122436042755","source":"Bitly","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've recommended #Scenesse (#afamelanotide) for the rare disease #erythropoietic #protoporphyria: http://t.co/OskK1djUpB","id":"525642122436042755","possibly_sensitive":false,"created_at":"2014-10-24T13:37:02.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":74,"end":96,"url":"http://t.co/mOCFFGlaCc","expanded_url":"http://bit.ly/1DHTHnE","display_url":"bit.ly/1DHTHnE"}],"annotations":{},"hashtags":[{"start":18,"end":27,"tag":"Lynparza"},{"start":29,"end":38,"tag":"olaparib"},{"start":56,"end":64,"tag":"ovarian"},{"start":65,"end":72,"tag":"cancer"}]},"conversation_id":"525641495148523520","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've recommended #Lynparza (#olaparib) for approval in #ovarian #cancer: http://t.co/mOCFFGlaCc","id":"525641495148523520","possibly_sensitive":false,"created_at":"2014-10-24T13:34:33.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":100,"end":122,"url":"http://t.co/mb0NLHmaEc","expanded_url":"http://bit.ly/1ytRCss","display_url":"bit.ly/1ytRCss"}],"annotations":{},"hashtags":[{"start":81,"end":91,"tag":"medicines"}]},"conversation_id":"525641222715887616","source":"Bitly","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the highlights of this week's meeting of our committee for human #medicines (CHMP): http://t.co/mb0NLHmaEc","id":"525641222715887616","possibly_sensitive":false,"created_at":"2014-10-24T13:33:28.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":69,"end":91,"url":"http://t.co/yKVx9VvGlF","expanded_url":"http://bit.ly/1rmWXQU","display_url":"bit.ly/1rmWXQU"}],"annotations":{},"hashtags":[{"start":92,"end":104,"tag":"recruitment"}]},"conversation_id":"525570624245485568","source":"Bitly","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks to apply to our vacancy for a Continuous Improvement Lead: http://t.co/yKVx9VvGlF #recruitment","id":"525570624245485568","possibly_sensitive":false,"created_at":"2014-10-24T08:52:56.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":117,"end":139,"url":"http://t.co/y0QF3ba7TS","expanded_url":"http://bit.ly/1sYX7A6","display_url":"bit.ly/1sYX7A6"}],"annotations":{},"hashtags":{}},"conversation_id":"525570295730831360","source":"Bitly","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"One week to comment on draft functional specifications to be audited for the clinical trials EU portal and database: http://t.co/y0QF3ba7TS","id":"525570295730831360","possibly_sensitive":false,"created_at":"2014-10-24T08:51:37.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":114,"end":136,"url":"http://t.co/3rWsxM7P2L","expanded_url":"http://bit.ly/1mRpcY6","display_url":"bit.ly/1mRpcY6"}],"annotations":{},"hashtags":[{"start":29,"end":39,"tag":"guideline"},{"start":49,"end":56,"tag":"plasma"},{"start":81,"end":93,"tag":"coagulation"}]},"conversation_id":"525569983045468161","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"One week to comment on draft #guideline on human #plasma-derived and recombinant #coagulation factor-IX products: http://t.co/3rWsxM7P2L","id":"525569983045468161","possibly_sensitive":false,"created_at":"2014-10-24T08:50:23.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":82,"end":104,"url":"http://t.co/6NBT0afyDm","expanded_url":"http://bit.ly/11B4qT7","display_url":"bit.ly/11B4qT7"}],"annotations":{},"hashtags":[{"start":29,"end":36,"tag":"herbal"},{"start":50,"end":60,"tag":"Hieracium"}]},"conversation_id":"525569768372584448","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week to comment on draft #herbal monograph on #Hieracium pilosella L., herba: http://t.co/6NBT0afyDm","id":"525569768372584448","possibly_sensitive":false,"created_at":"2014-10-24T08:49:32.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":110,"end":132,"url":"http://t.co/bFHbqHYYUY","expanded_url":"http://bit.ly/UQeunm","display_url":"bit.ly/UQeunm"}],"annotations":{},"hashtags":[{"start":40,"end":50,"tag":"guideline"},{"start":93,"end":108,"tag":"immunoglobulin"}]},"conversation_id":"525569609630773248","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week to comment on concept paper on #guideline on clinical investigation of human normal #immunoglobulin: http://t.co/bFHbqHYYUY","id":"525569609630773248","possibly_sensitive":false,"created_at":"2014-10-24T08:48:54.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":122,"end":144,"url":"http://t.co/qyYQI1PhXm","expanded_url":"http://bit.ly/1nRf8gh","display_url":"bit.ly/1nRf8gh"}],"annotations":{},"hashtags":[{"start":58,"end":65,"tag":"gluten"},{"start":96,"end":106,"tag":"guideline"}]},"conversation_id":"525569245409984512","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week to comment on Q&amp;A on wheat starch containing #gluten in the context of revision of #guideline on excipients: http://t.co/qyYQI1PhXm","id":"525569245409984512","possibly_sensitive":false,"created_at":"2014-10-24T08:47:27.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":91,"end":113,"url":"http://t.co/THCyEobhVP","expanded_url":"http://bit.ly/1u2XwyG","display_url":"bit.ly/1u2XwyG"}],"annotations":{},"hashtags":[{"start":49,"end":60,"tag":"Picrorhiza"},{"start":114,"end":121,"tag":"herbal"}]},"conversation_id":"525568890974535683","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week to comment on draft public statement on #Picrorhiza kurroa Royle ex Benth, radix: http://t.co/THCyEobhVP #herbal","id":"525568890974535683","possibly_sensitive":false,"created_at":"2014-10-24T08:46:02.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":112,"end":134,"url":"http://t.co/06YJd2wH7a","expanded_url":"http://bit.ly/1AD26It","display_url":"bit.ly/1AD26It"}],"annotations":{},"hashtags":[{"start":29,"end":39,"tag":"guideline"},{"start":87,"end":94,"tag":"sodium"},{"start":105,"end":109,"tag":"18F"}]},"conversation_id":"525568719066775552","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week to comment on draft #guideline on core summary of product characteristics for #sodium fluoride (#18F): http://t.co/06YJd2wH7a","id":"525568719066775552","possibly_sensitive":false,"created_at":"2014-10-24T08:45:21.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":90,"end":112,"url":"http://t.co/0K6ujODxaL","expanded_url":"http://bit.ly/1wgxQ4e","display_url":"bit.ly/1wgxQ4e"}],"annotations":{},"hashtags":[{"start":29,"end":36,"tag":"herbal"},{"start":50,"end":63,"tag":"Eschscholzia"}]},"conversation_id":"525568505929031681","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week to comment on draft #herbal monograph on #Eschscholzia californica Cham., herba: http://t.co/0K6ujODxaL","id":"525568505929031681","possibly_sensitive":false,"created_at":"2014-10-24T08:44:31.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":112,"end":134,"url":"http://t.co/WtlVKSHAsF","expanded_url":"http://bit.ly/WPwMXL","display_url":"bit.ly/WPwMXL"}],"annotations":{},"hashtags":[{"start":50,"end":61,"tag":"cocrystals"}]},"conversation_id":"525568352597860352","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week to comment on reflection paper on use of #cocrystals and other solid-state forms of active substances: http://t.co/WtlVKSHAsF","id":"525568352597860352","possibly_sensitive":false,"created_at":"2014-10-24T08:43:54.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":82,"end":104,"url":"http://t.co/DimgP5Wflm","expanded_url":"http://bit.ly/1kdZXy6","display_url":"bit.ly/1kdZXy6"}],"annotations":{},"hashtags":[{"start":29,"end":36,"tag":"herbal"},{"start":50,"end":61,"tag":"Matricaria"}]},"conversation_id":"525568105503006720","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week to comment on draft #herbal monograph on #Matricaria recutita L., flos:  http://t.co/DimgP5Wflm","id":"525568105503006720","possibly_sensitive":false,"created_at":"2014-10-24T08:42:55.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":88,"end":110,"url":"http://t.co/CUbnW3zrIz","expanded_url":"http://bit.ly/UvpQNk","display_url":"bit.ly/UvpQNk"}],"annotations":{},"hashtags":[{"start":29,"end":36,"tag":"herbal"},{"start":50,"end":61,"tag":"Matricaria"}]},"conversation_id":"525567825721974784","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week to comment on draft #herbal monograph on #Matricaria recutita L., aetheroleum: http://t.co/CUbnW3zrIz","id":"525567825721974784","possibly_sensitive":false,"created_at":"2014-10-24T08:41:48.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":115,"end":137,"url":"http://t.co/nigo8HLsDP","expanded_url":"http://bit.ly/1x6QhFI","display_url":"bit.ly/1x6QhFI"}],"annotations":{},"hashtags":[{"start":55,"end":62,"tag":"herbal"},{"start":82,"end":92,"tag":"Artemisia"}]},"conversation_id":"525567618317815808","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week to answer call for scientific data for use in #herbal assessment work on #Artemisia absinthium L., herba: http://t.co/nigo8HLsDP","id":"525567618317815808","possibly_sensitive":false,"created_at":"2014-10-24T08:40:59.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":112,"end":134,"url":"http://t.co/F3yd5yOllS","expanded_url":"http://bit.ly/1Absgle","display_url":"bit.ly/1Absgle"}],"annotations":{},"hashtags":[{"start":55,"end":62,"tag":"herbal"},{"start":82,"end":92,"tag":"Equisetum"}]},"conversation_id":"525567439665631232","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week to answer call for scientific data for use in #herbal assessment work on #Equisetum arvense L., herba: http://t.co/F3yd5yOllS","id":"525567439665631232","possibly_sensitive":false,"created_at":"2014-10-24T08:40:16.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":110,"end":132,"url":"http://t.co/HEtAoVcS7M","expanded_url":"http://bit.ly/1rd7FHe","display_url":"bit.ly/1rd7FHe"}],"annotations":{},"hashtags":[{"start":55,"end":62,"tag":"herbal"},{"start":82,"end":90,"tag":"Curcuma"}]},"conversation_id":"525567278205927424","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week to answer call for scientific data for use in #herbal assessment work on #Curcuma longa L., rhizoma: http://t.co/HEtAoVcS7M","id":"525567278205927424","possibly_sensitive":false,"created_at":"2014-10-24T08:39:38.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":117,"end":139,"url":"http://t.co/rrSKgeollE","expanded_url":"http://bit.ly/1z7YP2f","display_url":"bit.ly/1z7YP2f"}],"annotations":{},"hashtags":[{"start":55,"end":62,"tag":"herbal"},{"start":82,"end":93,"tag":"Centaurium"}]},"conversation_id":"525567100795240448","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week to answer call for scientific data for use in #herbal assessment work on #Centaurium erythraea Rafn, herba: http://t.co/rrSKgeollE","id":"525567100795240448","possibly_sensitive":false,"created_at":"2014-10-24T08:38:56.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":109,"end":131,"url":"http://t.co/uEx71U8H8k","expanded_url":"http://bit.ly/UvlSnX","display_url":"bit.ly/UvlSnX"}],"annotations":{},"hashtags":[{"start":55,"end":62,"tag":"herbal"},{"start":82,"end":91,"tag":"Gentiana"}]},"conversation_id":"525566907853070337","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week to answer call for scientific data for use in #herbal assessment work on #Gentiana lutea L., radix: http://t.co/uEx71U8H8k","id":"525566907853070337","possibly_sensitive":false,"created_at":"2014-10-24T08:38:10.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":118,"end":140,"url":"http://t.co/nTCexuC4Qz","expanded_url":"http://bit.ly/1jXr3sN","display_url":"bit.ly/1jXr3sN"}],"annotations":{},"hashtags":[{"start":55,"end":62,"tag":"herbal"},{"start":82,"end":92,"tag":"Juniperus"}]},"conversation_id":"525566721940549632","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week to answer call for scientific data for use in #herbal assessment work on #Juniperus communis L., summitates: http://t.co/nTCexuC4Qz","id":"525566721940549632","possibly_sensitive":false,"created_at":"2014-10-24T08:37:25.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":106,"end":128,"url":"http://t.co/nuRMD5Yn4t","expanded_url":"http://bit.ly/1x0AfNJ","display_url":"bit.ly/1x0AfNJ"}],"annotations":{},"hashtags":[{"start":47,"end":63,"tag":"aminoglycosides"}]},"conversation_id":"525566424807636992","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"One week to comment on concept paper on use of #aminoglycosides in animals and development of resistance: http://t.co/nuRMD5Yn4t","id":"525566424807636992","possibly_sensitive":false,"created_at":"2014-10-24T08:36:14.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":111,"end":133,"url":"http://t.co/TH8TzuQg8q","expanded_url":"http://bit.ly/1tzbzQb","display_url":"bit.ly/1tzbzQb"}],"annotations":{},"hashtags":[{"start":134,"end":139,"tag":"ATMP"}]},"conversation_id":"525565982216290304","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week left to comment on a draft reflection paper on classification of advanced-therapy medicinal products: http://t.co/TH8TzuQg8q #ATMP","id":"525565982216290304","possibly_sensitive":false,"created_at":"2014-10-24T08:34:29.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":86,"end":108,"url":"http://t.co/2QhJUJk89X","expanded_url":"http://bit.ly/1sp7Wfb","display_url":"bit.ly/1sp7Wfb"}],"annotations":{},"hashtags":[{"start":72,"end":75,"tag":"IT"},{"start":109,"end":121,"tag":"recruitment"}]},"conversation_id":"525310193417347073","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"One day left to apply to our vacancy for an Enterprise Architect in our #IT Division: http://t.co/2QhJUJk89X #recruitment","id":"525310193417347073","possibly_sensitive":false,"created_at":"2014-10-23T15:38:04.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":15,"username":"CPME_EUROPA","id":"440810430"},{"start":47,"end":57,"username":"JunckerEU","id":"169426475"}],"urls":[{"start":114,"end":136,"url":"http://t.co/dC29wtoEI9","expanded_url":"http://bit.ly/1wo4yil","display_url":"bit.ly/1wo4yil"}],"annotations":{},"hashtags":[{"start":32,"end":46,"tag":"Pharma4health"},{"start":74,"end":81,"tag":"pharma"},{"start":96,"end":103,"tag":"health"}]},"conversation_id":"524972339361230848","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @CPME_EUROPA: Breaking news! #Pharma4health @JunckerEU decides to keep #pharma policy in the #health portfolio http://t.co/dC29wtoEI9","id":"524972339361230848","possibly_sensitive":false,"created_at":"2014-10-22T17:15:33.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524902409085399040"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"urls":[{"start":118,"end":140,"url":"http://t.co/tmJRSptCYC","expanded_url":"http://ht.ly/D3vQ9","display_url":"ht.ly/D3vQ9"}],"annotations":[{"start":14,"end":16,"probability":0.8853,"type":"Organization","normalized_text":"FDA"}],"hashtags":[{"start":99,"end":105,"tag":"Ebola"}]},"conversation_id":"524972215507644416","source":"TweetDeck","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDA_MCMi: FDA actively using orphan designation (+ other programs) to encourage development of #Ebola treatments. http://t.co/tmJRSptCYC","id":"524972215507644416","possibly_sensitive":false,"created_at":"2014-10-22T17:15:04.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524908716341342209"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":86,"end":108,"url":"http://t.co/zPY9wXvVAT","expanded_url":"http://bit.ly/1wjGopW","display_url":"bit.ly/1wjGopW"}],"annotations":{},"hashtags":[{"start":13,"end":25,"tag":"CallForData"},{"start":34,"end":41,"tag":"oxides"},{"start":46,"end":57,"tag":"hydroxides"}]},"conversation_id":"524971827391918080","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSA_EU: #CallForData on iron #oxides and #hydroxides (E 172) permitted in the EU http://t.co/zPY9wXvVAT","id":"524971827391918080","possibly_sensitive":false,"created_at":"2014-10-22T17:13:31.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524923136366882817"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"ESEndocrinology","id":"221055586"}],"urls":[{"start":113,"end":135,"url":"http://t.co/b1lf65CXyF","expanded_url":"http://dx.doi.org/10.1530/EJE-14-0254","display_url":"dx.doi.org/10.1530/EJE-14…"}],"annotations":{},"hashtags":[{"start":96,"end":112,"tag":"hyperthyroidism"}]},"conversation_id":"524971626782556161","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"fr","text":"RT @ESEndocrinology: Juliette Abeillon-du Payrat et al. investigate factors predicting neonatal #hyperthyroidism http://t.co/b1lf65CXyF","id":"524971626782556161","possibly_sensitive":false,"created_at":"2014-10-22T17:12:44.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524930233430835201"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":[{"start":117,"end":139,"url":"http://t.co/kGntfgE56x","expanded_url":"http://bit.ly/1txjVF7","display_url":"bit.ly/1txjVF7"}],"annotations":{},"hashtags":{}},"conversation_id":"524971476743888896","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @edqm_news: One day left to find our next Junior Laboratory Technician! Read the job description and apply today: http://t.co/kGntfgE56x…","id":"524971476743888896","possibly_sensitive":false,"created_at":"2014-10-22T17:12:08.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524936696606257152"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"myCORDIS","id":"818505470608572416"}],"urls":[{"start":59,"end":81,"url":"http://t.co/IGQDO52MFR","expanded_url":"http://cordis.europa.eu/result/rcn/148965_en.html","display_url":"cordis.europa.eu/result/rcn/148…"}],"annotations":{},"hashtags":[{"start":28,"end":38,"tag":"influenza"},{"start":39,"end":45,"tag":"virus"},{"start":82,"end":89,"tag":"ribfp7"}]},"conversation_id":"524971430237454336","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @myCORDIS: Understanding #influenza #virus transmission http://t.co/IGQDO52MFR #ribfp7","id":"524971430237454336","possibly_sensitive":false,"created_at":"2014-10-22T17:11:57.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524939718841339906"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"urls":[{"start":73,"end":95,"url":"http://t.co/BKx8KDkbHn","expanded_url":"http://us8.campaign-archive2.com/?u=7864f766b10b8edd18f19aa56&id=59ce8b4d76&e=bc4d5ec78c","display_url":"us8.campaign-archive2.com/?u=7864f766b10…"}],"annotations":{},"hashtags":{}},"conversation_id":"524971391763091456","source":"TweetDeck","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @NICEcomms: The October issue of our newsletter NICE News is out now: http://t.co/BKx8KDkbHn","id":"524971391763091456","possibly_sensitive":false,"created_at":"2014-10-22T17:11:47.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524941966170411010"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":14,"username":"IAPOtweets","id":"14682411"},{"start":49,"end":57,"username":"IHF_FIH","id":"1154042060"}],"urls":{},"annotations":{},"hashtags":{}},"conversation_id":"524971211269615617","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IAPOtweets: New resource! Joint journal with @IHF_FIH on patient engagement in hospitals, full of great case studies: http://t.co/Pbt2E…","id":"524971211269615617","possibly_sensitive":false,"created_at":"2014-10-22T17:11:04.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524948067716726784"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"annotations":{},"hashtags":{}},"conversation_id":"524923019966578689","source":"TweetDeck","public_metrics":{"retweet_count":29,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: Supplement that marks 20th anniversary of establishment of the Global Project on Anti-TB Drug Resistance Surveillance http://t.co/…","id":"524923019966578689","possibly_sensitive":false,"created_at":"2014-10-22T13:59:35.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524915856846094336"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":[{"start":104,"end":126,"url":"http://t.co/rt1gOg3nUK","expanded_url":"http://bit.ly/1nyZdoF","display_url":"bit.ly/1nyZdoF"}],"annotations":{},"hashtags":{}},"conversation_id":"524922900122701825","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_ECHA: New webpages for formulators launched with useful information to fulfil their obligations. http://t.co/rt1gOg3nUK http://t.co/…","id":"524922900122701825","possibly_sensitive":false,"created_at":"2014-10-22T13:59:06.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524920248391462913"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":94,"end":116,"url":"http://t.co/1sOyzdfRHP","expanded_url":"http://bit.ly/ZETfah","display_url":"bit.ly/ZETfah"}],"annotations":{},"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":36,"end":54,"tag":"pharmacovigilance"}]},"conversation_id":"524874574052458497","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"We've published the #minutes of our #pharmacovigilance committee (PRAC) meeting in September: http://t.co/1sOyzdfRHP","id":"524874574052458497","possibly_sensitive":false,"created_at":"2014-10-22T10:47:04.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":105,"end":127,"url":"http://t.co/1sOyzdfRHP","expanded_url":"http://bit.ly/ZETfah","display_url":"bit.ly/ZETfah"}],"annotations":{},"hashtags":[{"start":25,"end":33,"tag":"minutes"},{"start":68,"end":86,"tag":"pharmacovigilance"}]},"conversation_id":"524610142726524929","source":"Bitly","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"We've just published the #minutes from the September meeting of our #pharmacovigilance committee (PRAC): http://t.co/1sOyzdfRHP","id":"524610142726524929","possibly_sensitive":false,"created_at":"2014-10-21T17:16:19.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"annotations":{},"hashtags":[{"start":53,"end":56,"tag":"TB"}]},"conversation_id":"524594322885591040","source":"TweetDeck","public_metrics":{"retweet_count":92,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: Multidrug-resistant tuberculosis is form of #TB caused by bacteria that don't respond at least to the 2 most powerful standard ant…","id":"524594322885591040","possibly_sensitive":false,"created_at":"2014-10-21T16:13:27.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524587094086533120"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":{},"annotations":{},"hashtags":{}},"conversation_id":"524593735884353536","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_ECHA: Over 200 experts across the world participate in the scientific workshop on nanomaterials this week. Read more at: http://t.co…","id":"524593735884353536","possibly_sensitive":false,"created_at":"2014-10-21T16:11:07.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524578280792670208"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"},{"start":47,"end":60,"username":"sureclinical","id":"1210298131"}],"urls":[{"start":112,"end":134,"url":"http://t.co/5vgWkTfjZ0","expanded_url":"http://bit.ly/1t8pifW","display_url":"bit.ly/1t8pifW"}],"annotations":{},"hashtags":{}},"conversation_id":"524593161298264064","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @DrugInfoAssn: Join DIA in cooperation with @sureclinical 10/28 for a complementary webinar - sign up today! http://t.co/5vgWkTfjZ0 http…","id":"524593161298264064","possibly_sensitive":false,"created_at":"2014-10-21T16:08:50.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524571458924982272"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":{},"annotations":[{"start":120,"end":127,"probability":0.4874,"type":"Place","normalized_text":"Brussels"}],"hashtags":[{"start":35,"end":46,"tag":"Innovation"}]},"conversation_id":"524593109737693184","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @innovationunion: Fast Track to #Innovation Pilot (2015-2016) A Free Interactive Information Event - 9 January 2015, Brussels: This… htt…","id":"524593109737693184","possibly_sensitive":false,"created_at":"2014-10-21T16:08:38.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524570311266549760"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":92,"end":114,"url":"http://t.co/0gmOIwPFSC","expanded_url":"http://bit.ly/1yUHtYY","display_url":"bit.ly/1yUHtYY"}],"annotations":{},"hashtags":{}},"conversation_id":"524592673760768000","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSA_EU: Attend as an observer EFSA’s meeting on Biological Hazards. Register by 18 Nov http://t.co/0gmOIwPFSC","id":"524592673760768000","possibly_sensitive":false,"created_at":"2014-10-21T16:06:54.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524566585202057216"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":103,"end":125,"url":"http://t.co/yXTlfletbQ","expanded_url":"http://bit.ly/1uzRX9f","display_url":"bit.ly/1uzRX9f"}],"annotations":{},"hashtags":{}},"conversation_id":"524587821643071488","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @AEMPSGOB: Publication of the monthly bulletin from the Spanish medicines agency for September 2014 http://t.co/yXTlfletbQ","id":"524587821643071488","possibly_sensitive":false,"created_at":"2014-10-21T15:47:37.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":{},"annotations":{},"hashtags":[{"start":24,"end":32,"tag":"ESCAIDE"}]},"conversation_id":"524587305735315456","source":"TweetDeck","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_EU: 2 weeks to #ESCAIDE, register online by 27 Oct. This year: special sessions on Ebola &amp; on cross-border health threats http://t…","id":"524587305735315456","possibly_sensitive":false,"created_at":"2014-10-21T15:45:34.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524521747106643968"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":105,"end":127,"url":"http://t.co/rKTJg4ZcoF","expanded_url":"http://bit.ly/1yVbQ1g","display_url":"bit.ly/1yVbQ1g"}],"annotations":{},"hashtags":{}},"conversation_id":"524586997495898112","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @URPLWMiPB: Information on minimising the risk of blood-vessel obstruction in patients taking Iclusig http://t.co/rKTJg4ZcoF","id":"524586997495898112","possibly_sensitive":false,"created_at":"2014-10-21T15:44:21.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":103,"end":125,"url":"http://t.co/Z847oDDeEV","expanded_url":"http://bit.ly/1w2omLu","display_url":"bit.ly/1w2omLu"}],"annotations":{},"hashtags":[{"start":75,"end":89,"tag":"AIFAEditorial"}]},"conversation_id":"524552299960877056","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"RT @Aifa_ufficiale: Pharmaceutical challenges in an ultra-globalised world #AIFAEditorial by Luca Pani http://t.co/Z847oDDeEV","id":"524552299960877056","possibly_sensitive":false,"created_at":"2014-10-21T13:26:28.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"annotations":[{"start":9,"end":16,"probability":0.9089,"type":"Person","normalized_text":"Dr Kieny"},{"start":109,"end":114,"probability":0.9872,"type":"Place","normalized_text":"Africa"}],"hashtags":[{"start":49,"end":55,"tag":"Ebola"}]},"conversation_id":"524551430175457280","source":"TweetDeck","public_metrics":{"retweet_count":74,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: Dr Kieny: Clinical trials for candidate #Ebola vaccine safety in children will likely take place in Africa","id":"524551430175457280","possibly_sensitive":false,"created_at":"2014-10-21T13:23:01.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524512126074114048"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"annotations":[{"start":9,"end":16,"probability":0.914,"type":"Person","normalized_text":"Dr Kieny"}],"hashtags":[{"start":55,"end":61,"tag":"Ebola"}]},"conversation_id":"524551383635472384","source":"TweetDeck","public_metrics":{"retweet_count":59,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: Dr Kieny: Volunteers to the current candidate #Ebola vaccine clinical trials are healthy adults, 18-65 years old","id":"524551383635472384","possibly_sensitive":false,"created_at":"2014-10-21T13:22:50.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524511641179004928"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"annotations":[{"start":9,"end":16,"probability":0.9365,"type":"Person","normalized_text":"Dr Kieny"}],"hashtags":[{"start":79,"end":85,"tag":"Ebola"}]},"conversation_id":"524551343609217024","source":"TweetDeck","public_metrics":{"retweet_count":67,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: Dr Kieny: Normal development of a vaccine takes years. Development of #Ebola vaccines has been accelerated","id":"524551343609217024","possibly_sensitive":false,"created_at":"2014-10-21T13:22:40.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524511040537886720"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"annotations":[{"start":9,"end":16,"probability":0.9642,"type":"Person","normalized_text":"Dr Kieny"}],"hashtags":[{"start":34,"end":40,"tag":"Ebola"},{"start":44,"end":51,"tag":"taking"},{"start":66,"end":72,"tag":"Ebola"}]},"conversation_id":"524551107503480832","source":"TweetDeck","public_metrics":{"retweet_count":56,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: Dr Kieny: You cannot get #Ebola by #taking the candidate #Ebola vaccines","id":"524551107503480832","possibly_sensitive":false,"created_at":"2014-10-21T13:21:44.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524509509382078464"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"annotations":[{"start":9,"end":16,"probability":0.9095,"type":"Person","normalized_text":"Dr Kieny"},{"start":62,"end":69,"probability":0.9791,"type":"Place","normalized_text":"Lausanne"}],"hashtags":[{"start":44,"end":50,"tag":"Ebola"}]},"conversation_id":"524551087559553024","source":"TweetDeck","public_metrics":{"retweet_count":61,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: Dr Kieny: Volunteers for candidate #Ebola vaccine in Lausanne to receive 2 doses; in Geneva 5 doses [different candidate vaccines]","id":"524551087559553024","possibly_sensitive":false,"created_at":"2014-10-21T13:21:39.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524509030535159808"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"annotations":[{"start":9,"end":16,"probability":0.9243,"type":"Person","normalized_text":"Dr Kieny"},{"start":118,"end":128,"probability":0.9895,"type":"Place","normalized_text":"Switzerland"},{"start":131,"end":138,"probability":0.4805,"type":"Place","normalized_text":"Lausanne"}],"hashtags":[{"start":55,"end":61,"tag":"Ebola"}]},"conversation_id":"524551061840072704","source":"TweetDeck","public_metrics":{"retweet_count":88,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: Dr Kieny: Clinical trials from lead candidate #Ebola vaccines to involve abt 250 volunteers. Half of them in Switzerland (Lausanne…","id":"524551061840072704","possibly_sensitive":false,"created_at":"2014-10-21T13:21:33.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524508503537614848"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"annotations":[{"start":9,"end":16,"probability":0.8832,"type":"Person","normalized_text":"Dr Kieny"},{"start":96,"end":106,"probability":0.9544,"type":"Place","normalized_text":"West Africa"}],"hashtags":[{"start":19,"end":25,"tag":"Ebola"}]},"conversation_id":"524508118965702656","source":"TweetDeck","public_metrics":{"retweet_count":244,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: Dr Kieny: #Ebola vaccine [once clinical trials are completed] is expected to be use in West Africa early 2015","id":"524508118965702656","possibly_sensitive":false,"created_at":"2014-10-21T10:30:55.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524507331208683520"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"annotations":[{"start":9,"end":16,"probability":0.9423,"type":"Person","normalized_text":"Dr Kieny"}],"hashtags":[{"start":100,"end":106,"tag":"Ebola"}]},"conversation_id":"524508063764451328","source":"TweetDeck","public_metrics":{"retweet_count":29,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: Dr Kieny: People [live in the countries mentioned earlier] can volunteer for the candidate #Ebola vaccine clinical trials","id":"524508063764451328","possibly_sensitive":false,"created_at":"2014-10-21T10:30:41.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524506852361789440"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"annotations":[{"start":9,"end":16,"probability":0.9326,"type":"Person","normalized_text":"Dr Kieny"}],"hashtags":[{"start":51,"end":57,"tag":"Ebola"}]},"conversation_id":"524507573592936448","source":"TweetDeck","public_metrics":{"retweet_count":72,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: Dr Kieny: Initial data from the candidate #Ebola vaccine clinical trials are expected to be available in December","id":"524507573592936448","possibly_sensitive":false,"created_at":"2014-10-21T10:28:45.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524506010351042560"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"annotations":[{"start":9,"end":16,"probability":0.9314,"type":"Person","normalized_text":"Dr Kieny"}],"hashtags":[{"start":55,"end":61,"tag":"Ebola"}]},"conversation_id":"524507553888088064","source":"TweetDeck","public_metrics":{"retweet_count":49,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: Dr Kieny: What's important from the candidate #Ebola vaccine clinical trials are not only safety, but also to know the right dose …","id":"524507553888088064","possibly_sensitive":false,"created_at":"2014-10-21T10:28:40.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524505448708599808"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"annotations":[{"start":9,"end":16,"probability":0.9359,"type":"Person","normalized_text":"Dr Kieny"},{"start":94,"end":97,"probability":0.984,"type":"Place","normalized_text":"U.S."},{"start":105,"end":111,"probability":0.9929,"type":"Place","normalized_text":"Germany"},{"start":114,"end":124,"probability":0.9555,"type":"Place","normalized_text":"Switzerland"}],"hashtags":[{"start":32,"end":38,"tag":"Ebola"}]},"conversation_id":"524507436065886208","source":"TweetDeck","public_metrics":{"retweet_count":50,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: Dr Kieny: Another lead #Ebola vax - which was donated to WHO, clinical trials in the U.S., also Germany, Switzerland (Geneva), Gab…","id":"524507436065886208","possibly_sensitive":false,"created_at":"2014-10-21T10:28:12.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524503964042420224"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"annotations":[{"start":9,"end":16,"probability":0.95,"type":"Person","normalized_text":"Dr Kieny"},{"start":98,"end":101,"probability":0.9221,"type":"Place","normalized_text":"U.S."},{"start":104,"end":109,"probability":0.53,"type":"Place","normalized_text":"Oxford"},{"start":112,"end":115,"probability":0.5669,"type":"Place","normalized_text":"Mali"},{"start":121,"end":128,"probability":0.9162,"type":"Place","normalized_text":"Lausanne"}],"hashtags":[{"start":41,"end":47,"tag":"Ebola"}]},"conversation_id":"524507327898984448","source":"TweetDeck","public_metrics":{"retweet_count":113,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: Dr Kieny: One of lead candidate #Ebola vax is currently going thru clinical trial in the U.S., Oxford, Mali. In Lausanne, Switzerl…","id":"524507327898984448","possibly_sensitive":false,"created_at":"2014-10-21T10:27:46.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524503318778089472"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":114,"end":136,"url":"http://t.co/w5tQrEbNsy","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/10/news_detail_002190.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"annotations":[{"start":13,"end":15,"probability":0.6039,"type":"Organization","normalized_text":"EMA"}],"hashtags":[{"start":73,"end":79,"tag":"Ebola"}]},"conversation_id":"524507247183790080","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @GCessak: EMA encourages developers of treatments or vaccines against #Ebola to apply for orphan designation.  http://t.co/w5tQrEbNsy","id":"524507247183790080","possibly_sensitive":false,"created_at":"2014-10-21T10:27:27.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524502611505213440"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":94,"end":116,"url":"http://t.co/d1qvUmxlhk","expanded_url":"http://bit.ly/1wjBdWn","display_url":"bit.ly/1wjBdWn"}],"annotations":{},"hashtags":[{"start":14,"end":20,"tag":"Ebola"},{"start":73,"end":80,"tag":"orphan"}]},"conversation_id":"524499602297593856","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Developers of #Ebola treatments or vaccines should consider applying for #orphan designation: http://t.co/d1qvUmxlhk","id":"524499602297593856","possibly_sensitive":false,"created_at":"2014-10-21T09:57:04.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":121,"end":143,"url":"http://t.co/Yj4QTRvmAs","expanded_url":"http://bit.ly/1wr6W9P","display_url":"bit.ly/1wr6W9P"}],"annotations":{},"hashtags":[{"start":13,"end":22,"tag":"Versican"},{"start":61,"end":75,"tag":"parainfluenza"},{"start":77,"end":91,"tag":"leptospirosis"},{"start":98,"end":105,"tag":"rabies"}]},"conversation_id":"524499443383795712","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The EPAR for #Versican Plus Pi/L4R, a vaccine against canine #parainfluenza, #leptospirosis &amp; #rabies, is available: http://t.co/Yj4QTRvmAs","id":"524499443383795712","possibly_sensitive":false,"created_at":"2014-10-21T09:56:26.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":120,"end":142,"url":"http://t.co/Yj4QTRvmAs","expanded_url":"http://bit.ly/1wr6W9P","display_url":"bit.ly/1wr6W9P"}],"annotations":{},"hashtags":[{"start":13,"end":22,"tag":"Versican"},{"start":61,"end":75,"tag":"parainfluenza"},{"start":77,"end":91,"tag":"leptospirosis"},{"start":98,"end":105,"tag":"rabies"}]},"conversation_id":"524499181420154880","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The EPAR for #Versican Plus Pi/L4R, a vaccine against canine #parainfluenza, #leptospirosis &amp; #rabies is available: http://t.co/Yj4QTRvmAs","id":"524499181420154880","possibly_sensitive":false,"created_at":"2014-10-21T09:55:24.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":101,"end":123,"url":"http://t.co/u711RIOmcf","expanded_url":"http://bit.ly/1omiKJA","display_url":"bit.ly/1omiKJA"}],"annotations":{},"hashtags":[{"start":13,"end":22,"tag":"Versican"},{"start":34,"end":45,"tag":"veterinary"},{"start":71,"end":85,"tag":"leptospirosis"}]},"conversation_id":"524498982677282816","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"The EPAR for #Versican Plus L4, a #veterinary vaccine for dogs against #leptospirosis, is available: http://t.co/u711RIOmcf","id":"524498982677282816","possibly_sensitive":false,"created_at":"2014-10-21T09:54:36.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":82,"end":104,"url":"http://t.co/zXgnhE7g2C","expanded_url":"http://bit.ly/1CLhjp6","display_url":"bit.ly/1CLhjp6"}],"annotations":{},"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":33,"end":42,"tag":"medicine"}]},"conversation_id":"524498861843558400","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"The #agenda of this week's human #medicine committee (CHMP) meeting is available: http://t.co/zXgnhE7g2C","id":"524498861843558400","possibly_sensitive":false,"created_at":"2014-10-21T09:54:08.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":112,"end":134,"url":"http://t.co/G9Bspraq7F","expanded_url":"http://bit.ly/1yUck84","display_url":"bit.ly/1yUck84"}],"annotations":{},"hashtags":[{"start":45,"end":60,"tag":"nanotechnology"},{"start":71,"end":80,"tag":"zoonoses"}]},"conversation_id":"524498394522595328","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSA_EU: Networks for risk assessment of #nanotechnology &amp; for #zoonoses monitoring meet today.Agendas: http://t.co/G9Bspraq7F http://t…","id":"524498394522595328","possibly_sensitive":false,"created_at":"2014-10-21T09:52:16.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524497058586046464"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":8,"username":"Eu2P","id":"420241833"}],"urls":[{"start":77,"end":99,"url":"http://t.co/cc00rRFQii","expanded_url":"http://youtu.be/GOrE7Bf_PKQ","display_url":"youtu.be/GOrE7Bf_PKQ"}],"annotations":{},"hashtags":[{"start":52,"end":70,"tag":"Pharmacovigilance"},{"start":71,"end":76,"tag":"ISoP"}]},"conversation_id":"524498079945588736","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Eu2P: The story of the International Society of #Pharmacovigilance #ISoP http://t.co/cc00rRFQii","id":"524498079945588736","possibly_sensitive":false,"created_at":"2014-10-21T09:51:01.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524492377788907520"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"urls":{},"annotations":{},"hashtags":[{"start":47,"end":50,"tag":"EU"}]},"conversation_id":"524476931299737600","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @myESMO: Info. on suspected side effects of #EU nationally authorised medicines now available in 1 website maintained by EMA http://t.co…","id":"524476931299737600","possibly_sensitive":false,"created_at":"2014-10-21T08:26:59.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524476674281574400"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":49,"end":60,"username":"HCWHeurope","id":"282063958"}],"urls":{},"annotations":{},"hashtags":[{"start":112,"end":122,"tag":"PieDebate"}]},"conversation_id":"524475981998727168","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: Finding Solutions Together: EFPIA and @HCWHEurope Meet to Discuss Pharmaceuticals in the Environment #PieDebate http://t.co/I8HE…","id":"524475981998727168","possibly_sensitive":false,"created_at":"2014-10-21T08:23:13.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524475638821191680"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":64,"end":86,"url":"http://t.co/1rqxnOVu6A","expanded_url":"http://www.bbc.com/news/health-29700476","display_url":"bbc.com/news/health-29…"}],"annotations":[{"start":13,"end":20,"probability":0.8433,"type":"Organization","normalized_text":"BBC News"},{"start":38,"end":39,"probability":0.8457,"type":"Place","normalized_text":"UK"}],"hashtags":{}},"conversation_id":"524472739520724992","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @GCessak: BBC News | Ebola crisis: UK vaccine tests continue http://t.co/1rqxnOVu6A","id":"524472739520724992","possibly_sensitive":false,"created_at":"2014-10-21T08:10:20.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524465314822897664"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"myCORDIS","id":"818505470608572416"},{"start":92,"end":102,"username":"FP7MABSOT","id":"1417699849"}],"urls":[{"start":69,"end":91,"url":"http://t.co/DG9phvUaZp","expanded_url":"http://cordis.europa.eu/news/rcn/121899_en.html","display_url":"cordis.europa.eu/news/rcn/12189…"}],"annotations":{},"hashtags":[{"start":27,"end":38,"tag":"antibodies"},{"start":49,"end":55,"tag":"organ"},{"start":56,"end":68,"tag":"transplants"}]},"conversation_id":"524472437073657856","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @myCORDIS: Neutralising #antibodies for safer #organ #transplants http://t.co/DG9phvUaZp @FP7MABSOT","id":"524472437073657856","possibly_sensitive":false,"created_at":"2014-10-21T08:09:07.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524462913508356096"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"ESEndocrinology","id":"221055586"}],"urls":{},"annotations":{},"hashtags":[{"start":93,"end":101,"tag":"insulin"},{"start":119,"end":127,"tag":"obesity"}]},"conversation_id":"524257084561321984","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ESEndocrinology: EJE study evaluates role of glucocorticoid metabolism in development of #insulin resistance &amp; #obesity http://t.co/N0k…","id":"524257084561321984","possibly_sensitive":false,"created_at":"2014-10-20T17:53:23.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524204162527928320"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"urls":[{"start":71,"end":93,"url":"http://t.co/jWZVY4DMMu","expanded_url":"http://go.usa.gov/fsDT","display_url":"go.usa.gov/fsDT"}],"annotations":{},"hashtags":[{"start":55,"end":59,"tag":"CDC"},{"start":63,"end":69,"tag":"Ebola"}]},"conversation_id":"524256662756941824","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDACBER: Get the facts and latest updates from the #CDC on #Ebola. http://t.co/jWZVY4DMMu","id":"524256662756941824","possibly_sensitive":false,"created_at":"2014-10-20T17:51:43.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524254420700520449"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":9,"username":"BioRunUp","id":"102527566"}],"urls":[{"start":39,"end":61,"url":"http://t.co/zXgnhE7g2C","expanded_url":"http://bit.ly/1CLhjp6","display_url":"bit.ly/1CLhjp6"}],"annotations":{},"hashtags":{}},"conversation_id":"524208817132011520","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"@BioRunUp The agenda is now published: http://t.co/zXgnhE7g2C","id":"524213576282939392","possibly_sensitive":false,"created_at":"2014-10-20T15:00:30.000Z","author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"524208817132011520"}],"in_reply_to_user_id":"102527566","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":92,"end":114,"url":"http://t.co/zXgnhE7g2C","expanded_url":"http://bit.ly/1CLhjp6","display_url":"bit.ly/1CLhjp6"}],"annotations":{},"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":55,"end":65,"tag":"medicines"}]},"conversation_id":"524213462239834112","source":"Bitly","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've published the #agenda of our committee for human #medicines (CHMP) meeting this week: http://t.co/zXgnhE7g2C","id":"524213462239834112","possibly_sensitive":false,"created_at":"2014-10-20T15:00:03.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"myCORDIS","id":"818505470608572416"}],"urls":[{"start":88,"end":110,"url":"http://t.co/Q0boSd2gkD","expanded_url":"http://cordis.europa.eu/result/rcn/148931_en.html","display_url":"cordis.europa.eu/result/rcn/148…"}],"annotations":{},"hashtags":[{"start":20,"end":24,"tag":"bio"},{"start":36,"end":47,"tag":"diagnostic"},{"start":60,"end":67,"tag":"cancer"},{"start":72,"end":78,"tag":"brain"},{"start":111,"end":118,"tag":"ribfp7"}]},"conversation_id":"524194165500833792","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @myCORDIS: Novel #bio-analytical #diagnostic methods for #cancer and #brain diseases http://t.co/Q0boSd2gkD #ribfp7","id":"524194165500833792","possibly_sensitive":false,"created_at":"2014-10-20T13:43:22.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524154895461797889"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"urls":{},"annotations":{},"hashtags":[{"start":15,"end":25,"tag":"Alzheimer"},{"start":120,"end":133,"tag":"patientights"}]},"conversation_id":"524194017953595392","source":"TweetDeck","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: #Alzheimer report: early diagnosis progress, improving knowledge, sharing best practices &amp; promoting #patientights http://t.…","id":"524194017953595392","possibly_sensitive":false,"created_at":"2014-10-20T13:42:47.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524165551447228418"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"my_ueg","id":"487344065"}],"urls":[{"start":75,"end":97,"url":"http://t.co/O6ONRkeYd9","expanded_url":"http://bit.ly/1wr66Kf","display_url":"bit.ly/1wr66Kf"},{"start":98,"end":120,"url":"http://t.co/mF6BYNc9Oy","expanded_url":"http://ow.ly/i/7ht68","display_url":"ow.ly/i/7ht68"}],"annotations":{},"hashtags":{}},"conversation_id":"524193491140608000","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @my_ueg: What will European Healthcare be like in 2040? Cast your vote! http://t.co/O6ONRkeYd9 http://t.co/mF6BYNc9Oy","id":"524193491140608000","possibly_sensitive":false,"created_at":"2014-10-20T13:40:42.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524193343476359168"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"FDAcdrhIndustry","id":"66367559"}],"urls":[{"start":92,"end":114,"url":"http://t.co/IdTsfSbhtK","expanded_url":"http://1.usa.gov/1tELBek","display_url":"1.usa.gov/1tELBek"}],"annotations":{},"hashtags":[{"start":115,"end":119,"tag":"fda"},{"start":120,"end":134,"tag":"medicaldevice"}]},"conversation_id":"524193448291598336","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDAcdrhIndustry: eCopy Program for Medical Device Submissions - New Resources Available http://t.co/IdTsfSbhtK #fda #medicaldevice","id":"524193448291598336","possibly_sensitive":false,"created_at":"2014-10-20T13:40:31.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524193240489402368"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":120,"end":142,"url":"http://t.co/y1AzvQNgPD","expanded_url":"http://bit.ly/1wjCNaK","display_url":"bit.ly/1wjCNaK"}],"annotations":{},"hashtags":[{"start":29,"end":38,"tag":"Versican"}]},"conversation_id":"524190331047542784","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the EPAR for #Versican Plus Pi/L4, a vaccine for dogs against canine parainfluenza &amp; leptospirosis: http://t.co/y1AzvQNgPD","id":"524190331047542784","possibly_sensitive":false,"created_at":"2014-10-20T13:28:08.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":118,"end":140,"url":"http://t.co/Yj4QTRvmAs","expanded_url":"http://bit.ly/1wr6W9P","display_url":"bit.ly/1wr6W9P"}],"annotations":{},"hashtags":{}},"conversation_id":"524189871087575040","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the EPAR for Versican Plus Pi/L4R, a dog vaccine against canine parainfluenza, leptospirosis, rabies: http://t.co/Yj4QTRvmAs","id":"524189871087575040","possibly_sensitive":false,"created_at":"2014-10-20T13:26:18.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/u711RIOmcf","expanded_url":"http://bit.ly/1omiKJA","display_url":"bit.ly/1omiKJA"}],"annotations":{},"hashtags":[{"start":42,"end":51,"tag":"Versican"},{"start":63,"end":74,"tag":"veterinary"},{"start":100,"end":114,"tag":"leptospirosis"}]},"conversation_id":"524188630743810048","source":"Bitly","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the assessment report for #Versican Plus L4, a #veterinary vaccine for dogs against #leptospirosis: http://t.co/u711RIOmcf","id":"524188630743810048","possibly_sensitive":false,"created_at":"2014-10-20T13:21:23.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":96,"end":118,"url":"http://t.co/d1qvUmxlhk","expanded_url":"http://bit.ly/1wjBdWn","display_url":"bit.ly/1wjBdWn"}],"annotations":{},"hashtags":[{"start":32,"end":38,"tag":"Ebola"},{"start":75,"end":82,"tag":"orphan"}]},"conversation_id":"524188031230943233","source":"Bitly","public_metrics":{"retweet_count":11,"reply_count":2,"like_count":3,"quote_count":0},"lang":"en","text":"We're encouraging developers of #Ebola treatments or vaccines to apply for #orphan designation: http://t.co/d1qvUmxlhk","id":"524188031230943233","possibly_sensitive":false,"created_at":"2014-10-20T13:19:00.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":13,"username":"ActionTilson","id":"95037503"}],"urls":[{"start":67,"end":89,"url":"http://t.co/HyQjuzbxl5","expanded_url":"http://bit.ly/1wZtWe6","display_url":"bit.ly/1wZtWe6"}],"annotations":{},"hashtags":{}},"conversation_id":"523952245571072001","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"@ActionTilson Please see our website section on compassionate use: http://t.co/HyQjuzbxl5","id":"524115080317644801","possibly_sensitive":false,"created_at":"2014-10-20T08:29:07.000Z","author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"523952245571072001"}],"in_reply_to_user_id":"95037503","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"annotations":{},"hashtags":[{"start":36,"end":49,"tag":"publichealth"}]},"conversation_id":"524114460235939840","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @edqm_news: Role of the media in #publichealth: EDQM-FAHMP journalist workshop to discuss impact and approaches in communication http://…","id":"524114460235939840","possibly_sensitive":false,"created_at":"2014-10-20T08:26:39.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"524114163602558976"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"EURightsAgency","id":"217422465"}],"urls":{},"annotations":[{"start":36,"end":41,"probability":0.9725,"type":"Place","normalized_text":"Vienna"}],"hashtags":[{"start":44,"end":55,"tag":"EUagencies"},{"start":127,"end":130,"tag":"EU"}]},"conversation_id":"523133634279006209","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EURightsAgency: Panel debate in Vienna: #EUagencies play a key role in helping efficient &amp; effective implementation of #EU policies htt…","id":"523133634279006209","possibly_sensitive":false,"created_at":"2014-10-17T15:29:12.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"523132284598509568"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"eupatientsforum","id":"545343465"},{"start":21,"end":30,"username":"EMA_News","id":"116716199"}],"urls":{},"annotations":{},"hashtags":{}},"conversation_id":"523114037219823616","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @eupatientsforum: @EMA_News published its 2013 report on interaction with patients, consumers, and healthcare professionals http://t.co/…","id":"523114037219823616","possibly_sensitive":false,"created_at":"2014-10-17T14:11:20.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"523108597581246464"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"urls":{},"annotations":{},"hashtags":[{"start":21,"end":25,"tag":"FDA"}]},"conversation_id":"523113848148983808","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDAanimalhealth: #FDA Issues Draft Guidance for Drug Sponsors Re: Two-Phased Chemistry, Manufacturing, and Controls Technical Data http…","id":"523113848148983808","possibly_sensitive":false,"created_at":"2014-10-17T14:10:35.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"523100877490782208"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"urls":[{"start":85,"end":107,"url":"http://t.co/FNLsMipSrN","expanded_url":"http://www.nationaljournal.com/health-care/ebola-has-the-fda-working-overtime-on-reviewing-experimental-drugs-20141016","display_url":"nationaljournal.com/health-care/eb…"}],"annotations":[{"start":32,"end":34,"probability":0.6716,"type":"Organization","normalized_text":"FDA"}],"hashtags":{}},"conversation_id":"523113714501685249","source":"TweetDeck","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @DrugInfoAssn: Ebola Has the FDA Working Overtime on Reviewing Experimental Drugs http://t.co/FNLsMipSrN","id":"523113714501685249","possibly_sensitive":false,"created_at":"2014-10-17T14:10:03.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"523097557527191552"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":99,"end":121,"url":"http://t.co/TH8TzuQg8q","expanded_url":"http://bit.ly/1tzbzQb","display_url":"bit.ly/1tzbzQb"}],"annotations":{},"hashtags":[{"start":71,"end":87,"tag":"advancedtherapy"},{"start":123,"end":136,"tag":"consultation"}]},"conversation_id":"523074876224331776","source":"Twitter Web Client","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":2,"quote_count":0},"lang":"en","text":"Two more weeks to comment on our reflection paper on classification of #advancedtherapy medicines: http://t.co/TH8TzuQg8q  #consultation","id":"523074876224331776","possibly_sensitive":false,"created_at":"2014-10-17T11:35:43.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":94,"end":116,"url":"http://t.co/rrSKgeollE","expanded_url":"http://bit.ly/1z7YP2f","display_url":"bit.ly/1z7YP2f"}],"annotations":{},"hashtags":[{"start":71,"end":82,"tag":"Centaurium"},{"start":118,"end":125,"tag":"herbal"},{"start":126,"end":139,"tag":"consultation"}]},"conversation_id":"523074645277564928","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two more weeks to supply us with scientific data for the assessment of #Centaurium erythraea: http://t.co/rrSKgeollE  #herbal #consultation","id":"523074645277564928","possibly_sensitive":false,"created_at":"2014-10-17T11:34:48.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":69,"end":91,"url":"http://t.co/06YJd2wH7a","expanded_url":"http://bit.ly/1AD26It","display_url":"bit.ly/1AD26It"}],"annotations":{},"hashtags":[{"start":92,"end":105,"tag":"consultation"}]},"conversation_id":"523074403748573184","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two more weeks to comment on our guideline on sodium fluoride (18F): http://t.co/06YJd2wH7a #consultation","id":"523074403748573184","possibly_sensitive":false,"created_at":"2014-10-17T11:33:50.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":100,"end":122,"url":"http://t.co/0K6ujODxaL","expanded_url":"http://bit.ly/1wgxQ4e","display_url":"bit.ly/1wgxQ4e"}],"annotations":{},"hashtags":[{"start":33,"end":40,"tag":"herbal"},{"start":54,"end":67,"tag":"Eschscholzia"},{"start":123,"end":136,"tag":"consultation"}]},"conversation_id":"523073710899871744","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two more weeks to comment on the #herbal monograph on #Eschscholzia californica (California poppy): http://t.co/0K6ujODxaL #consultation","id":"523073710899871744","possibly_sensitive":false,"created_at":"2014-10-17T11:31:05.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":97,"end":119,"url":"http://t.co/6NBT0afyDm","expanded_url":"http://bit.ly/11B4qT7","display_url":"bit.ly/11B4qT7"}],"annotations":{},"hashtags":[{"start":33,"end":40,"tag":"herbal"},{"start":54,"end":64,"tag":"Hieracium"},{"start":121,"end":134,"tag":"consultation"}]},"conversation_id":"523073524454670336","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two more weeks to comment on the #herbal monograph on #Hieracium pilosella (mouse ear hawkweed): http://t.co/6NBT0afyDm  #consultation","id":"523073524454670336","possibly_sensitive":false,"created_at":"2014-10-17T11:30:21.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":98,"end":120,"url":"http://t.co/DimgP5Wflm","expanded_url":"http://bit.ly/1kdZXy6","display_url":"bit.ly/1kdZXy6"}],"annotations":{},"hashtags":[{"start":49,"end":56,"tag":"herbal"},{"start":70,"end":81,"tag":"Matricaria"},{"start":122,"end":135,"tag":"consultation"}]},"conversation_id":"523073362671960065","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two more weeks to comment on our draft Community #herbal monograph on #Matricaria recutita flower http://t.co/DimgP5Wflm  #consultation","id":"523073362671960065","possibly_sensitive":false,"created_at":"2014-10-17T11:29:42.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":91,"end":113,"url":"http://t.co/F3yd5yOllS","expanded_url":"http://bit.ly/1Absgle","display_url":"bit.ly/1Absgle"}],"annotations":{},"hashtags":[{"start":71,"end":81,"tag":"Equisetum"},{"start":115,"end":122,"tag":"herbal"},{"start":123,"end":136,"tag":"consultation"}]},"conversation_id":"523073206379618304","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two more weeks to supply us with scientific data for the assessment of #Equisetum arvense: http://t.co/F3yd5yOllS  #herbal #consultation","id":"523073206379618304","possibly_sensitive":false,"created_at":"2014-10-17T11:29:05.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":94,"end":116,"url":"http://t.co/qyYQI1PhXm","expanded_url":"http://bit.ly/1nRf8gh","display_url":"bit.ly/1nRf8gh"}],"annotations":{},"hashtags":[{"start":68,"end":75,"tag":"gluten"},{"start":82,"end":92,"tag":"excipient"},{"start":118,"end":131,"tag":"consultation"}]},"conversation_id":"523073018093133824","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Two more weeks to comment on our Q&amp;A on wheat starch containing #gluten as an #excipient: http://t.co/qyYQI1PhXm  #consultation","id":"523073018093133824","possibly_sensitive":false,"created_at":"2014-10-17T11:28:20.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":96,"end":118,"url":"http://t.co/CUbnW3zrIz","expanded_url":"http://bit.ly/UvpQNk","display_url":"bit.ly/UvpQNk"}],"annotations":{},"hashtags":[{"start":49,"end":56,"tag":"herbal"},{"start":70,"end":81,"tag":"Matricaria"},{"start":120,"end":133,"tag":"consultation"}]},"conversation_id":"523072716191313921","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two more weeks to comment on our draft Community #herbal monograph on #Matricaria recutita oil: http://t.co/CUbnW3zrIz  #consultation","id":"523072716191313921","possibly_sensitive":false,"created_at":"2014-10-17T11:27:08.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":104,"end":126,"url":"http://t.co/A6KVktBIYq","expanded_url":"http://bit.ly/1s307IH","display_url":"bit.ly/1s307IH"}],"annotations":{},"hashtags":[{"start":38,"end":49,"tag":"veterinary"},{"start":127,"end":140,"tag":"consultation"}]},"conversation_id":"523072378088456192","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"One more week to comment: guidance on #veterinary medicines for minor use minor species/limited market: http://t.co/A6KVktBIYq #consultation","id":"523072378088456192","possibly_sensitive":false,"created_at":"2014-10-17T11:25:47.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":103,"end":125,"url":"http://t.co/bFHbqHYYUY","expanded_url":"http://bit.ly/UQeunm","display_url":"bit.ly/UQeunm"}],"annotations":{},"hashtags":[{"start":55,"end":70,"tag":"immunoglobulin"},{"start":127,"end":140,"tag":"consultation"}]},"conversation_id":"523072114799419392","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two more weeks to comment on our paper on human normal #immunoglobulin for intravenous administration: http://t.co/bFHbqHYYUY  #consultation","id":"523072114799419392","possibly_sensitive":false,"created_at":"2014-10-17T11:24:45.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":94,"end":116,"url":"http://t.co/nigo8HLsDP","expanded_url":"http://bit.ly/1x6QhFI","display_url":"bit.ly/1x6QhFI"}],"annotations":{},"hashtags":[{"start":71,"end":81,"tag":"Artemisia"},{"start":118,"end":125,"tag":"herbal"},{"start":126,"end":139,"tag":"consultation"}]},"conversation_id":"523071436307845121","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two more weeks to supply us with scientific data for the assessment of #Artemisia absinthium: http://t.co/nigo8HLsDP  #herbal #consultation","id":"523071436307845121","possibly_sensitive":false,"created_at":"2014-10-17T11:22:03.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":92,"end":114,"url":"http://t.co/THCyEobhVP","expanded_url":"http://bit.ly/1u2XwyG","display_url":"bit.ly/1u2XwyG"}],"annotations":{},"hashtags":[{"start":59,"end":70,"tag":"Picrorhiza"},{"start":116,"end":123,"tag":"herbal"},{"start":124,"end":137,"tag":"consultation"}]},"conversation_id":"523071142157090816","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two more weeks to comment on our draft public statement on #Picrorhiza kurroa (bitter root) http://t.co/THCyEobhVP  #herbal #consultation","id":"523071142157090816","possibly_sensitive":false,"created_at":"2014-10-17T11:20:53.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":114,"end":136,"url":"http://t.co/ylGqI9eEi3","expanded_url":"http://bit.ly/ZxfnDA","display_url":"bit.ly/ZxfnDA"}],"annotations":{},"hashtags":[{"start":10,"end":19,"tag":"medicine"}]},"conversation_id":"523070955653201920","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Our human #medicine committee (CHMP) holds its October meeting next week. We'll publish the highlights on Friday: http://t.co/ylGqI9eEi3","id":"523070955653201920","possibly_sensitive":false,"created_at":"2014-10-17T11:20:08.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":105,"end":127,"url":"http://t.co/y0QF3ba7TS","expanded_url":"http://bit.ly/1sYX7A6","display_url":"bit.ly/1sYX7A6"}],"annotations":{},"hashtags":[{"start":129,"end":142,"tag":"consultation"}]},"conversation_id":"523070653461962752","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"Two more weeks to comment on functional specifications for the EU clinical trials portal &amp; database: http://t.co/y0QF3ba7TS  #consultation","id":"523070653461962752","possibly_sensitive":false,"created_at":"2014-10-17T11:18:56.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":104,"end":126,"url":"http://t.co/WtlVKSHAsF","expanded_url":"http://bit.ly/WPwMXL","display_url":"bit.ly/WPwMXL"}],"annotations":{},"hashtags":[{"start":127,"end":140,"tag":"consultation"}]},"conversation_id":"523070317313675265","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Two more weeks to comment on our reflection paper on the use of cocrystals and other solid-state forms: http://t.co/WtlVKSHAsF #consultation","id":"523070317313675265","possibly_sensitive":false,"created_at":"2014-10-17T11:17:36.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":96,"end":118,"url":"http://t.co/nuRMD5Yn4t","expanded_url":"http://bit.ly/1x0AfNJ","display_url":"bit.ly/1x0AfNJ"}],"annotations":{},"hashtags":[{"start":57,"end":73,"tag":"aminoglycosides"},{"start":120,"end":133,"tag":"consultation"}]},"conversation_id":"523070091496554496","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Two more weeks to comment on our concept paper on use of #aminoglycosides in animals in the EU: http://t.co/nuRMD5Yn4t  #consultation","id":"523070091496554496","possibly_sensitive":false,"created_at":"2014-10-17T11:16:42.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":84,"end":106,"url":"http://t.co/dT7ZBZMOQe","expanded_url":"http://bit.ly/ZKOuNf","display_url":"bit.ly/ZKOuNf"}],"annotations":{},"hashtags":[{"start":31,"end":39,"tag":"vacancy"},{"start":108,"end":120,"tag":"recruitment"}]},"conversation_id":"523069850781249536","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One more week to apply for our #vacancy for a Scientific Officer in our SME Office: http://t.co/dT7ZBZMOQe  #recruitment","id":"523069850781249536","possibly_sensitive":false,"created_at":"2014-10-17T11:15:45.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":97,"end":119,"url":"http://t.co/0rngyzEagx","expanded_url":"http://bit.ly/1uYOzs0","display_url":"bit.ly/1uYOzs0"}],"annotations":[{"start":69,"end":94,"probability":0.4115,"type":"Organization","normalized_text":"Veterinary Novel Therapies"}],"hashtags":[{"start":31,"end":39,"tag":"vacancy"},{"start":121,"end":133,"tag":"recruitment"}]},"conversation_id":"523069738956492801","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One more week to apply for our #vacancy for a Scientific Officer for Veterinary Novel Therapies: http://t.co/0rngyzEagx  #recruitment","id":"523069738956492801","possibly_sensitive":false,"created_at":"2014-10-17T11:15:18.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":87,"end":109,"url":"http://t.co/HEtAoVcS7M","expanded_url":"http://bit.ly/1rd7FHe","display_url":"bit.ly/1rd7FHe"}],"annotations":{},"hashtags":[{"start":71,"end":79,"tag":"Curcuma"},{"start":111,"end":118,"tag":"herbal"},{"start":119,"end":132,"tag":"consultation"}]},"conversation_id":"523069531598888960","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two more weeks to supply us with scientific data for the assessment of #Curcuma longa: http://t.co/HEtAoVcS7M  #herbal #consultation","id":"523069531598888960","possibly_sensitive":false,"created_at":"2014-10-17T11:14:29.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":92,"end":114,"url":"http://t.co/nTCexuC4Qz","expanded_url":"http://bit.ly/1jXr3sN","display_url":"bit.ly/1jXr3sN"}],"annotations":{},"hashtags":[{"start":71,"end":81,"tag":"Juniperus"},{"start":116,"end":123,"tag":"herbal"},{"start":124,"end":137,"tag":"consultation"}]},"conversation_id":"523069358479003648","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two more weeks to supply us with scientific data for the assessment of #Juniperus communis: http://t.co/nTCexuC4Qz  #herbal #consultation","id":"523069358479003648","possibly_sensitive":false,"created_at":"2014-10-17T11:13:47.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":88,"end":110,"url":"http://t.co/uEx71U8H8k","expanded_url":"http://bit.ly/UvlSnX","display_url":"bit.ly/UvlSnX"}],"annotations":{},"hashtags":[{"start":71,"end":80,"tag":"Gentiana"},{"start":112,"end":119,"tag":"herbal"},{"start":120,"end":133,"tag":"consultation"}]},"conversation_id":"523068949911834624","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Two more weeks to supply us with scientific data for the assessment of #Gentiana lutea: http://t.co/uEx71U8H8k  #herbal #consultation","id":"523068949911834624","possibly_sensitive":false,"created_at":"2014-10-17T11:12:10.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":88,"end":110,"url":"http://t.co/2QhJUJk89X","expanded_url":"http://bit.ly/1sp7Wfb","display_url":"bit.ly/1sp7Wfb"}],"annotations":{},"hashtags":[{"start":31,"end":39,"tag":"vacancy"},{"start":112,"end":124,"tag":"recruitment"}]},"conversation_id":"523068836162318336","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One more week to apply for our #vacancy for an Enterprise Architect in our IT Division: http://t.co/2QhJUJk89X  #recruitment","id":"523068836162318336","possibly_sensitive":false,"created_at":"2014-10-17T11:11:43.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":101,"end":123,"url":"http://t.co/3rWsxM7P2L","expanded_url":"http://bit.ly/1mRpcY6","display_url":"bit.ly/1mRpcY6"}],"annotations":{},"hashtags":[{"start":79,"end":88,"tag":"factorIX"},{"start":89,"end":99,"tag":"medicines"},{"start":125,"end":138,"tag":"consultation"}]},"conversation_id":"523068224607617024","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two more weeks to comment on core summary of product characteristics for human #factorIX #medicines: http://t.co/3rWsxM7P2L  #consultation","id":"523068224607617024","possibly_sensitive":false,"created_at":"2014-10-17T11:09:17.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":{},"annotations":{},"hashtags":{}},"conversation_id":"523067770586820609","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_ECHA: Is your pre-natal toxicity information up-to-date? Read more about this information requirement in our Newsletter. http://t.co…","id":"523067770586820609","possibly_sensitive":false,"created_at":"2014-10-17T11:07:29.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"523064293991120896"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":84,"end":106,"url":"http://t.co/jIy43oaGo4","expanded_url":"http://bit.ly/1qHczev","display_url":"bit.ly/1qHczev"}],"annotations":[{"start":78,"end":82,"probability":0.8685,"type":"Place","normalized_text":"Parma"}],"hashtags":[{"start":54,"end":66,"tag":"flavourings"}]},"conversation_id":"523065224388440064","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSA_EU: Register for EFSA’s info session on food #flavourings. 20 Jan in Parma http://t.co/jIy43oaGo4","id":"523065224388440064","possibly_sensitive":false,"created_at":"2014-10-17T10:57:22.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"523061931163545600"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":106,"end":128,"url":"http://t.co/mzdoaB1wGP","expanded_url":"http://bit.ly/1odW7ag","display_url":"bit.ly/1odW7ag"}],"annotations":{},"hashtags":{}},"conversation_id":"523057911837491200","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Aifa_ufficiale: Chronic infections: resistant bacteria can exchange metabolites to increase virulence http://t.co/mzdoaB1wGP","id":"523057911837491200","possibly_sensitive":false,"created_at":"2014-10-17T10:28:18.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"annotations":{},"hashtags":[{"start":15,"end":31,"tag":"50thanniversary"},{"start":51,"end":56,"tag":"EDQM"},{"start":61,"end":70,"tag":"European"},{"start":71,"end":85,"tag":"Pharmacopoeia"}]},"conversation_id":"523052898369175552","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @edqm_news: #50thanniversary workshops provided #EDQM and #European #Pharmacopoeia Commission with valuable feed-back. Read PR: http://t…","id":"523052898369175552","possibly_sensitive":false,"created_at":"2014-10-17T10:08:23.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"523052277821886464"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":99,"end":121,"url":"http://t.co/TH8TzuQg8q","expanded_url":"http://bit.ly/1tzbzQb","display_url":"bit.ly/1tzbzQb"}],"annotations":{},"hashtags":[{"start":71,"end":87,"tag":"advancedtherapy"},{"start":122,"end":135,"tag":"consultation"}]},"conversation_id":"523051747083042816","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to comment on our reflection paper on classification of #advancedtherapy medicines: http://t.co/TH8TzuQg8q #consultation","id":"523051747083042816","possibly_sensitive":false,"created_at":"2014-10-17T10:03:48.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":94,"end":116,"url":"http://t.co/rrSKgeollE","expanded_url":"http://bit.ly/1z7YP2f","display_url":"bit.ly/1z7YP2f"}],"annotations":{},"hashtags":[{"start":71,"end":82,"tag":"Centaurium"},{"start":117,"end":124,"tag":"herbal"},{"start":125,"end":138,"tag":"consultation"}]},"conversation_id":"523039755219779584","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to supply us with scientific data for the assessment of #Centaurium erythraea: http://t.co/rrSKgeollE #herbal #consultation","id":"523039755219779584","possibly_sensitive":false,"created_at":"2014-10-17T09:16:09.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":80,"end":102,"url":"http://t.co/ylGqI9eEi3","expanded_url":"http://bit.ly/ZxfnDA","display_url":"bit.ly/ZxfnDA"}],"annotations":{},"hashtags":[{"start":10,"end":19,"tag":"medicine"}]},"conversation_id":"523039337609719808","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Our human #medicine committee (CHMP) meets next week. Highlights out on Friday: http://t.co/ylGqI9eEi3","id":"523039337609719808","possibly_sensitive":false,"created_at":"2014-10-17T09:14:30.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":68,"end":90,"url":"http://t.co/06YJd2wH7a","expanded_url":"http://bit.ly/1AD26It","display_url":"bit.ly/1AD26It"}],"annotations":{},"hashtags":[{"start":92,"end":105,"tag":"consultation"}]},"conversation_id":"523038760435728384","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to comment on our guideline on sodium fluoride (18F) http://t.co/06YJd2wH7a: #consultation","id":"523038760435728384","possibly_sensitive":false,"created_at":"2014-10-17T09:12:12.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":100,"end":122,"url":"http://t.co/0K6ujODxaL","expanded_url":"http://bit.ly/1wgxQ4e","display_url":"bit.ly/1wgxQ4e"}],"annotations":{},"hashtags":[{"start":33,"end":40,"tag":"herbal"},{"start":54,"end":67,"tag":"Eschscholzia"},{"start":123,"end":136,"tag":"consultation"}]},"conversation_id":"523038296960942081","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to comment on the #herbal monograph on #Eschscholzia californica (California poppy): http://t.co/0K6ujODxaL #consultation","id":"523038296960942081","possibly_sensitive":false,"created_at":"2014-10-17T09:10:22.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":97,"end":119,"url":"http://t.co/6NBT0afyDm","expanded_url":"http://bit.ly/11B4qT7","display_url":"bit.ly/11B4qT7"}],"annotations":{},"hashtags":[{"start":33,"end":40,"tag":"herbal"},{"start":54,"end":64,"tag":"Hieracium"},{"start":120,"end":133,"tag":"consultation"}]},"conversation_id":"523037791064956928","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to comment on the #herbal monograph on #Hieracium pilosella (mouse ear hawkweed): http://t.co/6NBT0afyDm #consultation","id":"523037791064956928","possibly_sensitive":false,"created_at":"2014-10-17T09:08:21.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":98,"end":120,"url":"http://t.co/DimgP5Wflm","expanded_url":"http://bit.ly/1kdZXy6","display_url":"bit.ly/1kdZXy6"}],"annotations":{},"hashtags":[{"start":49,"end":56,"tag":"herbal"},{"start":70,"end":81,"tag":"Matricaria"},{"start":121,"end":134,"tag":"consultation"}]},"conversation_id":"523037129346387968","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to comment on our draft Community #herbal monograph on #Matricaria recutita flower http://t.co/DimgP5Wflm #consultation","id":"523037129346387968","possibly_sensitive":false,"created_at":"2014-10-17T09:05:43.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":91,"end":113,"url":"http://t.co/F3yd5yOllS","expanded_url":"http://bit.ly/1Absgle","display_url":"bit.ly/1Absgle"}],"annotations":{},"hashtags":[{"start":71,"end":81,"tag":"Equisetum"},{"start":114,"end":121,"tag":"herbal"},{"start":122,"end":135,"tag":"consultation"}]},"conversation_id":"523036459537039361","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to supply us with scientific data for the assessment of #Equisetum arvense: http://t.co/F3yd5yOllS #herbal #consultation","id":"523036459537039361","possibly_sensitive":false,"created_at":"2014-10-17T09:03:04.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":94,"end":116,"url":"http://t.co/qyYQI1PhXm","expanded_url":"http://bit.ly/1nRf8gh","display_url":"bit.ly/1nRf8gh"}],"annotations":{},"hashtags":[{"start":68,"end":75,"tag":"gluten"},{"start":82,"end":92,"tag":"excipient"},{"start":117,"end":130,"tag":"consultation"}]},"conversation_id":"523035992006348801","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to comment on our Q&amp;A on wheat starch containing #gluten as an #excipient: http://t.co/qyYQI1PhXm #consultation","id":"523035992006348801","possibly_sensitive":false,"created_at":"2014-10-17T09:01:12.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":96,"end":118,"url":"http://t.co/CUbnW3zrIz","expanded_url":"http://bit.ly/UvpQNk","display_url":"bit.ly/UvpQNk"}],"annotations":{},"hashtags":[{"start":49,"end":56,"tag":"herbal"},{"start":70,"end":81,"tag":"Matricaria"},{"start":119,"end":132,"tag":"consultation"}]},"conversation_id":"523035358666448896","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to comment on our draft Community #herbal monograph on #Matricaria recutita oil: http://t.co/CUbnW3zrIz #consultation","id":"523035358666448896","possibly_sensitive":false,"created_at":"2014-10-17T08:58:41.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":104,"end":126,"url":"http://t.co/A6KVktBIYq","expanded_url":"http://bit.ly/1s307IH","display_url":"bit.ly/1s307IH"}],"annotations":{},"hashtags":[{"start":38,"end":49,"tag":"veterinary"},{"start":127,"end":140,"tag":"consultation"}]},"conversation_id":"523034774064353280","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week left to comment: guidance on #veterinary medicines for minor use minor species/limited market: http://t.co/A6KVktBIYq #consultation","id":"523034774064353280","possibly_sensitive":false,"created_at":"2014-10-17T08:56:22.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":103,"end":125,"url":"http://t.co/bFHbqHYYUY","expanded_url":"http://bit.ly/UQeunm","display_url":"bit.ly/UQeunm"}],"annotations":{},"hashtags":[{"start":55,"end":70,"tag":"immunoglobulin"},{"start":126,"end":139,"tag":"consultation"}]},"conversation_id":"523033941746651136","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to comment on our paper on human normal #immunoglobulin for intravenous administration: http://t.co/bFHbqHYYUY #consultation","id":"523033941746651136","possibly_sensitive":false,"created_at":"2014-10-17T08:53:03.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":94,"end":116,"url":"http://t.co/nigo8HLsDP","expanded_url":"http://bit.ly/1x6QhFI","display_url":"bit.ly/1x6QhFI"}],"annotations":{},"hashtags":[{"start":71,"end":81,"tag":"Artemisia"},{"start":117,"end":124,"tag":"herbal"},{"start":125,"end":138,"tag":"consultation"}]},"conversation_id":"523033425306218496","source":"Bitly","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to supply us with scientific data for the assessment of #Artemisia absinthium: http://t.co/nigo8HLsDP #herbal #consultation","id":"523033425306218496","possibly_sensitive":false,"created_at":"2014-10-17T08:51:00.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":92,"end":114,"url":"http://t.co/THCyEobhVP","expanded_url":"http://bit.ly/1u2XwyG","display_url":"bit.ly/1u2XwyG"}],"annotations":{},"hashtags":[{"start":59,"end":70,"tag":"Picrorhiza"},{"start":115,"end":122,"tag":"herbal"},{"start":123,"end":136,"tag":"consultation"}]},"conversation_id":"523032996858052608","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Two weeks left to comment on our draft public statement on #Picrorhiza kurroa (bitter root) http://t.co/THCyEobhVP #herbal #consultation","id":"523032996858052608","possibly_sensitive":false,"created_at":"2014-10-17T08:49:18.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":105,"end":127,"url":"http://t.co/y0QF3ba7TS","expanded_url":"http://bit.ly/1sYX7A6","display_url":"bit.ly/1sYX7A6"}],"annotations":{},"hashtags":[{"start":128,"end":141,"tag":"consultation"}]},"conversation_id":"523032405645737984","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to comment on functional specifications for the EU clinical trials portal &amp; database: http://t.co/y0QF3ba7TS #consultation","id":"523032405645737984","possibly_sensitive":false,"created_at":"2014-10-17T08:46:57.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":104,"end":126,"url":"http://t.co/WtlVKSHAsF","expanded_url":"http://bit.ly/WPwMXL","display_url":"bit.ly/WPwMXL"}],"annotations":{},"hashtags":[{"start":127,"end":140,"tag":"consultation"}]},"conversation_id":"523031762654756864","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to comment on our reflection paper on the use of cocrystals and other solid-state forms: http://t.co/WtlVKSHAsF #consultation","id":"523031762654756864","possibly_sensitive":false,"created_at":"2014-10-17T08:44:24.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":96,"end":118,"url":"http://t.co/nuRMD5Yn4t","expanded_url":"http://bit.ly/1x0AfNJ","display_url":"bit.ly/1x0AfNJ"}],"annotations":{},"hashtags":[{"start":57,"end":73,"tag":"aminoglycosides"},{"start":119,"end":132,"tag":"consultation"}]},"conversation_id":"523031271136825345","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to comment on our concept paper on use of #aminoglycosides in animals in the EU: http://t.co/nuRMD5Yn4t #consultation","id":"523031271136825345","possibly_sensitive":false,"created_at":"2014-10-17T08:42:27.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":84,"end":106,"url":"http://t.co/dT7ZBZMOQe","expanded_url":"http://bit.ly/ZKOuNf","display_url":"bit.ly/ZKOuNf"}],"annotations":{},"hashtags":[{"start":31,"end":39,"tag":"vacancy"},{"start":107,"end":119,"tag":"recruitment"}]},"conversation_id":"523030672932605952","source":"Bitly","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week left to apply for our #vacancy for a Scientific Officer in our SME Office: http://t.co/dT7ZBZMOQe #recruitment","id":"523030672932605952","possibly_sensitive":false,"created_at":"2014-10-17T08:40:04.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":97,"end":119,"url":"http://t.co/VR9cvPsomI","expanded_url":"http://bit.ly/1uYOzs0","display_url":"bit.ly/1uYOzs0"}],"annotations":[{"start":69,"end":94,"probability":0.4345,"type":"Organization","normalized_text":"Veterinary Novel Therapies"}],"hashtags":[{"start":31,"end":39,"tag":"vacancy"},{"start":120,"end":132,"tag":"recruitment"}]},"conversation_id":"523030068147539968","source":"Bitly","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week left to apply for our #vacancy for a Scientific Officer for Veterinary Novel Therapies: http://t.co/VR9cvPsomI #recruitment","id":"523030068147539968","possibly_sensitive":false,"created_at":"2014-10-17T08:37:40.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":87,"end":109,"url":"http://t.co/HEtAoVcS7M","expanded_url":"http://bit.ly/1rd7FHe","display_url":"bit.ly/1rd7FHe"}],"annotations":{},"hashtags":[{"start":71,"end":79,"tag":"Curcuma"},{"start":110,"end":117,"tag":"herbal"},{"start":118,"end":131,"tag":"consultation"}]},"conversation_id":"523029164790931457","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to supply us with scientific data for the assessment of #Curcuma longa: http://t.co/HEtAoVcS7M #herbal #consultation","id":"523029164790931457","possibly_sensitive":false,"created_at":"2014-10-17T08:34:04.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":92,"end":114,"url":"http://t.co/nTCexuC4Qz","expanded_url":"http://bit.ly/1jXr3sN","display_url":"bit.ly/1jXr3sN"}],"annotations":{},"hashtags":[{"start":71,"end":81,"tag":"Juniperus"},{"start":115,"end":122,"tag":"herbal"},{"start":123,"end":136,"tag":"consultation"}]},"conversation_id":"523028542406557696","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to supply us with scientific data for the assessment of #Juniperus communis: http://t.co/nTCexuC4Qz #herbal #consultation","id":"523028542406557696","possibly_sensitive":false,"created_at":"2014-10-17T08:31:36.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":89,"end":111,"url":"http://t.co/uEx71U8H8k","expanded_url":"http://bit.ly/UvlSnX","display_url":"bit.ly/UvlSnX"}],"annotations":{},"hashtags":[{"start":71,"end":80,"tag":"Gentiana"},{"start":112,"end":119,"tag":"herbal"},{"start":120,"end":133,"tag":"consultation"}]},"conversation_id":"523028068047519744","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to supply us with scientific data for the assessment of #Gentiana lutea:  http://t.co/uEx71U8H8k #herbal #consultation","id":"523028068047519744","possibly_sensitive":false,"created_at":"2014-10-17T08:29:43.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":88,"end":110,"url":"http://t.co/2QhJUJk89X","expanded_url":"http://bit.ly/1sp7Wfb","display_url":"bit.ly/1sp7Wfb"}],"annotations":{},"hashtags":[{"start":31,"end":39,"tag":"vacancy"},{"start":111,"end":123,"tag":"recruitment"}]},"conversation_id":"523027564282253312","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week left to apply for our #vacancy for an Enterprise Architect in our IT Division: http://t.co/2QhJUJk89X #recruitment","id":"523027564282253312","possibly_sensitive":false,"created_at":"2014-10-17T08:27:43.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":101,"end":123,"url":"http://t.co/3rWsxM7P2L","expanded_url":"http://bit.ly/1mRpcY6","display_url":"bit.ly/1mRpcY6"}],"annotations":{},"hashtags":[{"start":79,"end":88,"tag":"factorIX"},{"start":89,"end":99,"tag":"medicines"},{"start":124,"end":137,"tag":"consultation"}]},"conversation_id":"523027097909202944","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to comment on core summary of product characteristics for human #factorIX #medicines: http://t.co/3rWsxM7P2L #consultation","id":"523027097909202944","possibly_sensitive":false,"created_at":"2014-10-17T08:25:52.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"eumsplatform","id":"600110872"},{"start":36,"end":45,"username":"EMA_News","id":"116716199"},{"start":49,"end":55,"username":"EFPIA","id":"52084584"}],"urls":{},"annotations":[{"start":18,"end":29,"probability":0.9635,"type":"Person","normalized_text":"Jane Moseley"}],"hashtags":{}},"conversation_id":"523026142983651328","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @eumsplatform: Jane Moseley from @EMA_News at @EFPIA Collaboration Summit: \"Patient voice tells the suffering behind the statistics.\"","id":"523026142983651328","possibly_sensitive":false,"created_at":"2014-10-17T08:22:04.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"523024261322379264"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":24,"end":33,"username":"EMA_News","id":"116716199"}],"urls":{},"annotations":[{"start":11,"end":22,"probability":0.935,"type":"Person","normalized_text":"Jane Moseley"}],"hashtags":{}},"conversation_id":"523026125925388288","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: Jane Moseley @EMA_News at HCS event: \"The patient's voice can tell us the pain behind the statistics\".","id":"523026125925388288","possibly_sensitive":false,"created_at":"2014-10-17T08:22:00.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"523024161384693760"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"urls":{},"annotations":{},"hashtags":[{"start":51,"end":63,"tag":"raredisease"}]},"conversation_id":"523025947646509056","source":"TweetDeck","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @eurordis: What do you think about sharing your #raredisease clinical or genetic data to advance research &amp;  develop treatments? http://…","id":"523025947646509056","possibly_sensitive":false,"created_at":"2014-10-17T08:21:17.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"523023887538593792"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"WHO_Europe_VPI","id":"561122363"}],"urls":[{"start":77,"end":99,"url":"http://t.co/x80mYlniRy","expanded_url":"http://bit.ly/1odJ8p7","display_url":"bit.ly/1odJ8p7"}],"annotations":{},"hashtags":[{"start":36,"end":42,"tag":"polio"},{"start":100,"end":113,"tag":"vaccineswork"},{"start":114,"end":129,"tag":"immunizeEurope"}]},"conversation_id":"523025302575132672","source":"TweetDeck","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO_Europe_VPI: A world without #polio is in reach...\nWe are this close: http://t.co/x80mYlniRy\n#vaccineswork #immunizeEurope http://t.…","id":"523025302575132672","possibly_sensitive":false,"created_at":"2014-10-17T08:18:44.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"523014320532516864"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":82,"end":104,"url":"http://t.co/ZQk5dUh2Wq","expanded_url":"http://bit.ly/1zcS7eD","display_url":"bit.ly/1zcS7eD"}],"annotations":{},"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":20,"end":31,"tag":"paediatric"}]},"conversation_id":"522776249480249346","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The #minutes of our #paediatric committee meeting in September are now available: http://t.co/ZQk5dUh2Wq","id":"522776249480249346","possibly_sensitive":false,"created_at":"2014-10-16T15:49:05.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":76,"end":98,"url":"http://t.co/4cGxxwmVaE","expanded_url":"http://bit.ly/1txi6ea","display_url":"bit.ly/1txi6ea"}],"annotations":{},"hashtags":[{"start":29,"end":37,"tag":"Triumeq"},{"start":41,"end":50,"tag":"medicine"},{"start":60,"end":64,"tag":"HIV"}]},"conversation_id":"522776168907669505","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've published the EPAR for #Triumeq, a #medicine to treat #HIV infection: http://t.co/4cGxxwmVaE","id":"522776168907669505","possibly_sensitive":false,"created_at":"2014-10-16T15:48:46.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":79,"end":101,"url":"http://t.co/x2fIOYUHy1","expanded_url":"http://bit.ly/1DeUsUV","display_url":"bit.ly/1DeUsUV"}],"annotations":{},"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":20,"end":27,"tag":"herbal"}]},"conversation_id":"522776107435958272","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The #minutes of our #herbal medicines committee meeting in June are available: http://t.co/x2fIOYUHy1","id":"522776107435958272","possibly_sensitive":false,"created_at":"2014-10-16T15:48:31.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":49,"end":57,"username":"borgton","id":"1605512862"}],"urls":{},"annotations":{},"hashtags":[{"start":15,"end":18,"tag":"EU"},{"start":41,"end":47,"tag":"Ebola"}]},"conversation_id":"522775870231285760","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: #EU high level meeting on #Ebola: @borgton opening speech  'We remain vigilant &amp; consider all means of preparedness' http://…","id":"522775870231285760","possibly_sensitive":false,"created_at":"2014-10-16T15:47:34.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"522690660999385088"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"annotations":{},"hashtags":[{"start":67,"end":83,"tag":"50thanniversary"},{"start":91,"end":96,"tag":"EDQM"},{"start":101,"end":110,"tag":"European"},{"start":111,"end":125,"tag":"Pharmacopoeia"}]},"conversation_id":"522775839583526912","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @edqm_news: 300 delegates from 45 countries participated in the #50thanniversary of the #EDQM and #European #Pharmacopoeia http://t.co/m…","id":"522775839583526912","possibly_sensitive":false,"created_at":"2014-10-16T15:47:27.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"522690794474717184"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"},{"start":36,"end":45,"username":"Anses_fr","id":"1108628533"}],"urls":{},"annotations":{},"hashtags":[{"start":86,"end":97,"tag":"pesticides"}]},"conversation_id":"522775326972461056","source":"TweetDeck","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSA_EU: Two weeks left to EFSA/@Anses_fr  conference on occupational exposure to #pesticides: check the pre-programme  http://t.co/i6H…","id":"522775326972461056","possibly_sensitive":false,"created_at":"2014-10-16T15:45:25.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"522728822161276928"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"AlzheimerEurope","id":"1536274003"}],"urls":[{"start":116,"end":138,"url":"http://t.co/81cYwUjYTR","expanded_url":"http://goo.gl/uPnz5z","display_url":"goo.gl/uPnz5z"}],"annotations":[{"start":42,"end":47,"probability":0.7612,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":29,"end":38,"tag":"Dementia"}]},"conversation_id":"522775186429710336","source":"TweetDeck","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @AlzheimerEurope: Our new #Dementia In Europe magazine - DIE issue 18 - is available for purchase on our website http://t.co/81cYwUjYTR …","id":"522775186429710336","possibly_sensitive":false,"created_at":"2014-10-16T15:44:51.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"522737596532031489"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"},{"start":64,"end":73,"username":"expo2015","id":"25518771"}],"urls":[{"start":96,"end":118,"url":"http://t.co/LWZMyg0fjQ","expanded_url":"http://bit.ly/1stT5wP","display_url":"bit.ly/1stT5wP"}],"annotations":[{"start":74,"end":78,"probability":0.5358,"type":"Place","normalized_text":"Milan"}],"hashtags":[{"start":31,"end":36,"tag":"EFSA"}]},"conversation_id":"522774976144080896","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSA_EU: Save the date for #EFSA’s international conference @EXPO2015 Milan, 14-16 Oct 2015 http://t.co/LWZMyg0fjQ","id":"522774976144080896","possibly_sensitive":false,"created_at":"2014-10-16T15:44:01.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"522747327384412160"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"},{"start":30,"end":38,"username":"EU_ECHA","id":"331604970"}],"urls":[{"start":58,"end":80,"url":"http://t.co/st2JDRfSh6","expanded_url":"http://bit.ly/ZwdtTI","display_url":"bit.ly/ZwdtTI"},{"start":101,"end":123,"url":"http://t.co/5Apk6dyRH1","expanded_url":"http://bit.ly/1cij9R1","display_url":"bit.ly/1cij9R1"}],"annotations":{},"hashtags":{}},"conversation_id":"522774780089729024","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_ECHA: October issue of @EU_ECHA Newsletter is out! http://t.co/st2JDRfSh6 Subscribe to it at: http://t.co/5Apk6dyRH1 http://t.co/XZr…","id":"522774780089729024","possibly_sensitive":false,"created_at":"2014-10-16T15:43:14.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"522753356994191361"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":14,"username":"IAPOtweets","id":"14682411"}],"urls":[{"start":80,"end":102,"url":"http://t.co/sfMfOOlr9b","expanded_url":"http://iapo.org.uk/","display_url":"iapo.org.uk"},{"start":103,"end":125,"url":"http://t.co/B0SHhgDRjI","expanded_url":"https://twitter.com/IAPOtweets/status/522753468298457089/photo/1","display_url":"pic.twitter.com/B0SHhgDRjI"}],"annotations":{},"hashtags":{}},"conversation_id":"522774759416033280","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IAPOtweets: We launched the new IAPO website last week! Have a browse here: http://t.co/sfMfOOlr9b http://t.co/B0SHhgDRjI","id":"522774759416033280","possibly_sensitive":false,"created_at":"2014-10-16T15:43:10.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"522753468298457089"}],"attachments":{"media_keys":["3_522753454238740480"]}},{"entities":{"mentions":[{"start":3,"end":18,"username":"PrimaryCare4um","id":"164835748"},{"start":63,"end":72,"username":"EMA_News","id":"116716199"}],"urls":{},"annotations":{},"hashtags":[{"start":20,"end":25,"tag":"EFPC"},{"start":39,"end":51,"tag":"PrimaryCare"},{"start":55,"end":61,"tag":"India"}]},"conversation_id":"522774419622858752","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @PrimaryCare4um: #EFPC Newsflash19: #PrimaryCare in #India, @EMA_News interaction with patients, consumers, healthcare professionals htt…","id":"522774419622858752","possibly_sensitive":false,"created_at":"2014-10-16T15:41:49.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"522759633505501184"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"urls":{},"annotations":[{"start":89,"end":111,"probability":0.5845,"type":"Organization","normalized_text":"Alliance Regional Board"}],"hashtags":[{"start":36,"end":46,"tag":"hepatitis"}]},"conversation_id":"522774228110934016","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Hep_Alliance: Want to represent #hepatitis patients in your region? Nominate for the Alliance Regional Board now. Closes tomorrow http:…","id":"522774228110934016","possibly_sensitive":false,"created_at":"2014-10-16T15:41:03.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"522765844125085696"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":81,"end":103,"url":"http://t.co/x2fIOYUHy1","expanded_url":"http://bit.ly/1DeUsUV","display_url":"bit.ly/1DeUsUV"}],"annotations":{},"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":36,"end":43,"tag":"herbal"}]},"conversation_id":"522690109800718337","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the #minutes of our #herbal medicines committee meeting in June: http://t.co/x2fIOYUHy1","id":"522690109800718337","possibly_sensitive":false,"created_at":"2014-10-16T10:06:47.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":89,"end":111,"url":"http://t.co/4cGxxwmVaE","expanded_url":"http://bit.ly/1txi6ea","display_url":"bit.ly/1txi6ea"}],"annotations":{},"hashtags":[{"start":42,"end":50,"tag":"Triumeq"},{"start":54,"end":63,"tag":"medicine"},{"start":73,"end":77,"tag":"HIV"}]},"conversation_id":"522689672955580416","source":"Bitly","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've published the assessment report for #Triumeq, a #medicine to treat #HIV infection: http://t.co/4cGxxwmVaE","id":"522689672955580416","possibly_sensitive":false,"created_at":"2014-10-16T10:05:03.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":92,"end":114,"url":"http://t.co/QkY7wza2dv","expanded_url":"http://bit.ly/1yGDrTX","display_url":"bit.ly/1yGDrTX"}],"annotations":{},"hashtags":[{"start":42,"end":49,"tag":"herbal"}]},"conversation_id":"522688934896492544","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the meeting report of our #herbal medicines committee meeting in September: http://t.co/QkY7wza2dv","id":"522688934896492544","possibly_sensitive":false,"created_at":"2014-10-16T10:02:07.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":80,"end":102,"url":"http://t.co/ZQk5dUh2Wq","expanded_url":"http://bit.ly/1zcS7eD","display_url":"bit.ly/1zcS7eD"}],"annotations":{},"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":36,"end":47,"tag":"paediatric"}]},"conversation_id":"522688397383839745","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the #minutes of our #paediatric committee meeting in September: http://t.co/ZQk5dUh2Wq","id":"522688397383839745","possibly_sensitive":false,"created_at":"2014-10-16T09:59:59.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":92,"end":114,"url":"http://t.co/ZdGtXmyS6n","expanded_url":"http://bit.ly/11nQLP3","display_url":"bit.ly/11nQLP3"}],"annotations":{},"hashtags":[{"start":52,"end":62,"tag":"medicines"},{"start":115,"end":128,"tag":"consultation"}]},"conversation_id":"522687621575999488","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Comment on a paper on clinical investigation of new #medicines for acute coronary syndrome: http://t.co/ZdGtXmyS6n #consultation","id":"522687621575999488","possibly_sensitive":false,"created_at":"2014-10-16T09:56:54.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":100,"end":122,"url":"http://t.co/eeCiWbu1yp","expanded_url":"http://bit.ly/1xT9E7j","display_url":"bit.ly/1xT9E7j"}],"annotations":{},"hashtags":[{"start":29,"end":38,"tag":"Busulfan"},{"start":57,"end":66,"tag":"medicine"}]},"conversation_id":"522687465162031104","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've published the EPAR for #Busulfan Fresenius Kabi, a #medicine for blood stem-cell transplants: http://t.co/eeCiWbu1yp","id":"522687465162031104","possibly_sensitive":false,"created_at":"2014-10-16T09:56:17.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":17,"end":27,"username":"MHRAgovuk","id":"330993102"}],"urls":[{"start":112,"end":134,"url":"http://t.co/hU5zs8yq1H","expanded_url":"http://bit.ly/1ttKIVO","display_url":"bit.ly/1ttKIVO"}],"annotations":{},"hashtags":[{"start":92,"end":110,"tag":"pharmacovigilance"}]},"conversation_id":"522687360233136128","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Register for the @MHRAgovuk info day on the Medical Dictionary for Regulatory Activities in #pharmacovigilance: http://t.co/hU5zs8yq1H","id":"522687360233136128","possibly_sensitive":false,"created_at":"2014-10-16T09:55:52.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":87,"end":109,"url":"http://t.co/L7GbtvdFr3","expanded_url":"http://bit.ly/1ttm6fS","display_url":"bit.ly/1ttm6fS"}],"annotations":{},"hashtags":[{"start":62,"end":74,"tag":"antibiotics"}]},"conversation_id":"522686618931843072","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Report indicates encouraging signs of more responsible use of #antibiotics in animals: http://t.co/L7GbtvdFr3","id":"522686618931843072","possibly_sensitive":false,"created_at":"2014-10-16T09:52:55.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":21,"end":31,"username":"MHRAgovuk","id":"330993102"}],"urls":[{"start":115,"end":137,"url":"http://t.co/hU5zs8yq1H","expanded_url":"http://bit.ly/1ttKIVO","display_url":"bit.ly/1ttKIVO"}],"annotations":{},"hashtags":[{"start":96,"end":114,"tag":"pharmacovigilance"}]},"conversation_id":"522432333950242816","source":"Bitly","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Register now for the @MHRAgovuk info day on the Medical Dictionary for Regulatory Activities in #pharmacovigilance http://t.co/hU5zs8yq1H","id":"522432333950242816","possibly_sensitive":false,"created_at":"2014-10-15T17:02:29.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"PrimaryCare4um","id":"164835748"},{"start":20,"end":24,"username":"WHO","id":"14499829"}],"urls":[{"start":104,"end":126,"url":"http://t.co/htN77VmUsp","expanded_url":"http://www.who.int/ictrp/results/en/","display_url":"who.int/ictrp/results/…"}],"annotations":{},"hashtags":[{"start":80,"end":95,"tag":"clinicaltrials"},{"start":127,"end":137,"tag":"Alltrials"}]},"conversation_id":"522431861285720064","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @PrimaryCare4um: @WHO public consultation: Statement on Public Disclosure of #clinicaltrials Results http://t.co/htN77VmUsp #Alltrials #…","id":"522431861285720064","possibly_sensitive":false,"created_at":"2014-10-15T17:00:36.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"522416402041683968"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":113,"end":135,"url":"http://t.co/eeCiWbu1yp","expanded_url":"http://bit.ly/1xT9E7j","display_url":"bit.ly/1xT9E7j"}],"annotations":{},"hashtags":[{"start":42,"end":51,"tag":"Busulfan"},{"start":70,"end":79,"tag":"medicine"}]},"conversation_id":"522416180750221312","source":"Bitly","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the assessment report for #Busulfan Fresenius Kabi, a #medicine for blood stem-cell transplants: http://t.co/eeCiWbu1yp","id":"522416180750221312","possibly_sensitive":false,"created_at":"2014-10-15T15:58:18.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":117,"end":139,"url":"http://t.co/ZdGtXmyS6n","expanded_url":"http://bit.ly/11nQLP3","display_url":"bit.ly/11nQLP3"}],"annotations":{},"hashtags":[{"start":102,"end":115,"tag":"consultation"}]},"conversation_id":"522414714966798336","source":"Bitly","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"We've released a paper on the clinical investigation of new medicines for acute coronary syndrome for #consultation: http://t.co/ZdGtXmyS6n","id":"522414714966798336","possibly_sensitive":false,"created_at":"2014-10-15T15:52:28.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"urls":[{"start":78,"end":100,"url":"http://t.co/b4PwV5437k","expanded_url":"http://bit.ly/ZXMTnA","display_url":"bit.ly/ZXMTnA"}],"annotations":{},"hashtags":[{"start":101,"end":112,"tag":"regaffairs"}]},"conversation_id":"522413926206955520","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @TOPRANEWS: TOPRA's 2013-2014 Annual Report is out now: download your copy http://t.co/b4PwV5437k #regaffairs","id":"522413926206955520","possibly_sensitive":false,"created_at":"2014-10-15T15:49:20.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"522412325442424832"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"urls":[{"start":109,"end":131,"url":"http://t.co/ocNuR3yW1T","expanded_url":"http://ow.ly/CNTED","display_url":"ow.ly/CNTED"}],"annotations":{},"hashtags":{}},"conversation_id":"522411733651304448","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @MHRAgovuk: Early Access to Medicines scheme (EAMS) explained in latest edition of The Pharmacist page 27 http://t.co/ocNuR3yW1T","id":"522411733651304448","possibly_sensitive":false,"created_at":"2014-10-15T15:40:37.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"522411543846465536"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":13,"username":"farmazutical","id":"2830257207"}],"urls":[{"start":59,"end":81,"url":"http://t.co/81mvfkEvbJ","expanded_url":"http://bit.ly/X4lXwT","display_url":"bit.ly/X4lXwT"}],"annotations":{},"hashtags":{}},"conversation_id":"522407798194585602","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"@farmazutical Please could you send your question to us at http://t.co/81mvfkEvbJ so that we can reply to you directly and in full.","id":"522411416079589376","possibly_sensitive":false,"created_at":"2014-10-15T15:39:22.000Z","author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"522407798194585602"}],"in_reply_to_user_id":"2830257207","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"urls":[{"start":104,"end":126,"url":"http://t.co/R3StwP2PNY","expanded_url":"http://go.usa.gov/frMk","display_url":"go.usa.gov/frMk"}],"annotations":[{"start":12,"end":14,"probability":0.7411,"type":"Organization","normalized_text":"FDA"}],"hashtags":[{"start":127,"end":136,"tag":"research"}]},"conversation_id":"522407108445495296","source":"TweetDeck","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @US_FDA: FDA scientists are studying pediatric brain function—and they’re using an interesting tool: http://t.co/R3StwP2PNY #research","id":"522407108445495296","possibly_sensitive":false,"created_at":"2014-10-15T15:22:15.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"522399190824280064"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":30,"end":38,"username":"ECDC_EU","id":"204752573"}],"urls":[{"start":108,"end":130,"url":"http://t.co/hhrakFegu6","expanded_url":"http://europa.eu/!Nf97kn","display_url":"europa.eu/!Nf97kn"}],"annotations":[{"start":58,"end":76,"probability":0.5044,"type":"Other","normalized_text":"Ebola Virus Disease"},{"start":90,"end":98,"probability":0.9699,"type":"Place","normalized_text":"W. Africa"}],"hashtags":[{"start":15,"end":21,"tag":"Ebola"}]},"conversation_id":"522406882678673408","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: #Ebola Updated @ECDC_EU risk assessment on Ebola Virus Disease outbreak in W. Africa (13.10) http://t.co/hhrakFegu6 http://t…","id":"522406882678673408","possibly_sensitive":false,"created_at":"2014-10-15T15:21:21.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"522393137030123520"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"eu_eeas","id":"80803819"}],"urls":[{"start":65,"end":87,"url":"http://t.co/OaCCPLPP9z","expanded_url":"http://tinyurl.com/p54gq95","display_url":"tinyurl.com/p54gq95"}],"annotations":{},"hashtags":[{"start":22,"end":28,"tag":"Ebola"},{"start":61,"end":64,"tag":"EU"}]},"conversation_id":"522406844627943425","source":"TweetDeck","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @eu_eeas: Q&amp;A: #Ebola and health implications for the #EU http://t.co/OaCCPLPP9z","id":"522406844627943425","possibly_sensitive":false,"created_at":"2014-10-15T15:21:12.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"522399019008815105"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"urls":[{"start":118,"end":140,"url":"http://t.co/HbCNHVEMlk","expanded_url":"http://bit.ly/1yDCeNa","display_url":"bit.ly/1yDCeNa"}],"annotations":{},"hashtags":[{"start":75,"end":93,"tag":"pharmacovigilance"}]},"conversation_id":"522406778618019841","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ansm: The French medicines agency publishes minutes from the technical #pharmacovigilance committee of 20/05/2014 http://t.co/HbCNHVEMlk","id":"522406778618019841","possibly_sensitive":false,"created_at":"2014-10-15T15:20:56.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":100,"end":122,"url":"http://t.co/ApRznYjmpF","expanded_url":"http://bit.ly/1yDByHI","display_url":"bit.ly/1yDByHI"}],"annotations":{},"hashtags":{}},"conversation_id":"522405736685772801","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @LV_MPA: No conclusive evidence for increased risk of heart problems with testosterone medicines http://t.co/ApRznYjmpF","id":"522405736685772801","possibly_sensitive":false,"created_at":"2014-10-15T15:16:48.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"urls":{},"annotations":{},"hashtags":[{"start":29,"end":32,"tag":"EU"},{"start":92,"end":98,"tag":"Ebola"}]},"conversation_id":"522375325561671681","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @HAIEurope: Tomorrow, the #EU will hold a high-level meeting and press conference on its #Ebola response. Ebola Q&amp;A: http://t.co/ejucLQ3…","id":"522375325561671681","possibly_sensitive":false,"created_at":"2014-10-15T13:15:57.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"522374356249628672"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":100,"end":122,"url":"http://t.co/TlQ6QmFoDl","expanded_url":"http://bit.ly/1wGjGHw","display_url":"bit.ly/1wGjGHw"}],"annotations":{},"hashtags":{}},"conversation_id":"522375186893787136","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @LV_MPA: PRAC recommends further measures to reduce the risk of serious blood clots with Iclusig http://t.co/TlQ6QmFoDl","id":"522375186893787136","possibly_sensitive":false,"created_at":"2014-10-15T13:15:24.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"H2020SME","id":"874591855626858496"},{"start":50,"end":59,"username":"EU_H2020","id":"920249612329504768"}],"urls":[{"start":118,"end":140,"url":"http://t.co/93m6ud3MvT","expanded_url":"http://ow.ly/CyOpK","display_url":"ow.ly/CyOpK"}],"annotations":{},"hashtags":[{"start":60,"end":74,"tag":"SMEinstrument"},{"start":86,"end":97,"tag":"Biomarkers"}]},"conversation_id":"522375009688633344","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @H2020SME: Out of 580 proposals in Phase 2 for @EU_H2020 #SMEinstrument 81 were on #Biomarkers /diagnostic devices http://t.co/93m6ud3MvT","id":"522375009688633344","possibly_sensitive":false,"created_at":"2014-10-15T13:14:42.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"522373986752401408"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":43,"end":52,"username":"EMA_News","id":"116716199"}],"urls":[{"start":70,"end":92,"url":"http://t.co/qA2QnAOkNZ","expanded_url":"http://www.ifaheurope.org/ifah-media/press/228-ie-press-statement-4thesvac.html","display_url":"ifaheurope.org/ifah-media/pre…"}],"annotations":{},"hashtags":{}},"conversation_id":"522371214363598849","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IFAHEurope: Check out our statement re/@EMA_News 4th ESVAC report http://t.co/qA2QnAOkNZ","id":"522371214363598849","possibly_sensitive":false,"created_at":"2014-10-15T12:59:37.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"522371079214727168"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":97,"end":119,"url":"http://t.co/yKVx9VvGlF","expanded_url":"http://bit.ly/1rmWXQU","display_url":"bit.ly/1rmWXQU"}],"annotations":{},"hashtags":[{"start":21,"end":29,"tag":"vacancy"},{"start":120,"end":132,"tag":"recruitment"}]},"conversation_id":"522370660233134080","source":"Bitly","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The deadline for our #vacancy for a Continuous Improvement Lead has been extended to 7 November: http://t.co/yKVx9VvGlF #recruitment","id":"522370660233134080","possibly_sensitive":false,"created_at":"2014-10-15T12:57:25.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":95,"end":117,"url":"http://t.co/L7GbtvdFr3","expanded_url":"http://bit.ly/1ttm6fS","display_url":"bit.ly/1ttm6fS"}],"annotations":[{"start":65,"end":70,"probability":0.9875,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":37,"end":48,"tag":"veterinary"},{"start":49,"end":61,"tag":"antibiotics"}]},"conversation_id":"522369385760296961","source":"Bitly","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"There was a 15% decrease in sales of #veterinary #antibiotics in Europe between 2010 and 2012: http://t.co/L7GbtvdFr3","id":"522369385760296961","possibly_sensitive":false,"created_at":"2014-10-15T12:52:21.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":19,"end":33,"username":"EU_Commission","id":"157981564"}],"urls":[{"start":121,"end":143,"url":"http://t.co/E0fyAzykeg","expanded_url":"http://europa.eu/!jB63Rw","display_url":"europa.eu/!jB63Rw"}],"annotations":[{"start":72,"end":76,"probability":0.4736,"type":"Other","normalized_text":"Ebola"}],"hashtags":{}},"conversation_id":"522365992824229890","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EAHPtweet: The @EU_Commission has prepared a useful Q&amp;A document on Ebola and the health implications for the EU http://t.co/E0fyAzykeg","id":"522365992824229890","possibly_sensitive":false,"created_at":"2014-10-15T12:38:52.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"522365840121806849"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"ECDC_Outbreaks","id":"2754484003"}],"urls":[{"start":75,"end":97,"url":"http://t.co/CP1p7OzM5L","expanded_url":"http://bit.ly/1seWoYQ","display_url":"bit.ly/1seWoYQ"}],"annotations":{},"hashtags":[{"start":32,"end":38,"tag":"Ebola"},{"start":71,"end":74,"tag":"EU"}]},"conversation_id":"522354042765590528","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_Outbreaks: Q &amp; A:  #Ebola and health implications for the #EU http://t.co/CP1p7OzM5L","id":"522354042765590528","possibly_sensitive":false,"created_at":"2014-10-15T11:51:23.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"522353768156135424"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":85,"end":107,"url":"http://t.co/Er1MV5Jn9R","expanded_url":"http://europa.eu/rapid/press-release_MEMO-14-588_en.htm?locale=en","display_url":"europa.eu/rapid/press-re…"}],"annotations":{},"hashtags":{}},"conversation_id":"522351389448884224","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @GCessak: European Commission | Q&amp;A: Ebola and health implications for the EU http://t.co/Er1MV5Jn9R","id":"522351389448884224","possibly_sensitive":false,"created_at":"2014-10-15T11:40:50.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"522351120757587968"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":117,"end":131,"username":"EU_Commission","id":"157981564"}],"urls":[{"start":94,"end":116,"url":"http://t.co/sauX58R61j","expanded_url":"http://europa.eu/!jn37xX","display_url":"europa.eu/!jn37xX"}],"annotations":{},"hashtags":[{"start":15,"end":21,"tag":"Ebola"},{"start":43,"end":50,"tag":"health"},{"start":90,"end":93,"tag":"EU"}]},"conversation_id":"522344146636660737","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: #Ebola - read our Q&amp;A - #health implications &amp; preparedness in the #EU http://t.co/sauX58R61j @EU_Commission @ECSpokesFred #…","id":"522344146636660737","possibly_sensitive":false,"created_at":"2014-10-15T11:12:03.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"522342179059273728"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":14,"username":"luca__pani","id":"2176193576"}],"urls":[{"start":122,"end":144,"url":"http://t.co/r4lOnpBC3E","expanded_url":"http://bit.ly/1w21UiW","display_url":"bit.ly/1w21UiW"}],"annotations":{},"hashtags":{}},"conversation_id":"522315574161178624","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @luca__pani: The microbiome &amp; its thousands of biosynthetic gene clusters encoding natural thiopeptide antibiotics http://t.co/r4lOnpBC3E","id":"522315574161178624","possibly_sensitive":false,"created_at":"2014-10-15T09:18:31.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":89,"end":111,"url":"http://t.co/byzZipb9jI","expanded_url":"http://bit.ly/1w4XhDO","display_url":"bit.ly/1w4XhDO"}],"annotations":{},"hashtags":[{"start":13,"end":21,"tag":"Abasria"},{"start":23,"end":31,"tag":"insulin"},{"start":32,"end":41,"tag":"glargine"},{"start":46,"end":55,"tag":"medicine"},{"start":60,"end":69,"tag":"diabetes"}]},"conversation_id":"522306548174192640","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The EPAR for #Abasria (#insulin #glargine), a #medicine for #diabetes, is now available: http://t.co/byzZipb9jI","id":"522306548174192640","possibly_sensitive":false,"created_at":"2014-10-15T08:42:39.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":87,"end":109,"url":"http://t.co/byzZipb9jI","expanded_url":"http://bit.ly/1w4XhDO","display_url":"bit.ly/1w4XhDO"}],"annotations":{},"hashtags":[{"start":42,"end":50,"tag":"Abasria"},{"start":52,"end":60,"tag":"insulin"},{"start":61,"end":70,"tag":"glargine"},{"start":76,"end":85,"tag":"diabetes"}]},"conversation_id":"522063678884290560","source":"Bitly","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the assessment report for #Abasria (#insulin #glargine) for #diabetes: http://t.co/byzZipb9jI","id":"522063678884290560","possibly_sensitive":false,"created_at":"2014-10-14T16:37:35.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"urls":[{"start":101,"end":123,"url":"http://t.co/DREb7MWymC","expanded_url":"http://go.usa.gov/f3g9","display_url":"go.usa.gov/f3g9"}],"annotations":[{"start":12,"end":14,"probability":0.8675,"type":"Organization","normalized_text":"FDA"}],"hashtags":[{"start":37,"end":48,"tag":"sicklecell"}]},"conversation_id":"522063102565949440","source":"TweetDeck","public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @US_FDA: FDA is working to tackle #sicklecell disease and encouraging new treatments. Here’s how: http://t.co/DREb7MWymC","id":"522063102565949440","possibly_sensitive":false,"created_at":"2014-10-14T16:35:17.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"522058604829229056"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"urls":[{"start":74,"end":96,"url":"http://t.co/Y6m7QXiHuA","expanded_url":"http://bit.ly/hN7hpR","display_url":"bit.ly/hN7hpR"}],"annotations":{},"hashtags":[{"start":33,"end":40,"tag":"Animal"},{"start":97,"end":101,"tag":"FDA"}]},"conversation_id":"522062940086992896","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDAanimalhealth: See Updated #Animal Related Federal Register Notices http://t.co/Y6m7QXiHuA #FDA","id":"522062940086992896","possibly_sensitive":false,"created_at":"2014-10-14T16:34:39.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"522056399665496065"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"urls":{},"annotations":{},"hashtags":{}},"conversation_id":"522050796536733696","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @TOPRANEWS: TOPRA Annual Report 2013-2014: TOPRA's Annual Report is out now, containing a comprehensive summary of all our... http://t.c…","id":"522050796536733696","possibly_sensitive":false,"created_at":"2014-10-14T15:46:23.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"522033764168253441"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"urls":[{"start":45,"end":67,"url":"http://t.co/XaTSXQKOpR","expanded_url":"http://bit.ly/1u0iVGW","display_url":"bit.ly/1u0iVGW"}],"annotations":{},"hashtags":{}},"conversation_id":"522050650264588288","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @TOPRANEWS: TOPRA Annual Report 2013-2014 http://t.co/XaTSXQKOpR","id":"522050650264588288","possibly_sensitive":false,"created_at":"2014-10-14T15:45:48.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"522027776363085824"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":84,"end":106,"url":"http://t.co/Z3uuLqihr3","expanded_url":"http://bit.ly/1Cgx5YU","display_url":"bit.ly/1Cgx5YU"}],"annotations":{},"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":28,"end":39,"tag":"veterinary"}]},"conversation_id":"521978856115535872","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The #minutes of September's #veterinary committee (CVMP) meeting are now available: http://t.co/Z3uuLqihr3","id":"521978856115535872","possibly_sensitive":false,"created_at":"2014-10-14T11:00:31.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":82,"end":104,"url":"http://t.co/Z3uuLqihr3","expanded_url":"http://bit.ly/1Cgx5YU","display_url":"bit.ly/1Cgx5YU"}],"annotations":{},"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":44,"end":55,"tag":"veterinary"}]},"conversation_id":"521974943417118720","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the #minutes of September's #veterinary committee (CVMP) meeting: http://t.co/Z3uuLqihr3","id":"521974943417118720","possibly_sensitive":false,"created_at":"2014-10-14T10:44:58.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":8,"username":"Eu2P","id":"420241833"}],"urls":[{"start":77,"end":99,"url":"http://t.co/eBHzYCoNts","expanded_url":"http://www.safescimet.eu/wp-content/uploads/2014/10/SafeSciMET_InBrief_18.pdf","display_url":"safescimet.eu/wp-content/upl…"}],"annotations":{},"hashtags":{}},"conversation_id":"521967012420263936","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Eu2P: IMI-TRAIN first steps summarized in the last SafeSciMET newsletter http://t.co/eBHzYCoNts","id":"521967012420263936","possibly_sensitive":false,"created_at":"2014-10-14T10:13:28.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"521966549696278528"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":112,"end":134,"url":"http://t.co/YdxTJ7Yjhh","expanded_url":"http://bit.ly/1sx9dit","display_url":"bit.ly/1sx9dit"}],"annotations":{},"hashtags":[{"start":17,"end":26,"tag":"Velphoro"},{"start":92,"end":101,"tag":"dialysis"}]},"conversation_id":"521965286598393856","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"See the EPAR for #Velphoro (polynuclear iron(III)-oxyhydroxide, sucrose &amp; starches) for #dialysis patients: http://t.co/YdxTJ7Yjhh","id":"521965286598393856","possibly_sensitive":false,"created_at":"2014-10-14T10:06:36.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"urls":{},"annotations":[{"start":48,"end":50,"probability":0.4294,"type":"Organization","normalized_text":"EMA"}],"hashtags":{}},"conversation_id":"521965020859863040","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @TOPRANEWS: Publication of clinical reports: EMA adopts landmark policy: The European Medicines Agency (EMA) has decided t... http://t.c…","id":"521965020859863040","possibly_sensitive":false,"created_at":"2014-10-14T10:05:33.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"521964766923726849"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"urls":[{"start":75,"end":97,"url":"http://t.co/nnjQhYWVNY","expanded_url":"http://bit.ly/1sLnZCH","display_url":"bit.ly/1sLnZCH"}],"annotations":[{"start":48,"end":50,"probability":0.4826,"type":"Organization","normalized_text":"EMA"}],"hashtags":{}},"conversation_id":"521964987913633792","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @TOPRANEWS: Publication of clinical reports: EMA adopts landmark policy http://t.co/nnjQhYWVNY","id":"521964987913633792","possibly_sensitive":false,"created_at":"2014-10-14T10:05:25.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"521964765820624898"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"}],"urls":{},"annotations":[{"start":113,"end":118,"probability":0.9526,"type":"Place","normalized_text":"Madrid"}],"hashtags":{}},"conversation_id":"521702679413022722","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_eHealth: Stakeholder Forum of @EU_CHRODIS (the EU Joint Action on #ChronicDiseases) is on 24 Oct. 2014 in Madrid: http://t.co/vpdwME…","id":"521702679413022722","possibly_sensitive":false,"created_at":"2014-10-13T16:43:06.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"521701961788563456"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"MHRApress","id":"330990243"}],"urls":{},"annotations":{},"hashtags":{}},"conversation_id":"521689927546064896","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @MHRApress: 'One Stop Shop' providing regulatory advice for those working in life sciences on regenerative medicines launched http://t.c…","id":"521689927546064896","possibly_sensitive":false,"created_at":"2014-10-13T15:52:25.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"521688675437273088"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"urls":[{"start":118,"end":140,"url":"http://t.co/kIKMpaGYB4","expanded_url":"http://bit.ly/1v3C0vS","display_url":"bit.ly/1v3C0vS"}],"annotations":{},"hashtags":[{"start":66,"end":71,"tag":"CMDh"},{"start":105,"end":117,"tag":"domperidone"}]},"conversation_id":"521689842355548160","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ansm: The French medicines agency has published the September #CMDh minutes: following the review of #domperidone http://t.co/kIKMpaGYB4","id":"521689842355548160","possibly_sensitive":false,"created_at":"2014-10-13T15:52:05.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":104,"end":126,"url":"http://t.co/ATgea720Wk","expanded_url":"http://bit.ly/1tW4vHL","display_url":"bit.ly/1tW4vHL"}],"annotations":{},"hashtags":{}},"conversation_id":"521686922100764673","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"RT @AEMPSGOB: Valproic acid: new recommendations for use for girls and women of child-bearing potential http://t.co/ATgea720Wk","id":"521686922100764673","possibly_sensitive":false,"created_at":"2014-10-13T15:40:29.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":114,"end":136,"url":"http://t.co/YdxTJ7Yjhh","expanded_url":"http://bit.ly/1sx9dit","display_url":"bit.ly/1sx9dit"}],"annotations":{},"hashtags":[{"start":13,"end":22,"tag":"Velphoro"},{"start":86,"end":95,"tag":"dialysis"}]},"conversation_id":"521663386091028480","source":"Bitly","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The EPAR for #Velphoro (polynuclear iron(III)-oxyhydroxide, sucrose and starches) for #dialysis patients is live: http://t.co/YdxTJ7Yjhh","id":"521663386091028480","possibly_sensitive":false,"created_at":"2014-10-13T14:06:57.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"urls":[{"start":114,"end":136,"url":"http://t.co/944y54VGF0","expanded_url":"http://www.nice.org.uk/news/article/tackling-the-rise-in-antibiotic-resistance","display_url":"nice.org.uk/news/article/t…"}],"annotations":{},"hashtags":[{"start":90,"end":111,"tag":"antibioticresistance"}]},"conversation_id":"521658768476893185","source":"TweetDeck","public_metrics":{"retweet_count":50,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @NICEcomms: NICE is developing two new guidelines to help tackle the growing threat of #antibioticresistance: \nhttp://t.co/944y54VGF0","id":"521658768476893185","possibly_sensitive":false,"created_at":"2014-10-13T13:48:37.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"521655193675763712"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"urls":[{"start":71,"end":93,"url":"http://t.co/Lau79o4LPs","expanded_url":"http://ow.ly/CFhrc","display_url":"ow.ly/CFhrc"}],"annotations":{},"hashtags":{}},"conversation_id":"521635870705979394","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @egagenerics: Frequently asked questions about biosimilar medicines http://t.co/Lau79o4LPs","id":"521635870705979394","possibly_sensitive":false,"created_at":"2014-10-13T12:17:37.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"521635625049804800"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":88,"end":110,"url":"http://t.co/2QhJUJk89X","expanded_url":"http://bit.ly/1sp7Wfb","display_url":"bit.ly/1sp7Wfb"}],"annotations":{},"hashtags":[{"start":111,"end":123,"tag":"recruitment"}]},"conversation_id":"521590731732176896","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to apply for our vacancy for an Enterprise Architect in our IT Division: http://t.co/2QhJUJk89X #recruitment","id":"521590731732176896","possibly_sensitive":false,"created_at":"2014-10-13T09:18:15.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":97,"end":119,"url":"http://t.co/7QLj2V1NQ2","expanded_url":"http://bit.ly/1tKNwIh","display_url":"bit.ly/1tKNwIh"}],"annotations":[{"start":69,"end":94,"probability":0.5231,"type":"Organization","normalized_text":"Veterinary Novel Therapies"}],"hashtags":[{"start":121,"end":133,"tag":"recruitment"}]},"conversation_id":"521590495840305152","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to apply for our vacancy for a Scientific Officer for Veterinary Novel Therapies: http://t.co/7QLj2V1NQ2  #recruitment","id":"521590495840305152","possibly_sensitive":false,"created_at":"2014-10-13T09:17:19.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":85,"end":107,"url":"http://t.co/dT7ZBZMOQe","expanded_url":"http://bit.ly/ZKOuNf","display_url":"bit.ly/ZKOuNf"}],"annotations":{},"hashtags":[{"start":72,"end":76,"tag":"SME"}]},"conversation_id":"521590380102688768","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Two weeks left to apply for our vacancy for a Scientific Officer in our #SME Office: http://t.co/dT7ZBZMOQe","id":"521590380102688768","possibly_sensitive":false,"created_at":"2014-10-13T09:16:51.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":74,"end":96,"url":"http://t.co/yKVx9VvGlF","expanded_url":"http://bit.ly/1rmWXQU","display_url":"bit.ly/1rmWXQU"}],"annotations":{},"hashtags":[{"start":98,"end":110,"tag":"recruitment"}]},"conversation_id":"521590266361569280","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to apply to our vacancy for a Continuous Improvement Lead: http://t.co/yKVx9VvGlF  #recruitment","id":"521590266361569280","possibly_sensitive":false,"created_at":"2014-10-13T09:16:24.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":109,"end":131,"url":"http://t.co/BLHE4z7uEW","expanded_url":"http://bit.ly/1q94Aq6","display_url":"bit.ly/1q94Aq6"}],"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"}]},"conversation_id":"521589860977901568","source":"Twitter Web Client","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"#Consultation now open on draft functional specifications for the clinical trials EU portal and EU database: http://t.co/BLHE4z7uEW","id":"521589860977901568","possibly_sensitive":false,"created_at":"2014-10-13T09:14:48.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/A5q9xbxDuB","expanded_url":"http://bit.ly/1q7AGCR","display_url":"bit.ly/1q7AGCR"}],"annotations":{},"hashtags":[{"start":4,"end":22,"tag":"pharmacovigilance"},{"start":93,"end":101,"tag":"Iclusig"},{"start":103,"end":113,"tag":"ponatinib"}]},"conversation_id":"521588796891365376","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Our #pharmacovigilance committee has recommended measures to minimise blood-vessel risk with #Iclusig (#ponatinib): http://t.co/A5q9xbxDuB","id":"521588796891365376","possibly_sensitive":false,"created_at":"2014-10-13T09:10:34.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/39cuipZRxo","expanded_url":"http://bit.ly/1vQWkzM","display_url":"bit.ly/1vQWkzM"}],"annotations":{},"hashtags":[{"start":4,"end":22,"tag":"pharmacovigilance"},{"start":90,"end":103,"tag":"testosterone"},{"start":104,"end":114,"tag":"medicines"}]},"conversation_id":"521588348939685888","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Our #pharmacovigilance committee's review did not confirm increase in heart problems with #testosterone #medicines: http://t.co/39cuipZRxo","id":"521588348939685888","possibly_sensitive":false,"created_at":"2014-10-13T09:08:47.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":117,"end":139,"url":"http://t.co/z2Okem4YNt","expanded_url":"http://bit.ly/10ZQpy1","display_url":"bit.ly/10ZQpy1"}],"annotations":{},"hashtags":[{"start":4,"end":22,"tag":"pharmacovigilance"},{"start":86,"end":96,"tag":"valproate"}]},"conversation_id":"521588157872365568","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Our #pharmacovigilance committee has recommended strengthening restrictions on use of #valproate in women and girls: http://t.co/z2Okem4YNt","id":"521588157872365568","possibly_sensitive":false,"created_at":"2014-10-13T09:08:02.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":108,"end":130,"url":"http://t.co/q4YTAWxqmR","expanded_url":"http://bit.ly/1qyyp2Q","display_url":"bit.ly/1qyyp2Q"}],"annotations":{},"hashtags":[{"start":30,"end":41,"tag":"veterinary"},{"start":42,"end":52,"tag":"medicines"}]},"conversation_id":"521588021209341952","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The highlights of last week's #veterinary #medicines committee (CVMP) meeting are available on our website: http://t.co/q4YTAWxqmR","id":"521588021209341952","possibly_sensitive":false,"created_at":"2014-10-13T09:07:29.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":104,"end":126,"url":"http://t.co/MQ6pkxFioj","expanded_url":"http://bit.ly/1C0MFI0","display_url":"bit.ly/1C0MFI0"}],"annotations":{},"hashtags":[{"start":30,"end":48,"tag":"pharmacovigilance"}]},"conversation_id":"521587649069744128","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The highlights of last week's #pharmacovigilance committee (PRAC) meeting are available on our website: http://t.co/MQ6pkxFioj","id":"521587649069744128","possibly_sensitive":false,"created_at":"2014-10-13T09:06:00.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":78,"end":100,"url":"http://t.co/QK87TYJkZD","expanded_url":"http://bit.ly/1sXO2qJ","display_url":"bit.ly/1sXO2qJ"}],"annotations":{},"hashtags":[{"start":101,"end":114,"tag":"consultation"}]},"conversation_id":"521587387299012608","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Holding public hearings at the EMA. Comment on our draft rules by 15 October: http://t.co/QK87TYJkZD #consultation","id":"521587387299012608","possibly_sensitive":false,"created_at":"2014-10-13T09:04:58.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":92,"end":114,"url":"http://t.co/N9iJcxbV9d","expanded_url":"http://bit.ly/1w0VpvM","display_url":"bit.ly/1w0VpvM"}],"annotations":{},"hashtags":{}},"conversation_id":"521582921313173504","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @LV_MPA: PRAC recommends further restrictions on the use of valproate in women and girls http://t.co/N9iJcxbV9d","id":"521582921313173504","possibly_sensitive":false,"created_at":"2014-10-13T08:47:13.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":111,"end":133,"url":"http://t.co/00azqYmuPh","expanded_url":"http://bit.ly/1w2LEPy","display_url":"bit.ly/1w2LEPy"}],"annotations":{},"hashtags":{}},"conversation_id":"521582415819862016","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @URPLWMiPB: The Polish medicines agency has published its September 2014 medicines bulletin on its website: http://t.co/00azqYmuPh","id":"521582415819862016","possibly_sensitive":false,"created_at":"2014-10-13T08:45:13.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"urls":{},"annotations":{},"hashtags":[{"start":64,"end":76,"tag":"raredisease"}]},"conversation_id":"521581839887380480","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @eurordis: Find out how patients are getting involved in EMA #raredisease benefit-risk marketing authorisation evaluations! http://t.co/…","id":"521581839887380480","possibly_sensitive":false,"created_at":"2014-10-13T08:42:55.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"521563586171510784"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":87,"end":109,"url":"http://t.co/q4YTAWxqmR","expanded_url":"http://bit.ly/1qyyp2Q","display_url":"bit.ly/1qyyp2Q"}],"annotations":{},"hashtags":[{"start":46,"end":57,"tag":"veterinary"},{"start":58,"end":68,"tag":"medicines"}]},"conversation_id":"520649175877582850","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've published the highlights of this week's #veterinary #medicines committee (CVMP): http://t.co/q4YTAWxqmR","id":"520649175877582850","possibly_sensitive":false,"created_at":"2014-10-10T18:56:51.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":117,"end":139,"url":"http://t.co/BLHE4z7uEW","expanded_url":"http://bit.ly/1q94Aq6","display_url":"bit.ly/1q94Aq6"}],"annotations":{},"hashtags":{}},"conversation_id":"520648931886518272","source":"Bitly","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"We've published the draft functional specifications for the clinical trials EU portal and EU database to be audited: http://t.co/BLHE4z7uEW","id":"520648931886518272","possibly_sensitive":false,"created_at":"2014-10-10T18:55:53.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":86,"end":108,"url":"http://t.co/QK87TYJkZD","expanded_url":"http://bit.ly/1sXO2qJ","display_url":"bit.ly/1sXO2qJ"}],"annotations":{},"hashtags":[{"start":109,"end":122,"tag":"consultation"}]},"conversation_id":"520623088434950144","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Public hearings at the EMA: one week left to comment on our draft rules of procedure: http://t.co/QK87TYJkZD #consultation","id":"520623088434950144","possibly_sensitive":false,"created_at":"2014-10-10T17:13:11.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":109,"end":131,"url":"http://t.co/A6KVktBIYq","expanded_url":"http://bit.ly/1s307IH","display_url":"bit.ly/1s307IH"}],"annotations":{},"hashtags":[{"start":42,"end":53,"tag":"veterinary"},{"start":54,"end":64,"tag":"medicines"}]},"conversation_id":"520622486015442944","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Two weeks to comment on draft guidance on #veterinary #medicines for minor use minor species/limited market: http://t.co/A6KVktBIYq","id":"520622486015442944","possibly_sensitive":false,"created_at":"2014-10-10T17:10:48.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":69,"end":91,"url":"http://t.co/yKVx9VvGlF","expanded_url":"http://bit.ly/1rmWXQU","display_url":"bit.ly/1rmWXQU"}],"annotations":{},"hashtags":[{"start":92,"end":104,"tag":"recruitment"}]},"conversation_id":"520621940135174145","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks to apply to our vacancy for a Continuous Improvement Lead: http://t.co/yKVx9VvGlF #recruitment","id":"520621940135174145","possibly_sensitive":false,"created_at":"2014-10-10T17:08:37.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":79,"end":101,"url":"http://t.co/dT7ZBZMOQe","expanded_url":"http://bit.ly/ZKOuNf","display_url":"bit.ly/ZKOuNf"}],"annotations":{},"hashtags":[{"start":66,"end":70,"tag":"SME"}]},"conversation_id":"520620103470444545","source":"Bitly","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks to apply to our vacancy for a Scientific Officer in our #SME Office: http://t.co/dT7ZBZMOQe","id":"520620103470444545","possibly_sensitive":false,"created_at":"2014-10-10T17:01:19.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":91,"end":113,"url":"http://t.co/7QLj2V1NQ2","expanded_url":"http://bit.ly/1tKNwIh","display_url":"bit.ly/1tKNwIh"}],"annotations":[{"start":63,"end":88,"probability":0.5457,"type":"Organization","normalized_text":"Veterinary Novel Therapies"}],"hashtags":[{"start":114,"end":126,"tag":"recruitment"}]},"conversation_id":"520619767406010368","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks to apply to our vacancy for a Scientific Officer for Veterinary Novel Therapies: http://t.co/7QLj2V1NQ2 #recruitment","id":"520619767406010368","possibly_sensitive":false,"created_at":"2014-10-10T16:59:59.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":102,"end":124,"url":"http://t.co/2QhJUJk89X","expanded_url":"http://bit.ly/1sp7Wfb","display_url":"bit.ly/1sp7Wfb"}],"annotations":{},"hashtags":[{"start":125,"end":137,"tag":"recruitment"}]},"conversation_id":"520619547280551936","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks to apply to our vacancy for an Enterprise Architect in our Information Technology Division: http://t.co/2QhJUJk89X #recruitment","id":"520619547280551936","possibly_sensitive":false,"created_at":"2014-10-10T16:59:07.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":118,"end":140,"url":"http://t.co/A5q9xbxDuB","expanded_url":"http://bit.ly/1q7AGCR","display_url":"bit.ly/1q7AGCR"}],"annotations":{},"hashtags":[{"start":4,"end":22,"tag":"pharmacovigilance"},{"start":108,"end":116,"tag":"Iclusig"}]},"conversation_id":"520548242887806976","source":"Bitly","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Our #pharmacovigilance committee recommends further measures to minimise risk of blood vessel blockage with #Iclusig: http://t.co/A5q9xbxDuB","id":"520548242887806976","possibly_sensitive":false,"created_at":"2014-10-10T12:15:47.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":111,"end":133,"url":"http://t.co/39cuipZRxo","expanded_url":"http://bit.ly/1vQWkzM","display_url":"bit.ly/1vQWkzM"}],"annotations":{},"hashtags":[{"start":0,"end":18,"tag":"Pharmacovigilance"},{"start":85,"end":98,"tag":"testosterone"},{"start":99,"end":109,"tag":"medicines"}]},"conversation_id":"520547975777755136","source":"Bitly","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#Pharmacovigilance committee review does not confirm increase in heart problems with #testosterone #medicines: http://t.co/39cuipZRxo","id":"520547975777755136","possibly_sensitive":false,"created_at":"2014-10-10T12:14:43.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":112,"end":134,"url":"http://t.co/z2Okem4YNt","expanded_url":"http://bit.ly/10ZQpy1","display_url":"bit.ly/10ZQpy1"}],"annotations":{},"hashtags":[{"start":4,"end":22,"tag":"pharmacovigilance"},{"start":81,"end":91,"tag":"valproate"}]},"conversation_id":"520547662211592192","source":"Bitly","public_metrics":{"retweet_count":7,"reply_count":1,"like_count":1,"quote_count":0},"lang":"en","text":"Our #pharmacovigilance committee recommends strengthening restrictions on use of #valproate in women and girls: http://t.co/z2Okem4YNt","id":"520547662211592192","possibly_sensitive":false,"created_at":"2014-10-10T12:13:28.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":76,"end":98,"url":"http://t.co/MQ6pkxFioj","expanded_url":"http://bit.ly/1C0MFI0","display_url":"bit.ly/1C0MFI0"}],"annotations":{},"hashtags":[{"start":46,"end":64,"tag":"pharmacovigilance"}]},"conversation_id":"520546877004337154","source":"Bitly","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the highlights of this week's #pharmacovigilance committee: http://t.co/MQ6pkxFioj","id":"520546877004337154","possibly_sensitive":false,"created_at":"2014-10-10T12:10:21.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":88,"end":110,"url":"http://t.co/KMZEObP4u7","expanded_url":"http://bit.ly/1oQo7LM","display_url":"bit.ly/1oQo7LM"}],"annotations":{},"hashtags":[{"start":13,"end":27,"tag":"CallForTender"}]},"conversation_id":"520242859430408193","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSA_EU: #CallForTender – Preparatory work for evidence-based scientific assessment http://t.co/KMZEObP4u7","id":"520242859430408193","possibly_sensitive":false,"created_at":"2014-10-09T16:02:18.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"520242293635579904"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"urls":{},"annotations":{},"hashtags":{}},"conversation_id":"520241265133514752","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @TOPRANEWS: Information on suspected side effects now available through a single website: Information on suspected side ef... http://t.c…","id":"520241265133514752","possibly_sensitive":false,"created_at":"2014-10-09T15:55:57.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"520240984626446336"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"},{"start":118,"end":127,"username":"EMA_News","id":"116716199"}],"urls":{},"annotations":{},"hashtags":{}},"conversation_id":"520238286250721282","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @TOPRANEWS: Suspected adverse drug reactions of an additional 1,700 active substances now available on one website @EMA_News http://t.co…","id":"520238286250721282","possibly_sensitive":false,"created_at":"2014-10-09T15:44:07.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"520234190479302656"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"urls":[{"start":92,"end":114,"url":"http://t.co/9fWffYGhUm","expanded_url":"http://bit.ly/1skIdCY","display_url":"bit.ly/1skIdCY"}],"annotations":{},"hashtags":{}},"conversation_id":"520238212800053248","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @TOPRANEWS: Information on suspected side effects now available through a single website http://t.co/9fWffYGhUm","id":"520238212800053248","possibly_sensitive":false,"created_at":"2014-10-09T15:43:50.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"520233988158259200"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":87,"end":109,"url":"http://t.co/58BIqBzuj0","expanded_url":"http://bit.ly/1xtzcYn","display_url":"bit.ly/1xtzcYn"}],"annotations":{},"hashtags":[{"start":25,"end":32,"tag":"agenda"},{"start":49,"end":60,"tag":"Paediatric"}]},"conversation_id":"520231926909894656","source":"Bitly","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've just published the #agenda for this week's #Paediatric Committee (PDCO) meeting: http://t.co/58BIqBzuj0","id":"520231926909894656","possibly_sensitive":false,"created_at":"2014-10-09T15:18:51.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":[{"start":52,"end":74,"url":"http://t.co/mrmP75WkAo","expanded_url":"http://bit.ly/futuretopics","display_url":"bit.ly/futuretopics"}],"annotations":{},"hashtags":[{"start":75,"end":79,"tag":"CNS"},{"start":80,"end":89,"tag":"diabetes"},{"start":90,"end":106,"tag":"neuropsychiatry"},{"start":107,"end":116,"tag":"vaccines"},{"start":117,"end":127,"tag":"pertussis"},{"start":128,"end":137,"tag":"patients"}]},"conversation_id":"520227742550618112","source":"TweetDeck","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IMI_JU: IMI 2 Call 2 indicative text now online http://t.co/mrmP75WkAo #CNS #diabetes #neuropsychiatry #vaccines #pertussis #patients","id":"520227742550618112","possibly_sensitive":false,"created_at":"2014-10-09T15:02:13.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"520208718374645761"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":{},"annotations":[{"start":68,"end":97,"probability":0.358,"type":"Other","normalized_text":"Disease Prevention and Control"}],"hashtags":{}},"conversation_id":"520226676358541313","source":"TweetDeck","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_EU: Vacancy published: Director of the European Centre for Disease Prevention and Control. Deadline: 5 November http://t.co/Vm3pwE…","id":"520226676358541313","possibly_sensitive":false,"created_at":"2014-10-09T14:57:59.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"520184638904762368"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"urls":[{"start":104,"end":126,"url":"http://t.co/EQVPMkXfe9","expanded_url":"http://www.pharmaceutical-journal.com//news-and-analysis/news/european-medicines-agency-reduces-clinical-trial-secrecy/20066722.fullarticle","display_url":"pharmaceutical-journal.com//news-and-anal…"}],"annotations":[{"start":15,"end":39,"probability":0.4239,"type":"Organization","normalized_text":"European Medicines Agency"}],"hashtags":{}},"conversation_id":"520226269305532417","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EAHPtweet: European Medicines Agency reduces clinical trial secrecy | News | Pharmaceutical Journal http://t.co/EQVPMkXfe9","id":"520226269305532417","possibly_sensitive":false,"created_at":"2014-10-09T14:56:22.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"520174471571709954"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":15,"username":"PedroPedroso81","id":"1223273226"},{"start":16,"end":26,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":116,"end":138,"url":"http://t.co/0detryUayj","expanded_url":"http://bit.ly/1uti0UB","display_url":"bit.ly/1uti0UB"}],"annotations":{},"hashtags":{}},"conversation_id":"520156358734516224","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"@PedroPedroso81 @URPLWMiPB We've invited all companies developing Ebola treatments to contact us. Latest info here: http://t.co/0detryUayj","id":"520218512523268096","possibly_sensitive":false,"created_at":"2014-10-09T14:25:33.000Z","author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"520173838819393537"}],"in_reply_to_user_id":"1223273226","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":118,"end":140,"url":"http://t.co/nMRLFumnXJ","expanded_url":"http://bit.ly/1riJ1CS","display_url":"bit.ly/1riJ1CS"}],"annotations":{},"hashtags":[{"start":94,"end":103,"tag":"vaccines"}]},"conversation_id":"520161893026398208","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Aifa_ufficiale: Italian medicines agency publishes determination for authorisation of flu #vaccines for 2014-2015 http://t.co/nMRLFumnXJ","id":"520161893026398208","possibly_sensitive":false,"created_at":"2014-10-09T10:40:34.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":105,"end":127,"url":"http://t.co/ulOModCAlT","expanded_url":"http://bit.ly/1riHxsj","display_url":"bit.ly/1riHxsj"}],"annotations":{},"hashtags":{}},"conversation_id":"520156358734516224","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"RT @URPLWMiPB: EMA position on the planned review of data on experimental medicines to treat Ebola virus\nhttp://t.co/ulOModCAlT","id":"520156358734516224","possibly_sensitive":false,"created_at":"2014-10-09T10:18:34.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":8,"username":"Eu2P","id":"420241833"}],"urls":[{"start":118,"end":140,"url":"http://t.co/6QaOe7VlHd","expanded_url":"http://elearninginfographics.com/7-questions-ask-joining-online-learning-program-infographic/","display_url":"elearninginfographics.com/7-questions-as…"}],"annotations":[{"start":24,"end":27,"probability":0.4137,"type":"Organization","normalized_text":"Eu2P"}],"hashtags":[{"start":59,"end":77,"tag":"pharmacovigilance"}]},"conversation_id":"520147984219373569","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Eu2P: Interested by Eu2P online training programmes in #pharmacovigilance? Make sure online learning is for you: \nhttp://t.co/6QaOe7VlHd","id":"520147984219373569","possibly_sensitive":false,"created_at":"2014-10-09T09:45:17.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"520147471939694592"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":80,"end":102,"url":"http://t.co/BRfJPZcp67","expanded_url":"http://bit.ly/1ucDP9s","display_url":"bit.ly/1ucDP9s"}],"annotations":[{"start":17,"end":19,"probability":0.6103,"type":"Organization","normalized_text":"EMA"}],"hashtags":[{"start":103,"end":116,"tag":"consultation"}]},"conversation_id":"520146546839810048","source":"Twitter Web Client","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Have your say on EMA public hearings. Comment on our draft rules by 15 October: http://t.co/BRfJPZcp67 #consultation","id":"520146546839810048","possibly_sensitive":false,"created_at":"2014-10-09T09:39:35.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":78,"end":100,"url":"http://t.co/Eo3VuknpZG","expanded_url":"http://bit.ly/1nZn1CC","display_url":"bit.ly/1nZn1CC"}],"annotations":{},"hashtags":[{"start":34,"end":45,"tag":"paediatric"},{"start":67,"end":76,"tag":"oncology"},{"start":101,"end":114,"tag":"consultation"}]},"conversation_id":"520135646472843264","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Comment on our draft inventory of #paediatric therapeutic needs in #oncology: http://t.co/Eo3VuknpZG #consultation","id":"520135646472843264","possibly_sensitive":false,"created_at":"2014-10-09T08:56:16.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":25,"end":34,"username":"EMA_News","id":"116716199"}],"urls":{},"annotations":{},"hashtags":{}},"conversation_id":"520133697308467200","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EAHPtweet: Well done @EMA_News! Citizens &amp; HCPs can now access information on suspected ADRs associated with 100s more medicines http:/…","id":"520133697308467200","possibly_sensitive":false,"created_at":"2014-10-09T08:48:31.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"520133125687357440"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":98,"end":105,"username":"imi_ju","id":"1473203261469790214"}],"urls":[{"start":106,"end":128,"url":"http://t.co/r3bjN5NIjV","expanded_url":"http://imi.efpia.eu","display_url":"imi.efpia.eu"}],"annotations":{},"hashtags":{}},"conversation_id":"520132715417726976","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: The launch of IMI2 marks the beginning of a new and exciting chapter in the IMI story \n@IMI_JU http://t.co/r3bjN5NIjV http://t.c…","id":"520132715417726976","possibly_sensitive":false,"created_at":"2014-10-09T08:44:37.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"520125321937682432"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":115,"end":137,"url":"http://t.co/o9FPlKy0EX","expanded_url":"http://bit.ly/1vOAsVW","display_url":"bit.ly/1vOAsVW"}],"annotations":{},"hashtags":{}},"conversation_id":"520132585654349824","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @URPLWMiPB: Information on the positive risk-benefit ratio for antidepressant Valdoxan / Thymanax (agomelatine) http://t.co/o9FPlKy0EX","id":"520132585654349824","possibly_sensitive":false,"created_at":"2014-10-09T08:44:06.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":104,"end":126,"url":"http://t.co/UCVmipSZ9Y","expanded_url":"http://bit.ly/1yMxTIo","display_url":"bit.ly/1yMxTIo"}],"annotations":{},"hashtags":[{"start":13,"end":27,"tag":"CallForTender"},{"start":41,"end":50,"tag":"journals"},{"start":63,"end":73,"tag":"databases"}]},"conversation_id":"519926662180634624","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSA_EU: #CallForTender – Electronic #journals, electronic #databases and books/e-books acquisition http://t.co/UCVmipSZ9Y","id":"519926662180634624","possibly_sensitive":false,"created_at":"2014-10-08T19:05:50.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"519849708563755008"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"urls":{},"annotations":{},"hashtags":[{"start":21,"end":25,"tag":"FDA"},{"start":67,"end":78,"tag":"Veterinary"}]},"conversation_id":"519926551530713088","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDAanimalhealth: #FDA Issues Final Guidance on Terminology for #Veterinary Medicinal Products Adverse Event Reporting http://t.co/93dJv…","id":"519926551530713088","possibly_sensitive":false,"created_at":"2014-10-08T19:05:24.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"519856325594218496"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"ECDC_Outbreaks","id":"2754484003"}],"urls":[{"start":108,"end":130,"url":"http://t.co/QwOSuoQh59","expanded_url":"http://bit.ly/1yMNVC4","display_url":"bit.ly/1yMNVC4"}],"annotations":[{"start":38,"end":43,"probability":0.9946,"type":"Place","normalized_text":"Europe"},{"start":96,"end":106,"probability":0.9646,"type":"Place","normalized_text":"West Africa"}],"hashtags":[{"start":28,"end":34,"tag":"Ebola"}]},"conversation_id":"519926519578501120","source":"TweetDeck","public_metrics":{"retweet_count":60,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_Outbreaks: Risk of #Ebola to Europe can only be eliminated by stopping the outbreak in West Africa http://t.co/QwOSuoQh59","id":"519926519578501120","possibly_sensitive":false,"created_at":"2014-10-08T19:05:16.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"519858442455248896"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":{},"annotations":{},"hashtags":[{"start":114,"end":124,"tag":"Parkinson"}]},"conversation_id":"519926407104069632","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @euparkinsons: The dopaminergic system in upper limb motor blocks investigated during bimanual coordination in #Parkinson’s disease: htt…","id":"519926407104069632","possibly_sensitive":false,"created_at":"2014-10-08T19:04:49.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"519865303019159552"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"annotations":{},"hashtags":[{"start":56,"end":70,"tag":"Certification"}]},"conversation_id":"519926355438604289","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @edqm_news: The last monthly activity report for the #Certification of Substances Division is now available. September Report: http://t.…","id":"519926355438604289","possibly_sensitive":false,"created_at":"2014-10-08T19:04:37.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"519866336131162113"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"urls":[{"start":104,"end":126,"url":"http://t.co/aprtdHFPHV","expanded_url":"http://ow.ly/Crz5B","display_url":"ow.ly/Crz5B"}],"annotations":{},"hashtags":{}},"conversation_id":"519926295002902528","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @MHRAgovuk: Good Manufacturing Practice (GMP) is one of the ways we ensure the quality of medicines. http://t.co/aprtdHFPHV","id":"519926295002902528","possibly_sensitive":false,"created_at":"2014-10-08T19:04:23.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"519871868673998848"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"FDAWomen","id":"65416742"}],"urls":[{"start":83,"end":105,"url":"http://t.co/H94rN7kvay","expanded_url":"http://ow.ly/BYApd","display_url":"ow.ly/BYApd"}],"annotations":{},"hashtags":[{"start":36,"end":45,"tag":"diabetes"}]},"conversation_id":"519926127876661248","source":"TweetDeck","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDAWomen: 7 million people have #diabetes and do not know it. Learn the signs: http://t.co/H94rN7kvay (via @NDEP)","id":"519926127876661248","possibly_sensitive":false,"created_at":"2014-10-08T19:03:43.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"519887822388752384"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":104,"end":126,"url":"http://t.co/oeoJiA3cbK","expanded_url":"http://bit.ly/1tLJzIV","display_url":"bit.ly/1tLJzIV"}],"annotations":{},"hashtags":[{"start":83,"end":93,"tag":"Myroxylon"},{"start":127,"end":134,"tag":"herbal"}]},"conversation_id":"519925749319733248","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One more week to answer our call for scientific data for use in assessment work on #Myroxylon balsamum: http://t.co/oeoJiA3cbK #herbal","id":"519925749319733248","possibly_sensitive":false,"created_at":"2014-10-08T19:02:13.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":115,"end":137,"url":"http://t.co/LUFiVfMdNo","expanded_url":"http://bit.ly/1mUoCGB","display_url":"bit.ly/1mUoCGB"}],"annotations":{},"hashtags":[{"start":32,"end":42,"tag":"medicines"}]},"conversation_id":"519925682689036288","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Comment on our concept paper on #medicines for prophylaxis of venous thromboembolic risk in non-surgical patients: http://t.co/LUFiVfMdNo","id":"519925682689036288","possibly_sensitive":false,"created_at":"2014-10-08T19:01:57.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":[{"start":117,"end":139,"url":"http://t.co/kGntfgE56x","expanded_url":"http://bit.ly/1txjVF7","display_url":"bit.ly/1txjVF7"}],"annotations":{},"hashtags":[{"start":15,"end":20,"tag":"EDQM"},{"start":44,"end":55,"tag":"Laboratory"}]},"conversation_id":"519869328569958401","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @edqm_news: #EDQM looking to hire Junior #Laboratory Technician to test medicinal products. Full job description: http://t.co/kGntfgE56x…","id":"519869328569958401","possibly_sensitive":false,"created_at":"2014-10-08T15:18:01.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"519869288090705921"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":99,"end":121,"url":"http://t.co/Eo3VuknpZG","expanded_url":"http://bit.ly/1nZn1CC","display_url":"bit.ly/1nZn1CC"}],"annotations":{},"hashtags":[{"start":32,"end":43,"tag":"paediatric"},{"start":88,"end":97,"tag":"oncology"}]},"conversation_id":"519827845456330752","source":"Bitly","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"Comment on a draft inventory of #paediatric therapeutic needs in the area of paediatric #oncology: http://t.co/Eo3VuknpZG","id":"519827845456330752","possibly_sensitive":false,"created_at":"2014-10-08T12:33:10.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":102,"end":124,"url":"http://t.co/BRfJPZcp67","expanded_url":"http://bit.ly/1ucDP9s","display_url":"bit.ly/1ucDP9s"}],"annotations":{},"hashtags":[{"start":125,"end":138,"tag":"transparency"}]},"conversation_id":"519818603001286656","source":"Bitly","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week left to comment on draft rules of procedure for organisation and conduct of public hearings: http://t.co/BRfJPZcp67 #transparency","id":"519818603001286656","possibly_sensitive":false,"created_at":"2014-10-08T11:56:27.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":111,"end":133,"url":"http://t.co/iSABkslRC5","expanded_url":"http://bit.ly/1mUoCGB","display_url":"bit.ly/1mUoCGB"}],"annotations":{},"hashtags":[{"start":28,"end":38,"tag":"medicines"}]},"conversation_id":"519766639311454209","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Comment on concept paper on #medicines for prophylaxis of venous thromboembolic risk in non-surgical patients: http://t.co/iSABkslRC5","id":"519766639311454209","possibly_sensitive":false,"created_at":"2014-10-08T08:29:58.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":99,"end":121,"url":"http://t.co/gOj3Wwxt3r","expanded_url":"http://bit.ly/1tLJzIV","display_url":"bit.ly/1tLJzIV"}],"annotations":{},"hashtags":[{"start":78,"end":88,"tag":"Myroxylon"},{"start":122,"end":129,"tag":"herbal"}]},"conversation_id":"519765770033569794","source":"Bitly","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week to answer our call for scientific data for use in assessment work on #Myroxylon balsamum: http://t.co/gOj3Wwxt3r #herbal","id":"519765770033569794","possibly_sensitive":false,"created_at":"2014-10-08T08:26:31.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":75,"end":97,"url":"http://t.co/2GNqg9cPsA","expanded_url":"http://bit.ly/1vKk20z","display_url":"bit.ly/1vKk20z"}],"annotations":{},"hashtags":[{"start":10,"end":17,"tag":"agenda"},{"start":34,"end":45,"tag":"veterinary"},{"start":46,"end":56,"tag":"medicines"}]},"conversation_id":"519765297826246656","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Check the #agenda for this week's #veterinary #medicines committee (CVMP): http://t.co/2GNqg9cPsA","id":"519765297826246656","possibly_sensitive":false,"created_at":"2014-10-08T08:24:38.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":82,"end":104,"url":"http://t.co/N6fAth6Gew","expanded_url":"http://bit.ly/1nYmJfa","display_url":"bit.ly/1nYmJfa"}],"annotations":{},"hashtags":[{"start":0,"end":8,"tag":"Minutes"},{"start":74,"end":79,"tag":"COMP"}]},"conversation_id":"519764863074066432","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#Minutes available of the July meeting of our orphan medicines committee (#COMP): http://t.co/N6fAth6Gew","id":"519764863074066432","possibly_sensitive":false,"created_at":"2014-10-08T08:22:54.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"urls":{},"annotations":{},"hashtags":{}},"conversation_id":"519531674842202112","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @TOPRANEWS: Human medicines highlights - Issue 67 - September 2014: The September 2014 issue of the European Medicines Age... http://t.c…","id":"519531674842202112","possibly_sensitive":false,"created_at":"2014-10-07T16:56:18.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"519531635138506752"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"urls":[{"start":70,"end":92,"url":"http://t.co/DJ16ufSUP2","expanded_url":"http://bit.ly/1y1L5I6","display_url":"bit.ly/1y1L5I6"}],"annotations":{},"hashtags":{}},"conversation_id":"519525414897995776","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @TOPRANEWS: Human medicines highlights - Issue 67 - September 2014 http://t.co/DJ16ufSUP2","id":"519525414897995776","possibly_sensitive":false,"created_at":"2014-10-07T16:31:25.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"519524391508398080"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"urls":[{"start":79,"end":101,"url":"http://t.co/ZLAl3cOQqd","expanded_url":"http://go.usa.gov/wrsz","display_url":"go.usa.gov/wrsz"}],"annotations":{},"hashtags":{}},"conversation_id":"519519686850256896","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDA_Drug_Info: New! Drug Supply Chain Security Act (DSCSA) draft guidance: http://t.co/ZLAl3cOQqd.","id":"519519686850256896","possibly_sensitive":false,"created_at":"2014-10-07T16:08:40.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"519518677092536320"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":{},"annotations":{},"hashtags":[{"start":81,"end":91,"tag":"medicines"}]},"conversation_id":"519511610508210177","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @euparkinsons: Information on suspected side effects of nationally authorised #medicines now available through a single website: http://…","id":"519511610508210177","possibly_sensitive":false,"created_at":"2014-10-07T15:36:34.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"519498891910066176"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"urls":[{"start":117,"end":139,"url":"http://t.co/7orOQqiMae","expanded_url":"http://bit.ly/1vMBanz","display_url":"bit.ly/1vMBanz"}],"annotations":[{"start":20,"end":22,"probability":0.4556,"type":"Organization","normalized_text":"EMA"}],"hashtags":{}},"conversation_id":"519511357482610688","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"RT @Legemiddelinfo: EMA has started a major effort to collect available information on experimental Ebola medicines: http://t.co/7orOQqiMae","id":"519511357482610688","possibly_sensitive":false,"created_at":"2014-10-07T15:35:34.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"},{"start":71,"end":75,"username":"WHO","id":"14499829"}],"urls":{},"annotations":{},"hashtags":[{"start":26,"end":30,"tag":"flu"}]},"conversation_id":"519511022852648960","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_Flu: Recommended #flu vaccine composition for S-hemisphere by @WHO - what are indications for flu season in N-hemisphere? http://t…","id":"519511022852648960","possibly_sensitive":false,"created_at":"2014-10-07T15:34:14.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"519488005544116224"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":92,"end":114,"url":"http://t.co/chbK0o5j2Q","expanded_url":"http://bit.ly/1nYmJfa","display_url":"bit.ly/1nYmJfa"}],"annotations":{},"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":84,"end":89,"tag":"COMP"}]},"conversation_id":"519485919305695232","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the #minutes of the July meeting of our orphan medicines committee (#COMP): http://t.co/chbK0o5j2Q","id":"519485919305695232","possibly_sensitive":false,"created_at":"2014-10-07T13:54:29.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"FDAWomen","id":"65416742"}],"urls":[{"start":94,"end":116,"url":"http://t.co/905E0i1kX1","expanded_url":"http://ow.ly/CnctW","display_url":"ow.ly/CnctW"}],"annotations":{},"hashtags":{}},"conversation_id":"519484823048843264","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDAWomen: Don't forget to join today's webinar on FDASIA 907 Action Plan today at 1pm ET! http://t.co/905E0i1kX1","id":"519484823048843264","possibly_sensitive":false,"created_at":"2014-10-07T13:50:08.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"519480079022583808"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":44,"end":66,"url":"http://t.co/oUKeViyirZ","expanded_url":"http://bit.ly/1pLBAof","display_url":"bit.ly/1pLBAof"}],"annotations":{},"hashtags":{}},"conversation_id":"519484633919270912","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"RT @URPLWMiPB: Please report side effects!\n\nhttp://t.co/oUKeViyirZ","id":"519484633919270912","possibly_sensitive":false,"created_at":"2014-10-07T13:49:22.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"},{"start":29,"end":38,"username":"EMA_News","id":"116716199"}],"urls":[{"start":93,"end":115,"url":"http://t.co/G1HaYopRMN","expanded_url":"http://bit.ly/1y0vfxi","display_url":"bit.ly/1y0vfxi"}],"annotations":{},"hashtags":{}},"conversation_id":"519483801740005376","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @HAIEurope: Check out the @EMA_News' new leaflet on how to report adverse drug reactions! http://t.co/G1HaYopRMN","id":"519483801740005376","possibly_sensitive":false,"created_at":"2014-10-07T13:46:04.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"519453791629111297"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":82,"end":104,"url":"http://t.co/HMd7Prgw24","expanded_url":"http://bit.ly/1vKk20z","display_url":"bit.ly/1vKk20z"}],"annotations":{},"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":44,"end":55,"tag":"veterinary"}]},"conversation_id":"519442797540438016","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the #agenda for this week's #veterinary committee (CVMP) meeting: http://t.co/HMd7Prgw24","id":"519442797540438016","possibly_sensitive":false,"created_at":"2014-10-07T11:03:08.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":85,"end":107,"url":"http://t.co/aXOx6KT1b4","expanded_url":"http://bit.ly/10FyZql","display_url":"bit.ly/10FyZql"}],"annotations":{},"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":27,"end":45,"tag":"pharmacovigilance"}]},"conversation_id":"519436372932046848","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"The #agenda of this week's #pharmacovigilance committee (PRAC) meeting is available: http://t.co/aXOx6KT1b4","id":"519436372932046848","possibly_sensitive":false,"created_at":"2014-10-07T10:37:36.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":105,"end":127,"url":"http://t.co/GBJXXWORHg","expanded_url":"http://bit.ly/Z8Gbdg","display_url":"bit.ly/Z8Gbdg"}],"annotations":{},"hashtags":[{"start":93,"end":103,"tag":"medicines"}]},"conversation_id":"519436247736254464","source":"Twitter Web Client","public_metrics":{"retweet_count":14,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"A single website now provides information on suspected side effects of nationally authorised #medicines: http://t.co/GBJXXWORHg","id":"519436247736254464","possibly_sensitive":false,"created_at":"2014-10-07T10:37:06.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":108,"end":130,"url":"http://t.co/UKG8EBQg8d","expanded_url":"http://bit.ly/1BIs6jq","display_url":"bit.ly/1BIs6jq"}],"annotations":{},"hashtags":[{"start":27,"end":36,"tag":"patients"},{"start":41,"end":48,"tag":"carers"},{"start":97,"end":106,"tag":"medicine"}]},"conversation_id":"519435892629725185","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"See our latest leaflet for #patients and #carers on how to report a suspected side effect with a #medicine: http://t.co/UKG8EBQg8d","id":"519435892629725185","possibly_sensitive":false,"created_at":"2014-10-07T10:35:42.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":74,"end":96,"url":"http://t.co/dPGEASgVwn","expanded_url":"http://bit.ly/1vGg2go","display_url":"bit.ly/1vGg2go"}],"annotations":{},"hashtags":{}},"conversation_id":"519435800480849921","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The highlights of last week's Management Board meeting are now available: http://t.co/dPGEASgVwn","id":"519435800480849921","possibly_sensitive":false,"created_at":"2014-10-07T10:35:20.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":100,"end":122,"url":"http://t.co/mcj9ViXJ9U","expanded_url":"http://goo.gl/DOPb8w","display_url":"goo.gl/DOPb8w"}],"annotations":{},"hashtags":[{"start":93,"end":99,"tag":"Ebola"}]},"conversation_id":"519435045275463680","source":"TweetDeck","public_metrics":{"retweet_count":79,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: WHO is convening an informal consultation on how science can inform our response to #Ebola http://t.co/mcj9ViXJ9U","id":"519435045275463680","possibly_sensitive":false,"created_at":"2014-10-07T10:32:20.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"519434861409742848"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":{},"annotations":{},"hashtags":[{"start":33,"end":45,"tag":"OpenScience"},{"start":114,"end":123,"tag":"OpenEFSA"}]},"conversation_id":"519434216162222080","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSA_EU: Public consultation #OpenScience at EFSA: 1 week left to comment on the paper  ‘Transformation to an #OpenEFSA’ http://t.co/tx…","id":"519434216162222080","possibly_sensitive":false,"created_at":"2014-10-07T10:29:02.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"519429183362306048"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"},{"start":129,"end":139,"username":"edqm_news","id":"2242197968"}],"urls":{},"annotations":[{"start":90,"end":92,"probability":0.5074,"type":"Organization","normalized_text":"GMP"}],"hashtags":[{"start":106,"end":122,"tag":"50thanniversary"},{"start":123,"end":128,"tag":"EDQM"}]},"conversation_id":"519434010444185600","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @egagenerics: Greater oversight and enforcement through international collaboration on GMP inspections #50thanniversary #EDQM @edqm_news","id":"519434010444185600","possibly_sensitive":false,"created_at":"2014-10-07T10:28:13.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"519425653083766784"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":{},"annotations":{},"hashtags":{}},"conversation_id":"519433145230589953","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @GCessak: EMA: Information on suspected side effects of nationally authorised medicines now available through a single website.http://t.…","id":"519433145230589953","possibly_sensitive":false,"created_at":"2014-10-07T10:24:47.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"519412191540563968"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":70,"end":92,"url":"http://t.co/udc0HLCjG7","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/10/news_detail_002183.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"annotations":{},"hashtags":{}},"conversation_id":"519433063517147137","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @GCessak: EMA Management Board: highlights of October 2014 meeting\nhttp://t.co/udc0HLCjG7","id":"519433063517147137","possibly_sensitive":false,"created_at":"2014-10-07T10:24:27.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"519410358046687233"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"},{"start":131,"end":141,"username":"edqm_news","id":"2242197968"}],"urls":{},"annotations":{},"hashtags":[{"start":101,"end":117,"tag":"50thanniversary"},{"start":118,"end":123,"tag":"EDQM"},{"start":124,"end":130,"tag":"PhEur"}]},"conversation_id":"519402138624327680","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @egagenerics: Regulatory convergence in pharmacopoeias &amp; quality standards should be pursued, #50thanniversary #EDQM #PhEur @edqm_news","id":"519402138624327680","possibly_sensitive":false,"created_at":"2014-10-07T08:21:34.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"519399827416035328"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":{},"annotations":{},"hashtags":{}},"conversation_id":"519402041442328576","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: EFPIA blog \"We are ready to contribute to the development of an innovative Clinical Trials IT infrastructure\" http://t.co/cTSxBz…","id":"519402041442328576","possibly_sensitive":false,"created_at":"2014-10-07T08:21:11.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"519397501460557824"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"},{"start":65,"end":74,"username":"EMA_News","id":"116716199"}],"urls":[{"start":75,"end":97,"url":"http://t.co/zqXfjk0HGo","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2014/10/WC500174806.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"annotations":{},"hashtags":[{"start":32,"end":41,"tag":"patients"}]},"conversation_id":"519401936672784384","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @egagenerics: EGA encourages #patients to report side effects @EMA_news http://t.co/zqXfjk0HGo","id":"519401936672784384","possibly_sensitive":false,"created_at":"2014-10-07T08:20:46.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"519397253384257536"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"},{"start":92,"end":99,"username":"myESMO","id":"69232855"}],"urls":[{"start":69,"end":91,"url":"http://t.co/SGcBgpXTfU","expanded_url":"http://ow.ly/CmtTc","display_url":"ow.ly/CmtTc"}],"annotations":{},"hashtags":[{"start":46,"end":58,"tag":"rarecancers"}]},"conversation_id":"519401568383541248","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @cancereu: RCE consensus position paper on #rarecancers published http://t.co/SGcBgpXTfU @myESMO great example of patients/doctors colla…","id":"519401568383541248","possibly_sensitive":false,"created_at":"2014-10-07T08:19:18.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"519391367823642624"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":88,"end":110,"url":"http://t.co/aXOx6KT1b4","expanded_url":"http://bit.ly/10FyZql","display_url":"bit.ly/10FyZql"}],"annotations":{},"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":43,"end":61,"tag":"pharmacovigilance"}]},"conversation_id":"519163412400840705","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"We've published the #agenda of this week's #pharmacovigilance committee (PRAC) meeting: http://t.co/aXOx6KT1b4","id":"519163412400840705","possibly_sensitive":false,"created_at":"2014-10-06T16:32:57.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"ESEndocrinology","id":"221055586"}],"urls":[{"start":84,"end":106,"url":"http://t.co/vhT9spls3L","expanded_url":"http://dx.doi.org/10.1530/EJE-14-0252","display_url":"dx.doi.org/10.1530/EJE-14…"}],"annotations":{},"hashtags":[{"start":48,"end":53,"tag":"PCOS"},{"start":107,"end":117,"tag":"studiorum"}]},"conversation_id":"519163051334189056","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ESEndocrinology: Read the findings of ESE's #PCOS Special Interest Group survey http://t.co/vhT9spls3L #studiorum","id":"519163051334189056","possibly_sensitive":false,"created_at":"2014-10-06T16:31:31.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"519122209881616385"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"eumsplatform","id":"600110872"}],"urls":{},"annotations":{},"hashtags":[{"start":32,"end":45,"tag":"MSBoston2014"},{"start":109,"end":117,"tag":"ACTRIMS"},{"start":118,"end":126,"tag":"ECTRIMS"}]},"conversation_id":"519162984976101376","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @eumsplatform: Check out our #MSBoston2014 report with key highlights from the insightful and informative #ACTRIMS #ECTRIMS Meeting http…","id":"519162984976101376","possibly_sensitive":false,"created_at":"2014-10-06T16:31:15.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"519126206458109952"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"eupatientsforum","id":"545343465"},{"start":79,"end":88,"username":"EURACTIV","id":"14808226"}],"urls":[{"start":89,"end":111,"url":"http://t.co/qv2FZhVlQH","expanded_url":"http://www.euractiv.com/sections/2014-2019-what-next-eu-healthcare/internet-causing-more-problems-health-literacy-308912","display_url":"euractiv.com/sections/2014-…"}],"annotations":{},"hashtags":{}},"conversation_id":"519162863576174592","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @eupatientsforum: The Internet is causing more problems for health literacy @Euractiv http://t.co/qv2FZhVlQH","id":"519162863576174592","possibly_sensitive":false,"created_at":"2014-10-06T16:30:46.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"519128982860480512"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":{},"annotations":{},"hashtags":[{"start":53,"end":59,"tag":"ebola"}]},"conversation_id":"519162778427621377","source":"TweetDeck","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_EU: New technical report weighs the risk of #ebola transmission via donated blood and other substances of human origin http://t.co…","id":"519162778427621377","possibly_sensitive":false,"created_at":"2014-10-06T16:30:26.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"519132625790066688"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"}],"urls":[{"start":117,"end":139,"url":"http://t.co/fOUDZYKWMK","expanded_url":"http://ow.ly/Ckv7V","display_url":"ow.ly/Ckv7V"}],"annotations":{},"hashtags":[{"start":16,"end":27,"tag":"Healthcare"},{"start":40,"end":57,"tag":"interoperability"},{"start":93,"end":115,"tag":"DigitalMedicalRecords"}]},"conversation_id":"519162702753984512","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_eHealth: #Healthcare issues with #interoperability: \"Doctors Find Barriers to Sharing #DigitalMedicalRecords\" http://t.co/fOUDZYKWMK…","id":"519162702753984512","possibly_sensitive":false,"created_at":"2014-10-06T16:30:08.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"519136742713348096"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"urls":{},"annotations":{},"hashtags":[{"start":124,"end":131,"tag":"GMDP14"}]},"conversation_id":"519162491608506368","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @MHRAgovuk: Nearly fully booked for the Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) Symposium #GMDP14 http://…","id":"519162491608506368","possibly_sensitive":false,"created_at":"2014-10-06T16:29:18.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"519148683917791233"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"},{"start":100,"end":109,"username":"EMA_News","id":"116716199"}],"urls":{},"annotations":[{"start":72,"end":93,"probability":0.7823,"type":"Person","normalized_text":"Anabela de Lima Marçal"}],"hashtags":[{"start":37,"end":47,"tag":"medicines"},{"start":110,"end":126,"tag":"50thanniversary"}]},"conversation_id":"519161879282085890","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @edqm_news: Safety and quality of #medicines is a shared goal, tells Anabela de Lima Marçal from @EMA_News #50thanniversary http://t.co/…","id":"519161879282085890","possibly_sensitive":false,"created_at":"2014-10-06T16:26:52.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"519123610322354176"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":103,"end":125,"url":"http://t.co/6mLP1vukce","expanded_url":"http://bit.ly/1vDehmj","display_url":"bit.ly/1vDehmj"}],"annotations":{},"hashtags":[{"start":4,"end":12,"tag":"minutes"}]},"conversation_id":"519155709339258880","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The #minutes from the July meeting of our Committee for Advanced Therapies (CAT) are available online: http://t.co/6mLP1vukce","id":"519155709339258880","possibly_sensitive":false,"created_at":"2014-10-06T16:02:21.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":111,"end":133,"url":"http://t.co/UKG8EBQg8d","expanded_url":"http://bit.ly/1BIs6jq","display_url":"bit.ly/1BIs6jq"}],"annotations":{},"hashtags":[{"start":30,"end":39,"tag":"patients"},{"start":44,"end":51,"tag":"carers"},{"start":100,"end":109,"tag":"medicine"}]},"conversation_id":"519103548702064640","source":"Bitly","public_metrics":{"retweet_count":14,"reply_count":1,"like_count":1,"quote_count":0},"lang":"en","text":"We've published a leaflet for #patients and #carers on how to report a suspected side effect with a #medicine: http://t.co/UKG8EBQg8d","id":"519103548702064640","possibly_sensitive":false,"created_at":"2014-10-06T12:35:05.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":114,"end":136,"url":"http://t.co/GBJXXWORHg","expanded_url":"http://bit.ly/Z8Gbdg","display_url":"bit.ly/Z8Gbdg"}],"annotations":{},"hashtags":[{"start":63,"end":73,"tag":"medicines"}]},"conversation_id":"519102253245136896","source":"Bitly","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":6,"quote_count":0},"lang":"en","text":"Information on suspected side effects of nationally authorised #medicines now available through a single website: http://t.co/GBJXXWORHg","id":"519102253245136896","possibly_sensitive":false,"created_at":"2014-10-06T12:29:56.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":71,"end":93,"url":"http://t.co/dPGEASgVwn","expanded_url":"http://bit.ly/1vGg2go","display_url":"bit.ly/1vGg2go"}],"annotations":{},"hashtags":{}},"conversation_id":"519101889708064768","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":1,"quote_count":0},"lang":"en","text":"We've published the highlights of our latest Management Board meeting: http://t.co/dPGEASgVwn","id":"519101889708064768","possibly_sensitive":false,"created_at":"2014-10-06T12:28:29.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":16,"end":25,"username":"EMA_News","id":"116716199"}],"urls":{},"annotations":{},"hashtags":[{"start":37,"end":46,"tag":"clinical"},{"start":91,"end":101,"tag":"medicines"},{"start":118,"end":125,"tag":"CTdata"}]},"conversation_id":"519097611962556416","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: .@EMA_News to publish #clinical reports underpinning the decision-making on #medicines from 1 Jan 2015 #CTdata http://t.co/A…","id":"519097611962556416","possibly_sensitive":false,"created_at":"2014-10-06T12:11:29.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"519097064220033024"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":100,"end":122,"url":"http://t.co/KYU22bFVXg","expanded_url":"http://bit.ly/1n7wxDn","display_url":"bit.ly/1n7wxDn"}],"annotations":{},"hashtags":[{"start":38,"end":49,"tag":"veterinary"},{"start":50,"end":60,"tag":"medicines"},{"start":72,"end":83,"tag":"diclofenac"},{"start":124,"end":137,"tag":"consultation"}]},"conversation_id":"519039229075410944","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Comment on the risks to vultures from #veterinary #medicines containing #diclofenac by this Friday: http://t.co/KYU22bFVXg  #consultation","id":"519039229075410944","possibly_sensitive":false,"created_at":"2014-10-06T08:19:30.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":83,"end":105,"url":"http://t.co/b3mpsWA2IR","expanded_url":"http://bit.ly/1vDhu5j","display_url":"bit.ly/1vDhu5j"}],"annotations":{},"hashtags":[{"start":4,"end":15,"tag":"veterinary"}]},"conversation_id":"519038920190091264","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Our #veterinary committee (CVMP) is meeting this week. Highlights out this Friday: http://t.co/b3mpsWA2IR","id":"519038920190091264","possibly_sensitive":false,"created_at":"2014-10-06T08:18:16.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":104,"end":126,"url":"http://t.co/GdbTTutNoM","expanded_url":"http://bit.ly/1tnl0w8","display_url":"bit.ly/1tnl0w8"}],"annotations":{},"hashtags":[{"start":29,"end":37,"tag":"Eryseng"},{"start":38,"end":44,"tag":"Parvo"},{"start":48,"end":59,"tag":"veterinary"},{"start":60,"end":68,"tag":"vaccine"},{"start":73,"end":86,"tag":"parvovirosis"},{"start":91,"end":102,"tag":"erysipelas"}]},"conversation_id":"519038684629581824","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the EPAR for #Eryseng #Parvo, a #veterinary #vaccine for #parvovirosis and #erysipelas: http://t.co/GdbTTutNoM","id":"519038684629581824","possibly_sensitive":false,"created_at":"2014-10-06T08:17:20.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":102,"end":124,"url":"http://t.co/KYU22bFVXg","expanded_url":"http://bit.ly/1n7wxDn","display_url":"bit.ly/1n7wxDn"}],"annotations":{},"hashtags":[{"start":55,"end":66,"tag":"veterinary"},{"start":67,"end":77,"tag":"medicines"},{"start":89,"end":100,"tag":"diclofenac"},{"start":126,"end":139,"tag":"consultation"}]},"conversation_id":"518076650383491072","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"One more week to comment on the risks to vultures from #veterinary #medicines containing #diclofenac: http://t.co/KYU22bFVXg  #consultation","id":"518076650383491072","possibly_sensitive":false,"created_at":"2014-10-03T16:34:33.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":81,"end":103,"url":"http://t.co/b3mpsWA2IR","expanded_url":"http://bit.ly/1vDhu5j","display_url":"bit.ly/1vDhu5j"}],"annotations":{},"hashtags":[{"start":4,"end":15,"tag":"veterinary"}]},"conversation_id":"518075725837250560","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Our #veterinary committee (CVMP) is meeting next week. Highlights out on Friday: http://t.co/b3mpsWA2IR","id":"518075725837250560","possibly_sensitive":false,"created_at":"2014-10-03T16:30:53.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":83,"end":105,"url":"http://t.co/YynVgVxDa0","expanded_url":"http://bit.ly/1rSbLrn","display_url":"bit.ly/1rSbLrn"}],"annotations":{},"hashtags":[{"start":4,"end":22,"tag":"pharmacovigilance"}]},"conversation_id":"518075451684966401","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Our #pharmacovigilance committee (PRAC) meets next week. Highlights out on Friday: http://t.co/YynVgVxDa0","id":"518075451684966401","possibly_sensitive":false,"created_at":"2014-10-03T16:29:47.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":98,"end":120,"url":"http://t.co/6mLP1vukce","expanded_url":"http://bit.ly/1vDehmj","display_url":"bit.ly/1vDehmj"}],"annotations":{},"hashtags":[{"start":20,"end":28,"tag":"minutes"}]},"conversation_id":"518068401806524417","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the #minutes from the July meeting of our Committee for Advanced Therapies (CAT): http://t.co/6mLP1vukce","id":"518068401806524417","possibly_sensitive":false,"created_at":"2014-10-03T16:01:46.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":118,"end":140,"url":"http://t.co/GdbTTutNoM","expanded_url":"http://bit.ly/1tnl0w8","display_url":"bit.ly/1tnl0w8"}],"annotations":{},"hashtags":[{"start":46,"end":57,"tag":"veterinary"},{"start":58,"end":66,"tag":"vaccine"},{"start":67,"end":75,"tag":"Eryseng"},{"start":76,"end":82,"tag":"Parvo"},{"start":87,"end":100,"tag":"parvovirosis"},{"start":105,"end":116,"tag":"erysipelas"}]},"conversation_id":"518066243799375872","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the assessment report for the #veterinary #vaccine #Eryseng #Parvo for #parvovirosis and #erysipelas: http://t.co/GdbTTutNoM","id":"518066243799375872","possibly_sensitive":false,"created_at":"2014-10-03T15:53:12.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":117,"end":139,"url":"http://t.co/fFHetDlaSS","expanded_url":"http://bit.ly/1vA4Yll","display_url":"bit.ly/1vA4Yll"}],"annotations":{},"hashtags":[{"start":17,"end":27,"tag":"guideline"},{"start":56,"end":59,"tag":"3R"}]},"conversation_id":"518055774099353601","source":"Bitly","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Comment on draft #guideline on regulatory acceptance of #3R (Replacement, Reduction, Refinement) testing approaches: http://t.co/fFHetDlaSS","id":"518055774099353601","possibly_sensitive":false,"created_at":"2014-10-03T15:11:36.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":16,"username":"EuropeanLung","id":"121759520"}],"urls":{},"annotations":[{"start":37,"end":38,"probability":0.9754,"type":"Place","normalized_text":"UK"}],"hashtags":[{"start":67,"end":73,"tag":"colds"},{"start":90,"end":97,"tag":"asthma"}]},"conversation_id":"518049999079612417","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EuropeanLung: Researchers in the UK have been looking into why #colds seem to trigger #asthma attacks in people with the condition. htt…","id":"518049999079612417","possibly_sensitive":false,"created_at":"2014-10-03T14:48:39.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"517992704232652800"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":{},"annotations":[{"start":123,"end":128,"probability":0.734,"type":"Place","normalized_text":"London"}],"hashtags":[{"start":26,"end":33,"tag":"autism"}]},"conversation_id":"518049621566685184","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IMI_JU: Medicines for #autism: what are the ethical/social implications? Join our EU-AIMS project for a debate, 22/10, London http://t.…","id":"518049621566685184","possibly_sensitive":false,"created_at":"2014-10-03T14:47:09.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"518020563227660288"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"},{"start":40,"end":49,"username":"Anses_fr","id":"1108628533"}],"urls":{},"annotations":[{"start":119,"end":124,"probability":0.9915,"type":"Place","normalized_text":"France"}],"hashtags":[{"start":100,"end":111,"tag":"pesticides"}]},"conversation_id":"518049513731551233","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSA_EU: Still time to register for @Anses_fr &amp; EFSA conference on occupational exposure to #pesticides, 28 Oct in France  http://t.co/…","id":"518049513731551233","possibly_sensitive":false,"created_at":"2014-10-03T14:46:43.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"518026938456481793"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"ESEndocrinology","id":"221055586"}],"urls":[{"start":104,"end":126,"url":"http://t.co/YDzuef9inS","expanded_url":"http://dx.doi.org/10.1530/EJE-14-0067","display_url":"dx.doi.org/10.1530/EJE-14…"}],"annotations":[{"start":62,"end":71,"probability":0.9619,"type":"Person","normalized_text":"F. Santini"}],"hashtags":[{"start":21,"end":29,"tag":"Thyroid"},{"start":34,"end":42,"tag":"obesity"}]},"conversation_id":"518049404679618560","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ESEndocrinology: #Thyroid and #obesity - is there a link? F. Santini et al. review the relationship http://t.co/YDzuef9inS http://t.co/…","id":"518049404679618560","possibly_sensitive":false,"created_at":"2014-10-03T14:46:17.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"518033777247809537"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":87,"end":96,"username":"EMA_News","id":"116716199"}],"urls":[{"start":98,"end":120,"url":"http://t.co/eDaT3l6PkG","expanded_url":"http://bit.ly/1tkm5Vz","display_url":"bit.ly/1tkm5Vz"}],"annotations":{},"hashtags":[{"start":0,"end":7,"tag":"CTdata"}]},"conversation_id":"517987102139887616","source":"Bitly","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#CTdata policy: redaction decisions of any part of a clinical study report is taken by @EMA_News: http://t.co/eDaT3l6PkG","id":"517987102139887616","possibly_sensitive":false,"created_at":"2014-10-03T10:38:43.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":0,"end":16,"username":"egonwillighagen","id":"22911650"}],"urls":[{"start":95,"end":117,"url":"http://t.co/vFiMc2DY1V","expanded_url":"http://bit.ly/YYE4c9","display_url":"bit.ly/YYE4c9"}],"annotations":{},"hashtags":{}},"conversation_id":"517954714395480064","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"@egonwillighagen See our Q&amp;A which includes a definition of commercial purposes on page 5: http://t.co/vFiMc2DY1V","id":"517986616460476419","possibly_sensitive":false,"created_at":"2014-10-03T10:36:47.000Z","author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"517956602616639488"}],"in_reply_to_user_id":"22911650","attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":90,"end":112,"url":"http://t.co/YynVgVxDa0","expanded_url":"http://bit.ly/1rSbLrn","display_url":"bit.ly/1rSbLrn"}],"annotations":{},"hashtags":[{"start":4,"end":22,"tag":"pharmacovigilance"}]},"conversation_id":"517977044966453248","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Our #pharmacovigilance committee (PRAC) is meeting next week. Highlights out next Friday: http://t.co/YynVgVxDa0","id":"517977044966453248","possibly_sensitive":false,"created_at":"2014-10-03T09:58:45.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":86,"end":108,"url":"http://t.co/CDXWDV7EB1","expanded_url":"http://bit.ly/10mjFih","display_url":"bit.ly/10mjFih"}],"annotations":{},"hashtags":[{"start":33,"end":44,"tag":"veterinary"},{"start":45,"end":53,"tag":"vaccine"},{"start":54,"end":62,"tag":"Eryseng"},{"start":73,"end":84,"tag":"erysipelas"}]},"conversation_id":"517976546657964032","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the EPAR for the #veterinary #vaccine #Eryseng for swine #erysipelas: http://t.co/CDXWDV7EB1","id":"517976546657964032","possibly_sensitive":false,"created_at":"2014-10-03T09:56:46.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":104,"end":126,"url":"http://t.co/eDaT3l6PkG","expanded_url":"http://bit.ly/1tkm5Vz","display_url":"bit.ly/1tkm5Vz"}],"annotations":{},"hashtags":[{"start":0,"end":7,"tag":"CTdata"},{"start":39,"end":50,"tag":"innovation"},{"start":79,"end":89,"tag":"medicines"}]},"conversation_id":"517969956194250752","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"#CTdata policy: access to data fosters #innovation and increases efficiency of #medicines development : http://t.co/eDaT3l6PkG","id":"517969956194250752","possibly_sensitive":false,"created_at":"2014-10-03T09:30:35.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":102,"end":124,"url":"http://t.co/eDaT3l6PkG","expanded_url":"http://bit.ly/1tkm5Vz","display_url":"bit.ly/1tkm5Vz"}],"annotations":{},"hashtags":[{"start":0,"end":7,"tag":"CTdata"}]},"conversation_id":"517966720477450241","source":"Twitter Web Client","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"#CTdata policy: Unprecedented access to clinical data benefits patients, doctors, academia, industry: http://t.co/eDaT3l6PkG","id":"517966720477450241","possibly_sensitive":false,"created_at":"2014-10-03T09:17:44.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":108,"end":130,"url":"http://t.co/eDaT3l6PkG","expanded_url":"http://bit.ly/1tkm5Vz","display_url":"bit.ly/1tkm5Vz"}],"annotations":{},"hashtags":[{"start":0,"end":7,"tag":"CTdata"}]},"conversation_id":"517954714395480064","source":"Twitter Web Client","public_metrics":{"retweet_count":11,"reply_count":1,"like_count":5,"quote_count":0},"lang":"en","text":"#CTdata policy: Public can download, save, print clinical reports for academic and non-commercial research: http://t.co/eDaT3l6PkG","id":"517954714395480064","possibly_sensitive":false,"created_at":"2014-10-03T08:30:01.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":85,"end":107,"url":"http://t.co/eDaT3l6PkG","expanded_url":"http://bit.ly/1tkm5Vz","display_url":"bit.ly/1tkm5Vz"}],"annotations":{},"hashtags":[{"start":0,"end":7,"tag":"CTdata"}]},"conversation_id":"517947542911590400","source":"Twitter Web Client","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"#CTdata policy effective from 1 January 2015; applies to all new applications to us: http://t.co/eDaT3l6PkG","id":"517947542911590400","possibly_sensitive":false,"created_at":"2014-10-03T08:01:31.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":104,"end":126,"url":"http://t.co/eDaT3l6PkG","expanded_url":"http://bit.ly/1tkm5Vz","display_url":"bit.ly/1tkm5Vz"}],"annotations":[{"start":0,"end":2,"probability":0.4362,"type":"Organization","normalized_text":"EMA"}],"hashtags":[{"start":51,"end":58,"tag":"ctdata"},{"start":89,"end":102,"tag":"transparency"}]},"conversation_id":"517940491305095168","source":"Twitter Web Client","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"EMA is going to publish clinical reports; landmark #ctdata policy sets new standards for #transparency: http://t.co/eDaT3l6PkG","id":"517940491305095168","possibly_sensitive":false,"created_at":"2014-10-03T07:33:30.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":57,"end":79,"url":"http://t.co/eDaT3l6PkG","expanded_url":"http://bit.ly/1tkm5Vz","display_url":"bit.ly/1tkm5Vz"}],"annotations":{},"hashtags":[{"start":0,"end":7,"tag":"CTdata"}]},"conversation_id":"517722125378260992","source":"Bitly","public_metrics":{"retweet_count":7,"reply_count":1,"like_count":2,"quote_count":0},"lang":"en","text":"#CTdata policy: access to data builds trust in our work: http://t.co/eDaT3l6PkG","id":"517722125378260992","possibly_sensitive":false,"created_at":"2014-10-02T17:05:48.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":104,"end":126,"url":"http://t.co/eDaT3l6PkG","expanded_url":"http://bit.ly/1tkm5Vz","display_url":"bit.ly/1tkm5Vz"}],"annotations":{},"hashtags":[{"start":0,"end":7,"tag":"CTdata"},{"start":39,"end":50,"tag":"innovation"},{"start":79,"end":89,"tag":"medicines"}]},"conversation_id":"517720155418554368","source":"Bitly","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#CTdata policy: access to data fosters #innovation and increases efficiency of #medicines development : http://t.co/eDaT3l6PkG","id":"517720155418554368","possibly_sensitive":false,"created_at":"2014-10-02T16:57:58.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":102,"end":124,"url":"http://t.co/eDaT3l6PkG","expanded_url":"http://bit.ly/1tkm5Vz","display_url":"bit.ly/1tkm5Vz"}],"annotations":{},"hashtags":[{"start":0,"end":7,"tag":"CTdata"}]},"conversation_id":"517718650816827393","source":"Bitly","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"#CTdata policy: Unprecedented access to clinical data benefits patients, doctors, academia, industry: http://t.co/eDaT3l6PkG","id":"517718650816827393","possibly_sensitive":false,"created_at":"2014-10-02T16:51:59.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":17,"username":"EuroParlPress","id":"199196447"}],"urls":[{"start":70,"end":92,"url":"http://t.co/JFrHp7Cc65","expanded_url":"http://bit.ly/1r2suD3","display_url":"bit.ly/1r2suD3"},{"start":113,"end":135,"url":"http://t.co/bL4BEdySxL","expanded_url":"http://bit.ly/1uEdPFq","display_url":"bit.ly/1uEdPFq"}],"annotations":{},"hashtags":[{"start":38,"end":53,"tag":"EPhearings2014"},{"start":57,"end":67,"tag":"Georgieva"},{"start":99,"end":110,"tag":"Bienkowska"}]},"conversation_id":"517714416784392192","source":"Twitter Web App","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EuroParlPress: View the storified #EPhearings2014 of #Georgieva : http://t.co/JFrHp7Cc65 &amp; #Bienkowska : http://t.co/bL4BEdySxL","id":"517714416784392192","possibly_sensitive":false,"created_at":"2014-10-02T16:35:10.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"517713982850080768"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":108,"end":130,"url":"http://t.co/eDaT3l6PkG","expanded_url":"http://bit.ly/1tkm5Vz","display_url":"bit.ly/1tkm5Vz"}],"annotations":{},"hashtags":[{"start":0,"end":7,"tag":"CTdata"}]},"conversation_id":"517712743475195904","source":"Bitly","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"#CTdata policy: Public can download, save, print clinical reports for academic and non-commercial research: http://t.co/eDaT3l6PkG","id":"517712743475195904","possibly_sensitive":false,"created_at":"2014-10-02T16:28:31.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":85,"end":107,"url":"http://t.co/eDaT3l6PkG","expanded_url":"http://bit.ly/1tkm5Vz","display_url":"bit.ly/1tkm5Vz"}],"annotations":{},"hashtags":[{"start":0,"end":7,"tag":"CTdata"}]},"conversation_id":"517711313519513600","source":"Bitly","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"#CTdata policy effective from 1 January 2015; applies to all new applications to us: http://t.co/eDaT3l6PkG","id":"517711313519513600","possibly_sensitive":false,"created_at":"2014-10-02T16:22:50.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":104,"end":126,"url":"http://t.co/eDaT3l6PkG","expanded_url":"http://bit.ly/1tkm5Vz","display_url":"bit.ly/1tkm5Vz"}],"annotations":[{"start":0,"end":2,"probability":0.4362,"type":"Organization","normalized_text":"EMA"}],"hashtags":[{"start":51,"end":58,"tag":"Ctdata"},{"start":89,"end":102,"tag":"transparency"}]},"conversation_id":"517709133160914944","source":"Bitly","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"EMA is going to publish clinical reports; landmark #Ctdata policy sets new standards for #transparency: http://t.co/eDaT3l6PkG","id":"517709133160914944","possibly_sensitive":false,"created_at":"2014-10-02T16:14:10.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"urls":{},"annotations":[{"start":29,"end":31,"probability":0.8857,"type":"Organization","normalized_text":"FDA"}],"hashtags":[{"start":93,"end":108,"tag":"ClinicalTrials"}]},"conversation_id":"517689511753818112","source":"TweetDeck","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDA_Drug_Info: Learn how FDA will help improve data and representation for minorities in #ClinicalTrials at a webinar on 10/7 http://t.…","id":"517689511753818112","possibly_sensitive":false,"created_at":"2014-10-02T14:56:12.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"517686639481868288"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"urls":{},"annotations":{},"hashtags":[{"start":21,"end":25,"tag":"FDA"},{"start":105,"end":110,"tag":"Food"},{"start":121,"end":129,"tag":"Animals"}]},"conversation_id":"517678762125967362","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDAanimalhealth: #FDA Annual Summary Report on Antimicrobials Sold or Distributed in 2012 for Use in #Food-Producing #Animals http://t.…","id":"517678762125967362","possibly_sensitive":false,"created_at":"2014-10-02T14:13:29.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"517673154173747201"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"urls":[{"start":100,"end":122,"url":"http://t.co/SirsvYtYuo","expanded_url":"http://go.usa.gov/vnsH","display_url":"go.usa.gov/vnsH"}],"annotations":[{"start":54,"end":56,"probability":0.7958,"type":"Organization","normalized_text":"FDA"}],"hashtags":[{"start":12,"end":21,"tag":"FDAVoice"}]},"conversation_id":"517678663710834688","source":"TweetDeck","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @US_FDA: #FDAVoice: New Data Dashboard Tool Shares FDA’s Inspection, Compliance and Recall Data  http://t.co/SirsvYtYuo","id":"517678663710834688","possibly_sensitive":false,"created_at":"2014-10-02T14:13:06.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"517671621893840896"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":[{"start":110,"end":132,"url":"http://t.co/IzqY7AmuVk","expanded_url":"http://bit.ly/1qUhtU7","display_url":"bit.ly/1qUhtU7"}],"annotations":{},"hashtags":[{"start":13,"end":19,"tag":"Ebola"}]},"conversation_id":"517665331062796288","source":"TweetDeck","public_metrics":{"retweet_count":51,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_EU: #Ebola: without interventions &amp; behaviour change, projections show increasing trend in cases http://t.co/IzqY7AmuVk http://t.c…","id":"517665331062796288","possibly_sensitive":false,"created_at":"2014-10-02T13:20:07.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"517660882604929024"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":99,"end":121,"url":"http://t.co/CDXWDV7EB1","expanded_url":"http://bit.ly/10mjFih","display_url":"bit.ly/10mjFih"}],"annotations":{},"hashtags":[{"start":46,"end":57,"tag":"veterinary"},{"start":58,"end":66,"tag":"vaccine"},{"start":85,"end":96,"tag":"erysipelas"}]},"conversation_id":"517654528922255360","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the assessment report for the #veterinary #vaccine Eryseng for swine #erysipelas:\n http://t.co/CDXWDV7EB1","id":"517654528922255360","possibly_sensitive":false,"created_at":"2014-10-02T12:37:11.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":17,"username":"EuroParlPress","id":"199196447"},{"start":60,"end":72,"username":"EP_Industry","id":"951326846"},{"start":79,"end":95,"username":"EP_SingleMarket","id":"951348098"}],"urls":[{"start":111,"end":133,"url":"http://t.co/pcrjGpYf77","expanded_url":"http://bit.ly/1qxWnuO","display_url":"bit.ly/1qxWnuO"}],"annotations":{},"hashtags":[{"start":24,"end":39,"tag":"EPHearings2014"},{"start":43,"end":54,"tag":"Bienkowska"}]},"conversation_id":"517639258275061760","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EuroParlPress: NOW: #EPHearings2014 of #Bienkowska from @EP_Industry &amp; @EP_SingleMarket starts. LIVE:  http://t.co/pcrjGpYf77  &amp; http:/…","id":"517639258275061760","possibly_sensitive":false,"created_at":"2014-10-02T11:36:31.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"517637667014467584"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":92,"end":114,"url":"http://t.co/WAMYbjuvu6","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Agenda/2014/10/WC500174575.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"annotations":{},"hashtags":{}},"conversation_id":"517633151909502977","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @GCessak: Agenda of today's Management Board of EMA meeting is available on EMA website: http://t.co/WAMYbjuvu6","id":"517633151909502977","possibly_sensitive":false,"created_at":"2014-10-02T11:12:15.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"517632966693249024"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":69,"end":91,"url":"http://t.co/16g826jReA","expanded_url":"http://bit.ly/1vzSsTO","display_url":"bit.ly/1vzSsTO"}],"annotations":{},"hashtags":[{"start":45,"end":52,"tag":"agenda"}]},"conversation_id":"517631090140655616","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"Our Management Board is meeting now: see the #agenda on our website: http://t.co/16g826jReA","id":"517631090140655616","possibly_sensitive":false,"created_at":"2014-10-02T11:04:03.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":116,"end":138,"url":"http://t.co/v1tDAY2oEX","expanded_url":"http://www.europarl.europa.eu/ep-live/pl/committees/video?event=20141002-1330-COMMITTEE-HEARING2014EB","display_url":"europarl.europa.eu/ep-live/pl/com…"}],"annotations":{},"hashtags":[{"start":104,"end":115,"tag":"Bieńkowska"}]},"conversation_id":"517630833872879616","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @GCessak: Hearing of Commissioner for Internal Market, Industry, Entrepreneurship and SMEs: Elżbieta #Bieńkowska http://t.co/v1tDAY2oEX","id":"517630833872879616","possibly_sensitive":false,"created_at":"2014-10-02T11:03:02.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"517630179305615362"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":77,"end":99,"url":"http://t.co/16g826jReA","expanded_url":"http://bit.ly/1vzSsTO","display_url":"bit.ly/1vzSsTO"}],"annotations":{},"hashtags":[{"start":4,"end":11,"tag":"agenda"}]},"conversation_id":"517624036361506816","source":"Bitly","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The #agenda of today's Management Board meeting is available on our website: http://t.co/16g826jReA","id":"517624036361506816","possibly_sensitive":false,"created_at":"2014-10-02T10:36:01.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":113,"end":135,"url":"http://t.co/3rWsxM7P2L","expanded_url":"http://bit.ly/1mRpcY6","display_url":"bit.ly/1mRpcY6"}],"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":27,"end":37,"tag":"guideline"},{"start":47,"end":54,"tag":"plasma"},{"start":93,"end":102,"tag":"factorIX"}]},"conversation_id":"517600757844312064","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#Consultation open our our #guideline on human #plasma-derived &amp; recombinant coagulation #factorIX products: http://t.co/3rWsxM7P2L","id":"517600757844312064","possibly_sensitive":false,"created_at":"2014-10-02T09:03:31.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":117,"end":139,"url":"http://t.co/npqMwQOSTt","expanded_url":"http://bit.ly/1oAAOtS","display_url":"bit.ly/1oAAOtS"}],"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":56,"end":66,"tag":"guideline"},{"start":81,"end":91,"tag":"medicines"},{"start":107,"end":115,"tag":"colitis"}]},"conversation_id":"517599888151183360","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#Consultation open on our concept paper on revising the #guideline on developing #medicines for ulcerative #colitis: http://t.co/npqMwQOSTt","id":"517599888151183360","possibly_sensitive":false,"created_at":"2014-10-02T09:00:04.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"urls":{},"annotations":{},"hashtags":{}},"conversation_id":"517599716226629632","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @MHRAmedicines: Simplified information requirements for advertising medicines to prescribers and suppliers, and updated Blue Guide: http…","id":"517599716226629632","possibly_sensitive":false,"created_at":"2014-10-02T08:59:23.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"517599481618235392"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":114,"end":136,"url":"http://t.co/P7ei4XDZbo","expanded_url":"http://bit.ly/1thRMPp","display_url":"bit.ly/1thRMPp"}],"annotations":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":56,"end":66,"tag":"guideline"},{"start":81,"end":91,"tag":"medicines"},{"start":96,"end":102,"tag":"Crohn"}]},"conversation_id":"517599188012777472","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#Consultation now open on concept paper on revising the #guideline on developing #medicines for #Crohn’s disease: http://t.co/P7ei4XDZbo","id":"517599188012777472","possibly_sensitive":false,"created_at":"2014-10-02T08:57:17.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":15,"end":21,"username":"Bayer","id":"137319302"},{"start":22,"end":29,"username":"US_FDA","id":"208120290"},{"start":30,"end":45,"username":"invimacolombia","id":"374557401"}],"urls":[{"start":99,"end":121,"url":"http://t.co/gLQN0i0f7t","expanded_url":"http://bit.ly/XSfuFS","display_url":"bit.ly/XSfuFS"}],"annotations":{},"hashtags":{}},"conversation_id":"517166175290417153","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"@ChaoticPharma @bayer @US_FDA @invimacolombia We only deal with medicines and not medical devices: http://t.co/gLQN0i0f7t","id":"517590624909148160","possibly_sensitive":false,"created_at":"2014-10-02T08:23:16.000Z","author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"517166175290417153"}],"in_reply_to_user_id":"513331314","attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":{},"annotations":{},"hashtags":{}},"conversation_id":"517582351728402432","source":"TweetDeck","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @GCessak: At the 85th meeting of the Management Board. Main topics are EMA policy on publication of access to clinical-trial data &amp;EMA m…","id":"517582351728402432","possibly_sensitive":false,"created_at":"2014-10-02T07:50:23.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"517582147256066049"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/npqMwQOSTt","expanded_url":"http://bit.ly/1oAAOtS","display_url":"bit.ly/1oAAOtS"}],"annotations":{},"hashtags":[{"start":51,"end":61,"tag":"guideline"},{"start":80,"end":90,"tag":"medicines"},{"start":106,"end":114,"tag":"colitis"}]},"conversation_id":"517382031765172224","source":"Bitly","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've issued a draft concept paper on revising the #guideline on developing new #medicines for ulcerative #colitis: http://t.co/npqMwQOSTt","id":"517382031765172224","possibly_sensitive":false,"created_at":"2014-10-01T18:34:23.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/P7ei4XDZbo","expanded_url":"http://bit.ly/1thRMPp","display_url":"bit.ly/1thRMPp"}],"annotations":{},"hashtags":[{"start":54,"end":64,"tag":"guideline"},{"start":83,"end":93,"tag":"medicines"},{"start":98,"end":104,"tag":"Crohn"}]},"conversation_id":"517381670547496960","source":"Bitly","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published a draft concept paper on revising the #guideline on developing new #medicines for #Crohn’s disease: http://t.co/P7ei4XDZbo","id":"517381670547496960","possibly_sensitive":false,"created_at":"2014-10-01T18:32:57.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":{},"urls":[{"start":121,"end":143,"url":"http://t.co/3rWsxM7P2L","expanded_url":"http://bit.ly/1mRpcY6","display_url":"bit.ly/1mRpcY6"}],"annotations":{},"hashtags":[{"start":21,"end":31,"tag":"guideline"},{"start":55,"end":62,"tag":"plasma"}]},"conversation_id":"517381200655417344","source":"Bitly","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've issued a draft #guideline on core SmPC for human #plasma derived &amp; recombinant coagulation factor IX products: http://t.co/3rWsxM7P2L","id":"517381200655417344","possibly_sensitive":false,"created_at":"2014-10-01T18:31:05.000Z","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"urls":[{"start":107,"end":129,"url":"http://t.co/l6G1zxFo11","expanded_url":"http://go.usa.gov/vkqh","display_url":"go.usa.gov/vkqh"}],"annotations":[{"start":63,"end":65,"probability":0.8394,"type":"Organization","normalized_text":"FDA"}],"hashtags":{}},"conversation_id":"517380590975598592","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @US_FDA: Here is the latest Patient Network Newsletter from FDA with all the most recent health updates http://t.co/l6G1zxFo11","id":"517380590975598592","possibly_sensitive":false,"created_at":"2014-10-01T18:28:40.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"517334207786262528"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":10,"username":"Uroweb","id":"114455333"}],"urls":{},"annotations":[{"start":50,"end":55,"probability":0.9543,"type":"Place","normalized_text":"Madrid"},{"start":86,"end":91,"probability":0.9709,"type":"Place","normalized_text":"Europe"}],"hashtags":[{"start":40,"end":46,"tag":"EAU15"},{"start":103,"end":114,"tag":"urological"}]},"conversation_id":"517380568120852481","source":"TweetDeck","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Uroweb: Online registration for the #EAU15 in Madrid has opened! Get a preview of Europe's biggest #urological event http://t.co/p3m03X…","id":"517380568120852481","possibly_sensitive":false,"created_at":"2014-10-01T18:28:34.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"517335256727552000"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":19,"username":"ESEndocrinology","id":"221055586"}],"urls":{},"annotations":{},"hashtags":[{"start":57,"end":65,"tag":"ECE2015"}]},"conversation_id":"517380522251911168","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ESEndocrinology: Abstract submission is now open for #ECE2015! Head to this link for all the details on the congress http://t.co/E3X7SW…","id":"517380522251911168","possibly_sensitive":false,"created_at":"2014-10-01T18:28:23.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"517335633472126976"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"urls":{},"annotations":{},"hashtags":[{"start":15,"end":20,"tag":"EDQM"},{"start":111,"end":121,"tag":"reference"},{"start":122,"end":132,"tag":"standards"}]},"conversation_id":"517380506695237632","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @edqm_news: #EDQM looking for a project coordinator to work on construction of a secondary storage site for #reference #standards http:/…","id":"517380506695237632","possibly_sensitive":false,"created_at":"2014-10-01T18:28:19.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"517335407977959424"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":{},"annotations":{},"hashtags":[{"start":21,"end":27,"tag":"Ebola"}]},"conversation_id":"517380457890320384","source":"TweetDeck","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_EU: Once an #Ebola case is detected and infection control measures implemented, risk of transmission is very low:  http://t.co/qkn…","id":"517380457890320384","possibly_sensitive":false,"created_at":"2014-10-01T18:28:08.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"517338705498234880"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"urls":{},"annotations":{},"hashtags":[{"start":32,"end":37,"tag":"MERS"},{"start":77,"end":82,"tag":"Hajj"},{"start":122,"end":129,"tag":"Europe"}]},"conversation_id":"517380381927288833","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_Flu: ECDC will enhance #MERS-CoV surveillance activities around the #Hajj to detect early any possible threat to #Europe http://t.…","id":"517380381927288833","possibly_sensitive":false,"created_at":"2014-10-01T18:27:50.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"517342404223844353"}],"attachments":{"media_keys":{}}},{"entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"urls":{},"annotations":{},"hashtags":[{"start":96,"end":108,"tag":"RareDisease"},{"start":109,"end":118,"tag":"EYRD2019"}]},"conversation_id":"517380289543553026","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @eurordis: Webinar: Get involved in the exciting campaign to make 2019 the European Year for #RareDisease #EYRD2019 http://t.co/FVYKTV06…","id":"517380289543553026","possibly_sensitive":false,"created_at":"2014-10-01T18:27:28.000Z","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"517343899632021504"}],"attachments":{"media_keys":{}}}]
